<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Viruses</journal-id><journal-id journal-id-type="iso-abbrev">Viruses</journal-id><journal-id journal-id-type="publisher-id">viruses</journal-id><journal-title-group><journal-title>Viruses</journal-title></journal-title-group><issn pub-type="epub">1999-4915</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7232439</article-id><article-id pub-id-type="doi">10.3390/v12040376</article-id><article-id pub-id-type="publisher-id">viruses-12-00376</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Host&#x02013;Virus Interaction: How Host Cells Defend against Influenza A Virus Infection</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5497-0107</contrib-id><name><surname>Zhang</surname><given-names>Yun</given-names></name><xref ref-type="aff" rid="af1-viruses-12-00376">1</xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Zhichao</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cao</surname><given-names>Yongchang</given-names></name><xref rid="c1-viruses-12-00376" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-viruses-12-00376">State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou 510006, China; <email>zhangyun6@mail.sysu.edu.cn</email> (Y.Z.); <email>wsxzc35@163.com</email> (Z.X.)</aff><author-notes><corresp id="c1-viruses-12-00376"><label>*</label>Correspondence: <email>caoych@mail.sysu.edu.cn</email>; Tel.: +86-020-39332938</corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>3</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2020</year></pub-date><volume>12</volume><issue>4</issue><elocation-id>376</elocation-id><history><date date-type="received"><day>28</day><month>2</month><year>2020</year></date><date date-type="accepted"><day>25</day><month>3</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Influenza A viruses (IAVs) are highly contagious pathogens infecting human and numerous animals. The viruses cause millions of infection cases and thousands of deaths every year, thus making IAVs a continual threat to global health. Upon IAV infection, host innate immune system is triggered and activated to restrict virus replication and clear pathogens. Subsequently, host adaptive immunity is involved in specific virus clearance. On the other hand, to achieve a successful infection, IAVs also apply multiple strategies to avoid be detected and eliminated by the host immunity. In the current review, we present a general description on recent work regarding different host cells and molecules facilitating antiviral defenses against IAV infection and how IAVs antagonize host immune responses. </p></abstract><kwd-group><kwd>influenza A virus</kwd><kwd>innate immunity</kwd><kwd>adaptive immunity</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-viruses-12-00376"><title>1. Introduction</title><p>Influenza A virus (IAV) can infect a wide range of warm-blooded animals, including birds, pigs, horses, and humans. In humans, the viruses cause respiratory disease and be transmitted by inhalation of virus-containing dust particles or aerosols [<xref rid="B1-viruses-12-00376" ref-type="bibr">1</xref>]. Severe IAV infection can cause lung inflammation and acute respiratory distress syndrome (ARDS), which may lead to mortality. Thus, causing many influenza epidemics and pandemics, IAV has been a threat to public health for decades [<xref rid="B2-viruses-12-00376" ref-type="bibr">2</xref>].</p><p>The virus is an enveloped, segmented, negative-strand RNA virus, belonging to the <italic>Orthomyxoviriae</italic> family. The eight viral gene segments encode as many as 18 proteins. Besides polymerase basic 1 (PB1), PB1-N40, PB1-F2, PB2, polymerase acid (PA), hemagglutinin (HA), nucleoprotein (NP), neuraminidase (NA), matrix 1 (M1), matrix 2 (M2), nonstructural protein 1 (NS1) and NS2 (also known as nuclear export protein, NEP), new viral proteins were recently uncovered, such as PB2-S1 [<xref rid="B3-viruses-12-00376" ref-type="bibr">3</xref>], PA-X (product of ribosomal frameshifting) [<xref rid="B4-viruses-12-00376" ref-type="bibr">4</xref>], PA-related proteins PA-N155 and PA-N182 [<xref rid="B5-viruses-12-00376" ref-type="bibr">5</xref>], M42 [<xref rid="B6-viruses-12-00376" ref-type="bibr">6</xref>], and NS3 [<xref rid="B7-viruses-12-00376" ref-type="bibr">7</xref>]. HA, NA, and M2 proteins constitute surface of the IAV virion, where HA is the most abundant surface protein. According to the genetic and antigenic diversity of the HA and NA proteins, IAVs were divided into 18 HA and 11 NA subtypes. H17N10 and H18N11 subtypes were recently identified in bats [<xref rid="B8-viruses-12-00376" ref-type="bibr">8</xref>,<xref rid="B9-viruses-12-00376" ref-type="bibr">9</xref>].</p><sec id="sec1dot1-viruses-12-00376"><title>1.1. IAV Viral Proteins</title><p>HA is a type I glycosylated protein, which is responsible for virus entry to host cell. Functional HA protein is a homotrimer structurally composed of a stem region and a globular head region in each monomer. The head region bearing N-acetylneuraminic acid (sialic acid, SA) binding pocket is critical for receptor attachment, and contains most antigenic determinants. The stem region undergoing conformational changes is responsible for low pH-triggered membrane fusion [<xref rid="B10-viruses-12-00376" ref-type="bibr">10</xref>], and plays an important role in cross protection against heterosubtypic IAV infection [<xref rid="B11-viruses-12-00376" ref-type="bibr">11</xref>]. N38 glycan at this region is critical for elicitation of cross-group antibody responses [<xref rid="B12-viruses-12-00376" ref-type="bibr">12</xref>]. HA of diverse IAV subtypes that originated from different species presents distinct receptor-binding preference. For instance, human viruses prefer binding to SAs attached to cell-surface-associated &#x003b1;-2,6-linked galactose, whereas avian viruses prefer &#x003b1;-2,3-linked galactose [<xref rid="B13-viruses-12-00376" ref-type="bibr">13</xref>,<xref rid="B14-viruses-12-00376" ref-type="bibr">14</xref>,<xref rid="B15-viruses-12-00376" ref-type="bibr">15</xref>]. Residue substitutions in the receptor-binding site (RBS) of HA is crucial in determining receptor-binding properties [<xref rid="B16-viruses-12-00376" ref-type="bibr">16</xref>]. For instance, amino acid substitutions of S138A/G186V/T221P/Q226L within the RBS affected receptor-binding properties of avian H7N9 HA [<xref rid="B17-viruses-12-00376" ref-type="bibr">17</xref>], while G186V was reported to be pivotal for the avian-specific strain to acquire human receptor-binding capacity [<xref rid="B18-viruses-12-00376" ref-type="bibr">18</xref>].</p><p>NA is a type II glycoprotein with neuraminidase (sialidase) enzymatic activity. Each NA tetramer consists of four identical polypeptides, and each polypeptide contains an N-terminal, a hydrophobic membrane domain, a stalk region, and a globular head domain. NA can cleave SA from the mucus, cell surface, and from viral glycoproteins. While HA mediates virion-SA attachment and fusion, NA is responsible for terminal SA residues cleavage [<xref rid="B19-viruses-12-00376" ref-type="bibr">19</xref>]. N-glycolyl and O-acetyl modification of SA could reduce binding affinities of both NA and HA [<xref rid="B20-viruses-12-00376" ref-type="bibr">20</xref>]. In addition, NA possesses at least two calcium binding sites [<xref rid="B21-viruses-12-00376" ref-type="bibr">21</xref>]. Gene analysis of these Ca<sup>2+</sup> binding sites reveals that they are related to NA thermostability, further suggesting a correlation between NA thermostability and virus adaption [<xref rid="B22-viruses-12-00376" ref-type="bibr">22</xref>]. Furthermore, NA is also the major antigenic target of the host humoral immunity, and NA-specific antibodies function in limiting virus egress via interfering with the sialidase activity have drawn wide attention for development of antiviral therapies [<xref rid="B23-viruses-12-00376" ref-type="bibr">23</xref>,<xref rid="B24-viruses-12-00376" ref-type="bibr">24</xref>].</p><p>The viral ribonucleoprotein complex (vRNP) is a rod-shaped structure composed of multiple copies of NP and a single trimeric RNA-dependent RNA polymerase complex (PB1, PB2, and PA) associated with viral genomic RNA [<xref rid="B25-viruses-12-00376" ref-type="bibr">25</xref>]. NP mediates nuclear import of the vRNP complex, the PB1 subunit has the catalytic polymerase activity, the PB2 subunit contributes to cap binding, and the PA subunit is required for cleavage of the capped oligonucleotides. The complex is required for the transcription and replication of the viral genome [<xref rid="B26-viruses-12-00376" ref-type="bibr">26</xref>]. The structure, functions, and modulation of the IAV RNA polymerase complex were further discussed by Te Velthuis and Fordor [<xref rid="B27-viruses-12-00376" ref-type="bibr">27</xref>]. However, the mechanism of vRNP assembly remains largely unknown and several host proteins were reported to be involved during IAV infection [<xref rid="B28-viruses-12-00376" ref-type="bibr">28</xref>,<xref rid="B29-viruses-12-00376" ref-type="bibr">29</xref>,<xref rid="B30-viruses-12-00376" ref-type="bibr">30</xref>]. Recently, eleuthe roside B<sub>1</sub> was demonstrated to be able to inhibit the vRNP in vitro [<xref rid="B31-viruses-12-00376" ref-type="bibr">31</xref>].</p><p>M1 and M2 are encoded by the <italic>M</italic> gene on segment 7 of the viral genome [<xref rid="B32-viruses-12-00376" ref-type="bibr">32</xref>]. The conserved M1 bears a positively charged nuclear localization sequence (NLS) motif RKLKR, which is essential for membrane binding, virus replication, nuclear export of the vRNPs, and self-polymerization [<xref rid="B33-viruses-12-00376" ref-type="bibr">33</xref>]. M2 is a type III integral transmembrane proton channel, structurally containing three domains: an amino-terminal ectodomain, a transmembrane domain, and a cytoplasmic domain [<xref rid="B34-viruses-12-00376" ref-type="bibr">34</xref>]. It is essential for uncoating the vRNP complex within the endosome, the process of which is essential for viral entry [<xref rid="B35-viruses-12-00376" ref-type="bibr">35</xref>]. Moreover, in its retrograde migration route from the membrane to the cytoplasm, M2 was shown to prevent endosome fusion with the lysosome, suggesting new roles of the protein in the host cytoplasm after infection [<xref rid="B36-viruses-12-00376" ref-type="bibr">36</xref>].</p><p>NS1, structurally composed of an N-terminal dsRNA binding domain and a C-terminal effector domain, plays important roles in control of viral RNA synthesis, viral mRNA splicing, and virus particle morphogenesis during the virus life cycle [<xref rid="B37-viruses-12-00376" ref-type="bibr">37</xref>,<xref rid="B38-viruses-12-00376" ref-type="bibr">38</xref>]. It is also considered as the key factor to antagonize host immune system [<xref rid="B39-viruses-12-00376" ref-type="bibr">39</xref>], since it could inhibit activation of retinoic acid-inducible gene-I proteins (RIG-I), interferon-inducible RNA-dependent protein kinase (PKR), and 2&#x02032;-5&#x02032;-oligoadenylate synthetase of the innate immunity via blocking nuclear export of host messenger RNAs (mRNAs) [<xref rid="B40-viruses-12-00376" ref-type="bibr">40</xref>,<xref rid="B41-viruses-12-00376" ref-type="bibr">41</xref>,<xref rid="B42-viruses-12-00376" ref-type="bibr">42</xref>]. The mechanism underlying is revealed by determination of crystal structure of the NS1 and nuclear RNA export factor 1-nuclear transport factor 2-related export protein 1 (NXF1-NXT1) complex that NS1 could prevent mRNA export through the nuclear pore complex via binding of NXF1-NXT1 to nucleoporins [<xref rid="B43-viruses-12-00376" ref-type="bibr">43</xref>]. Conserved RNA secondary structures at RNA positions 82-148 and 497-564 are essential for NS1 protein expression, thus affecting viral reproduction and virus&#x02013;host interaction processes [<xref rid="B44-viruses-12-00376" ref-type="bibr">44</xref>]. A detailed description of structure and function of the NS1 was reviewed by Han and his colleagues [<xref rid="B45-viruses-12-00376" ref-type="bibr">45</xref>]. NS2, also known as NEP, contains a nuclear export signal and is responsible for chromosome region maintenance 1 (Crm1)-dependent nuclear export of RNPs in the infected cells [<xref rid="B46-viruses-12-00376" ref-type="bibr">46</xref>,<xref rid="B47-viruses-12-00376" ref-type="bibr">47</xref>]. Crm1 contains leucin-rich nuclear export signals (NES1 and NES2) [<xref rid="B47-viruses-12-00376" ref-type="bibr">47</xref>,<xref rid="B48-viruses-12-00376" ref-type="bibr">48</xref>], which are important for the NS2Crm1 interaction [<xref rid="B46-viruses-12-00376" ref-type="bibr">46</xref>,<xref rid="B48-viruses-12-00376" ref-type="bibr">48</xref>]. In addition, interaction of CHD3 and NES1 was identified to be important in the NS2-mediated vRNP nuclear export [<xref rid="B49-viruses-12-00376" ref-type="bibr">49</xref>].</p></sec><sec id="sec1dot2-viruses-12-00376"><title>1.2. Antigenic Shift and Antigenic Drift</title><p>Genome reassortment often occurs when two or more IAV strains infect a single host cell. This phenomenon is refereed as antigenic shift, resulting in novel progeny viruses with new HA and/or NA that are immunologically na&#x000ef;ve to the human immune system [<xref rid="B50-viruses-12-00376" ref-type="bibr">50</xref>,<xref rid="B51-viruses-12-00376" ref-type="bibr">51</xref>]. On the other hand, lack of proof-reading function of viral RNA polymerase results in accumulated point mutations during successive replication of the viral genome. This phenomenon is refereed as antigenic drift [<xref rid="B52-viruses-12-00376" ref-type="bibr">52</xref>]. The two mechanisms provide IAVs the ability to evolve rapidly as well as to evade host immunity, thus resulting in generation of viral strains which are highly pathogenic and/or can cross species barriers.</p><p>Since the &#x0201c;Spanish influenza&#x0201d; pandemic in 1918&#x02013;1919, despite application of updating licensed vaccines and drugs, seasonal and pandemic influenza still cause millions of infection cases each year and remains a worldwide public-health concern. Most seasonal IAV infections are minimally symptomatic, while severe infection causes damage to host immune responses, thus resulting in lung inflammation and injury [<xref rid="B53-viruses-12-00376" ref-type="bibr">53</xref>]. The virus itself, IAV&#x02013;host interaction, as well as a need for next-generation IAV prevention and control strategies attract extensive attention worldwide. Understanding the virus&#x02013;host interaction can facilitate investigation of antiviral measures. Therefore, in the current review, we summarized and discussed recent development in our understanding of IAV&#x02013;host immune interaction and how IAV antagonizes different immune responses to achieve a successful infection.</p></sec></sec><sec id="sec2-viruses-12-00376"><title>2. Influenza A Virus Host Adaption and Life Cycle</title><sec id="sec2dot1-viruses-12-00376"><title>2.1. Influenza A Virus Host Switch Events</title><p>IAVs can infect a broad spectrum of host species, including both wild and domestic birds, as well as many mammalian species. The virus is capable of interspecies transmission to new species. However, no interspecies transmission of the bat IAVs has been reported so far [<xref rid="B54-viruses-12-00376" ref-type="bibr">54</xref>]. Furthermore, the high frequency of mutations and recombination increases the risk of IAV adaptation in humans. Besides three pandemic subtypes (H1N1, H2N2, and H3N2), other subtypes, including H5N1, H5N6, H7N7, H7N9, N9N2, and H10N8 could cross the species barrier and cause human infections [<xref rid="B55-viruses-12-00376" ref-type="bibr">55</xref>,<xref rid="B56-viruses-12-00376" ref-type="bibr">56</xref>,<xref rid="B57-viruses-12-00376" ref-type="bibr">57</xref>,<xref rid="B58-viruses-12-00376" ref-type="bibr">58</xref>]. Several effect factors are essential in IAV host switch events, including the receptor-binding properties of HA [<xref rid="B16-viruses-12-00376" ref-type="bibr">16</xref>], as well as cellular receptors [<xref rid="B59-viruses-12-00376" ref-type="bibr">59</xref>,<xref rid="B60-viruses-12-00376" ref-type="bibr">60</xref>,<xref rid="B61-viruses-12-00376" ref-type="bibr">61</xref>,<xref rid="B62-viruses-12-00376" ref-type="bibr">62</xref>]. Long and his colleagues summarized the role of host factors in IAVs adaption to humans, and the review is recommended here for further reading [<xref rid="B63-viruses-12-00376" ref-type="bibr">63</xref>].</p><p>Noteworthy is the fact that most phylogenetically diverse IAVs with different origins could successfully replicate in swine [<xref rid="B64-viruses-12-00376" ref-type="bibr">64</xref>]. Since pigs have both SA &#x003b1;-2,6 and SA &#x003b1;-2,3 galactose receptors [<xref rid="B65-viruses-12-00376" ref-type="bibr">65</xref>], they can serve as a suitable mixing reservoir for both human and avian IAVs, thus raising global concern on periodic zoonotic infections. Take the emergence of influenza A (H1N1) pdm09 (pH1N1) and influenza A (H3N2) A/Canada/1158/2006 strains for instance, both strains are swine-origin IAVs and were the consequence of adaption and reassortment of several swine lineages [<xref rid="B66-viruses-12-00376" ref-type="bibr">66</xref>,<xref rid="B67-viruses-12-00376" ref-type="bibr">67</xref>]. Furthermore, some genes of these strains originated from avian IAVs [<xref rid="B68-viruses-12-00376" ref-type="bibr">68</xref>].</p><p>With the development of gene sequencing technology, machine learning (ML) facilitated with large genomic datasets are used in prediction about sequence changes in newly invaded viruses from other animal hosts, take the &#x0201c;Batch-Learning Self-Organizing Map (BLSOM)&#x0201d; method for instance [<xref rid="B69-viruses-12-00376" ref-type="bibr">69</xref>]. ML is also applied in characterization of distinct host tropism protein signatures [<xref rid="B70-viruses-12-00376" ref-type="bibr">70</xref>], and prediction of amino acid changes for interspecies transmission [<xref rid="B71-viruses-12-00376" ref-type="bibr">71</xref>]. These studies provided measures in identification of potential high-risk strains. In addition, the nucleotides and dinucleotide compositions of viruses play important roles in prediction of viral host species [<xref rid="B72-viruses-12-00376" ref-type="bibr">72</xref>]. Combining gene sequencing technology and ML methods, researchers applied large IAV genomic datasets to analyze species selection bias of IAV mono-/dinucleotide composition and predict human-adaptive swine or avian IAVs [<xref rid="B73-viruses-12-00376" ref-type="bibr">73</xref>,<xref rid="B74-viruses-12-00376" ref-type="bibr">74</xref>]. The application of multi-disciplinary subjects would provide useful information for prediction of pandemic influenza.</p></sec><sec id="sec2dot2-viruses-12-00376"><title>2.2. Life Cycle of Influenza A Virus</title><p>In general, the life cycle of the IAV is generally divided into four steps: virus entry into the host cell, transcription and replication of the viral genome, assembly, and virus budding. Though alveolar epithelial cell is the primary target cell for IAVs, different IAV subtypes have different patterns of viral attachment (PVA). For human IAVs, Alveolar type II epithelial cells, as well as immune cells such as alveolar macrophages and dendritic cells, are major target cells for an established infection [<xref rid="B75-viruses-12-00376" ref-type="bibr">75</xref>,<xref rid="B76-viruses-12-00376" ref-type="bibr">76</xref>]. Two seasonal IAVs and pandemic H1N1 virus, preferred to attach to ciliated epithelial cells and goblet cells in the upper respiratory tract (URT), and avian IAVs, take H5N1 for instance, attached seldom to these cells [<xref rid="B77-viruses-12-00376" ref-type="bibr">77</xref>]. In the lower respiratory tract (LRT), human IAV H1N1 and H3N2 attached to more cell types than avian IAV H5N1, a highly pathogenic avian IAV (HPAIV) strain. However, H5N1 could bind to type II pneumocytes [<xref rid="B78-viruses-12-00376" ref-type="bibr">78</xref>]. Considering the fact that metabolism in the type II pneumocytes is quite active, infection of HPAIVs is more likely to cause severe pneumonia [<xref rid="B78-viruses-12-00376" ref-type="bibr">78</xref>]. Other research on low pathogenic avian IAVs (LPAIVs), which generally do not cause severe pneumonia, showed that these viruses usually attach to human submucosal gland cells, thus can be cleared by the mucus [<xref rid="B79-viruses-12-00376" ref-type="bibr">79</xref>].</p><p>IAV infection starts from recognition of SA by HA protein, though in vitro research claimed that these N-linked glycans were not essential for virus entry [<xref rid="B80-viruses-12-00376" ref-type="bibr">80</xref>]. The cleavage of HA precursor protein HA0 into HA1 (containing receptor binding domain) and HA2 (containing fusion peptide) in low pH environment during HA transport is critical for virion internalization [<xref rid="B81-viruses-12-00376" ref-type="bibr">81</xref>]. Some research showed that type II transmembrane serine protease such as transmembrane protease serine 2 (TMPRSS2), human airway trypsin-like protease (HAT), transmembrane protease serine 4 (TMPRSS4), Homo sapiens serine protease DESC1 and Homo sapiens transmembrane protease, serine 13 (MSPL) can cleave human and avian IAV HA proteins at an arginine residue [<xref rid="B82-viruses-12-00376" ref-type="bibr">82</xref>]. In addition, for avian IAVs, HA0 of HPAIVs can be cleaved by subtilisin-like protease, while that of LPAIVs is cleaved by trypsin-like proteases [<xref rid="B83-viruses-12-00376" ref-type="bibr">83</xref>] or thrombin [<xref rid="B84-viruses-12-00376" ref-type="bibr">84</xref>]. Therefore, in avian IAVs, the cleavage sites are considered to be the major determinants for virus virulence [<xref rid="B85-viruses-12-00376" ref-type="bibr">85</xref>], and RNA folding in the cleavage region could be an important factor for virulence determination [<xref rid="B86-viruses-12-00376" ref-type="bibr">86</xref>,<xref rid="B87-viruses-12-00376" ref-type="bibr">87</xref>].</p><p>Proteins in the vRNP complex contain different nuclear localization signals (NLSs), thus helping the vRNP complex to enter the host cell nucleus via active transport, take the Crm1-dependent pathway for instance [<xref rid="B88-viruses-12-00376" ref-type="bibr">88</xref>]. The acidic environment of the endosome also activates M2 ion channel, hence acidifies the viral core, resulting in entrance of vRNP complex into the host cell [<xref rid="B34-viruses-12-00376" ref-type="bibr">34</xref>]. Replication of viral genome does not require a primer but a full-length complementary RNA (cRNA), which is essential for the newly formed vRNP complex. The viral RNA polymerases first bind to the 3&#x02032; end and the 5&#x02032; end of the segmented viral RNA and cRNA, respectively, then start replication with the help of the 5&#x02032; cap of host pre-mRNAs via a PB1-PB2-mediated &#x0201c;cap snatching&#x0201d; mechanism [<xref rid="B27-viruses-12-00376" ref-type="bibr">27</xref>,<xref rid="B89-viruses-12-00376" ref-type="bibr">89</xref>]. The conserved segment-specific nucleotides at the 3&#x02032; and 5&#x02032; ends of the viral genome could modulate genome expression and replication during infection [<xref rid="B90-viruses-12-00376" ref-type="bibr">90</xref>]. In addition, dephosphorylation at a specific position of the H1N1 NS1 protein results in attenuated virus replication [<xref rid="B91-viruses-12-00376" ref-type="bibr">91</xref>].</p><p>Mature viral mRNAs are transported to the cytoplasm by a &#x0201c;daisy-chain&#x0201d; complex and translated subsequently [<xref rid="B88-viruses-12-00376" ref-type="bibr">88</xref>,<xref rid="B92-viruses-12-00376" ref-type="bibr">92</xref>]. New synthesis of HA occurs on the rough endoplasmic reticulum (ER). Glycosylation and palmitoylation of the protein are completed later in the Golgi [<xref rid="B93-viruses-12-00376" ref-type="bibr">93</xref>,<xref rid="B94-viruses-12-00376" ref-type="bibr">94</xref>]. After synthesis and maturation of NA and M2 proteins, the trans-Golgi network (TGN), together with coat protein I (COPI) complex and GTPase Rab proteins, transport the newly synthesized HA, NA, and M2 proteins to the apical plasma membrane (PM). These proteins then assemble with viral genomic segments. The virions are finally closed and M1 and M2 proteins mediate virion budding from the apical side of the cells [<xref rid="B28-viruses-12-00376" ref-type="bibr">28</xref>,<xref rid="B95-viruses-12-00376" ref-type="bibr">95</xref>,<xref rid="B96-viruses-12-00376" ref-type="bibr">96</xref>,<xref rid="B97-viruses-12-00376" ref-type="bibr">97</xref>,<xref rid="B98-viruses-12-00376" ref-type="bibr">98</xref>]. NA protein cleavages the SA residues, which allows the virions to be released from the plasma membrane [<xref rid="B99-viruses-12-00376" ref-type="bibr">99</xref>].</p><p>Since IAV has a relatively small genome, host machinery is required in order to accomplish the viral life cycle. To uncover host dependency factors that are necessary for IAV replication, numerous large-scale RNA interference (RNAi) screens and genome-wide CRISPR/Cas 9 screen were performed [<xref rid="B29-viruses-12-00376" ref-type="bibr">29</xref>,<xref rid="B100-viruses-12-00376" ref-type="bibr">100</xref>,<xref rid="B101-viruses-12-00376" ref-type="bibr">101</xref>,<xref rid="B102-viruses-12-00376" ref-type="bibr">102</xref>,<xref rid="B103-viruses-12-00376" ref-type="bibr">103</xref>]. For instance, SON DNA binding protein was important for IAV virion trafficking in an early infection stage and CDC-like kinase 1 facilitated AIV replication [<xref rid="B29-viruses-12-00376" ref-type="bibr">29</xref>]. USP47 facilitated viral entry, whereas TNFSF12 (APRIL) and TNFSF12-TNFSF13 (TWEPRIL) helped with viral replication [<xref rid="B101-viruses-12-00376" ref-type="bibr">101</xref>]. Using genome-wide CRISPR/Cas9 screen, several genes of sialic acid biosynthesis and related glycosylation pathways were involved with H5N1 infection [<xref rid="B102-viruses-12-00376" ref-type="bibr">102</xref>], and WDR7, CCDC115, and TMEM199 were essential for viral entry and regulation of V-type ATPase assembly [<xref rid="B103-viruses-12-00376" ref-type="bibr">103</xref>]. Furthermore, single-cell transcriptome sequencing (RNA-seq) was applied to explore host&#x02013;virus interactions, revealing a correlation between defective viral genomes and virus-induced host transcriptional programs [<xref rid="B104-viruses-12-00376" ref-type="bibr">104</xref>]. These data provide valuable information for developing host-targeted therapeutics.</p></sec></sec><sec id="sec3-viruses-12-00376"><title>3. Host Immune Responses Against IAV Infection</title><p>Host immune system functions immediately after detection of the virus. Host mucosal immune system (MIS), induced after virus invasion, serves as the first line to prevent IAV from adhering to the susceptible cells. In the URT, mucosal response is induced in the naso-associated lymphoid tissues (NALT), while in the LRT, it occurs in bronchus-associated lymphoid tissues (BALT). Host innate immunity, including phagocytic cells, interferons (IFNs), proinflammatory cytokines, etc., applies multiple mechanisms in defending IAV infection [<xref rid="B105-viruses-12-00376" ref-type="bibr">105</xref>]. Host adaptive immunity, mediated by B lymphocytes and T lymphocytes, together with other immune mechanisms, reacts specifically to neutralize and eliminate the virus. On the other hand, to establish a successful infection, IAVs also employ a plethora of strategies to avoid being detected or being cleared by the host immunity. Notable strategies include regulation of IFN signaling [<xref rid="B106-viruses-12-00376" ref-type="bibr">106</xref>], inhibition of cytokine expressions [<xref rid="B107-viruses-12-00376" ref-type="bibr">107</xref>,<xref rid="B108-viruses-12-00376" ref-type="bibr">108</xref>], modulation of apoptosis [<xref rid="B109-viruses-12-00376" ref-type="bibr">109</xref>,<xref rid="B110-viruses-12-00376" ref-type="bibr">110</xref>,<xref rid="B111-viruses-12-00376" ref-type="bibr">111</xref>], interference of autophagy [<xref rid="B112-viruses-12-00376" ref-type="bibr">112</xref>], and effects on antibody production [<xref rid="B113-viruses-12-00376" ref-type="bibr">113</xref>]. The IAV&#x02013;host immunity interaction was summarized by several reviews [<xref rid="B114-viruses-12-00376" ref-type="bibr">114</xref>,<xref rid="B115-viruses-12-00376" ref-type="bibr">115</xref>].</p><sec id="sec3dot1-viruses-12-00376"><title>3.1. Immune Cells Involved in IAV Infection</title><p>Upon detection of infection, innate effector cells, including natural killer (NK) cells, neutrophils, and dendritic cells (DCs), etc., are recruited to the infected sites. NK cells are large granular lymphocytes, making up 10% of the resident lymphocytes in the lung. After recruitment from the blood, NK cells interact with DCs and macrophages to secret various cytokines and restrict infection via lysis of the IAV-infected cells. The lysis process is mediated by interaction between NK receptors p46 (most NKp46) and IAV HA protein expressed by the infected cell [<xref rid="B116-viruses-12-00376" ref-type="bibr">116</xref>,<xref rid="B117-viruses-12-00376" ref-type="bibr">117</xref>]. Interestingly, liver NK cells other than lung NK cells possessed a memory phenotype to protect mice against subsequent IAV infection, though the lung NK cells are important in control of primary IAV infection [<xref rid="B118-viruses-12-00376" ref-type="bibr">118</xref>]. However, NK cells are also shown to exacerbate IAV pathology, since depletion of NK cells led to increased resistance to high dose H1N1 infection in mice [<xref rid="B119-viruses-12-00376" ref-type="bibr">119</xref>,<xref rid="B120-viruses-12-00376" ref-type="bibr">120</xref>]. The contribution of NK cells to anti-IAV defense in mouse models was later shown to be strain and dose dependent. In addition, the host genetic background also played an important role [<xref rid="B121-viruses-12-00376" ref-type="bibr">121</xref>].</p><p>Neutrophils are key innate immune cells recruited to infection sites by cellular migration through vascular endothelium. They function in clearance of pathogens via phagocytosis, producing extracellular traps, and degranulation [<xref rid="B122-viruses-12-00376" ref-type="bibr">122</xref>]. In addition, they also regulate adaptive immunity via guiding influenza specific CD8<sup>+</sup> T cells to the infection sites [<xref rid="B123-viruses-12-00376" ref-type="bibr">123</xref>].</p><p>The function of dendritic cells (DCs) is to monitor invading pathogens. After IAV infection, the conventional DCs migrate from lung to lymph nodes through interaction between CCR7 and its ligand, and present antigens to T cells [<xref rid="B124-viruses-12-00376" ref-type="bibr">124</xref>,<xref rid="B125-viruses-12-00376" ref-type="bibr">125</xref>]. One study based on a mouse model showed that, during IAV infection, immature and mature DCs were specialized in IAV HA processing, since both types of DCs could present one epitope of H1N1 HA (HA amino acids 107&#x02013;119), whereas another epitope (HA amino acids 302&#x02013;313) could only be processed by mature DCs [<xref rid="B126-viruses-12-00376" ref-type="bibr">126</xref>]. The complex role of DCs in initiation of robust immunity against IAV infection is reviewed by Waithman and Mintern [<xref rid="B127-viruses-12-00376" ref-type="bibr">127</xref>].</p><p>T cells and B cells are critical components in adaptive immunity against IAV infection. CD8<sup>+</sup> T cells differentiate into cytotoxic T lymphocytes (CTLs) and defend IAV infection via producing cytokines and effector molecules, and cytotoxic effects (i.e., lysis) of infected cells mediated by MHC class I. CD4<sup>+</sup> T cells target IAV-infected epithelial cells through binding with MHC class II molecules and contribute to B cell activation thus consequently promote antibody production. The activation of T cells and B cells in IAV infection will be exposited in <xref ref-type="sec" rid="sec3dot5-viruses-12-00376">Section 3.5</xref>.</p></sec><sec id="sec3dot2-viruses-12-00376"><title>3.2. Activation of Innate Immunity in IAV Infection</title><p>The reaction of innate immunity is nonspecific. It is triggered by recognition of pathogen associated molecular patterns (PAMPs) via host pathogen recognition receptors (PRRs). Toll-like receptors (TLRs), retinoic acid-inducible gene-I proteins (RIG-I), and NOD-like receptors are common PRRs, the activation of which leads to activation of innate immune signaling and further production of cytokines as well as other antiviral molecules.</p><p>Toll-like receptors are responsible for sensing pathogens at cell membranes, endosomes, and lysosome [<xref rid="B128-viruses-12-00376" ref-type="bibr">128</xref>]. TLR3 and TLR7 are shown to be involved in IAV detection at endosomes [<xref rid="B105-viruses-12-00376" ref-type="bibr">105</xref>]. TLR3 recognizes double stranded RNA (dsRNA) which may be released by cellular stress and cell death [<xref rid="B105-viruses-12-00376" ref-type="bibr">105</xref>] and unidentified RNA structures in phagocytosed cells infected with IAVs [<xref rid="B129-viruses-12-00376" ref-type="bibr">129</xref>]. In macrophages and dendritic cells, TLR3 interacted with TIR-domain-containing adapter, then activated the serine-threonine kinase I&#x003ba;K&#x003b5; (IKK&#x003b5;) and TANK binding kinase 1 (TBK1) to phosphorylate interferon regulatory factor 3 (IRF3), the process of which further led to expression of IFN-&#x003b2; [<xref rid="B130-viruses-12-00376" ref-type="bibr">130</xref>]. In addition, an over-reacting TLR3 activation promoted IAV pathogenesis, which could be reduced by a single-stranded oligonucleotide (ssON) functioning as a TLR3 inhibitor, resulting in restrained viral loads both in vitro and in vivo [<xref rid="B131-viruses-12-00376" ref-type="bibr">131</xref>]. TLR7 recognizes single stranded RNA (ssRNA). In plasmacytoid dendritic cells (pDCs), after activation of TLR7 during IAV infection, IRF7 or nuclear factor kappa-light-chain-enhancer of activated B cells (NF-&#x003ba;B) were activated via myeloid differentiation factor 88 (MyD88) to induce type I IFNs [<xref rid="B132-viruses-12-00376" ref-type="bibr">132</xref>]. In avian macrophages, activation of TLR7 produced pro-inflammatory molecules such as interleukin (IL)-1&#x003b2; [<xref rid="B133-viruses-12-00376" ref-type="bibr">133</xref>]. In addition, in mouse models, TLR7 played an important role in activation of NK cells [<xref rid="B134-viruses-12-00376" ref-type="bibr">134</xref>]. It was also shown to be involved in development of adaptive immunity to prevent IAV infection [<xref rid="B135-viruses-12-00376" ref-type="bibr">135</xref>,<xref rid="B136-viruses-12-00376" ref-type="bibr">136</xref>].</p><p>RIG-I recognizes ssRNAs and transcriptional products of IAVs, which triggers activation of the caspase activation and recruitment domains (CARDs) via dephosphorylation or ubiquitination by E3 ligases, resulting in activation of transcription factors including IRFs and NF-&#x003ba;B [<xref rid="B137-viruses-12-00376" ref-type="bibr">137</xref>]. OTUB1 played an essential role in regulation of RIG-I [<xref rid="B138-viruses-12-00376" ref-type="bibr">138</xref>]. In addition, melanoma differentiation-associated gene 5 (MDA5) was also involved in sensing transcriptional products of IAVs in the cytoplasm [<xref rid="B139-viruses-12-00376" ref-type="bibr">139</xref>].</p><p>For NOD-like receptor family, pyrin domain containing 3 (NLRP3) and NLR apoptosis inhibitory protein 5 were activated after IAV infection [<xref rid="B140-viruses-12-00376" ref-type="bibr">140</xref>]. IAV M2 ion channel and PB1-F2 were involved in activation of NLRP3 inflammasome and stimulate IL-1&#x003b2; secretion subsequently [<xref rid="B141-viruses-12-00376" ref-type="bibr">141</xref>,<xref rid="B142-viruses-12-00376" ref-type="bibr">142</xref>]. The role of the NLRP3 inflammasome in regulation of anti-IAV responses is discussed in detail by Sarvestani and his colleagues [<xref rid="B143-viruses-12-00376" ref-type="bibr">143</xref>]. Delayed oseltamivir and sirolimus combined treatment could suppress NLRP3 inflammasome mediated secretion of IL-1&#x003b2; and IL-18, resulting in attenuation of H1N1-induced lung injury [<xref rid="B144-viruses-12-00376" ref-type="bibr">144</xref>].</p></sec><sec id="sec3dot3-viruses-12-00376"><title>3.3. The Host Interferon (IFN) Response in IAV Infection</title><p>After detecting viral components, transcription factors including NF-&#x003ba;B and IRFs are activated, leading to transcription of IFNs and pro-inflammatory cytokines. IFNs bind to receptors, resulting in upregulation of multiple interferon-stimulated genes (ISGs) [<xref rid="B145-viruses-12-00376" ref-type="bibr">145</xref>]. It is well known that type I IFNs (IFN-&#x003b1; and IFN-&#x003b2;) and type III IFNs (IFN-&#x003bb; 1-4) play critical roles in antiviral responses. Mice failed to restrict non-pathogenic IAV when both type I and type III IFN receptors were knocked out [<xref rid="B146-viruses-12-00376" ref-type="bibr">146</xref>].</p><p>The expressed IFNs consequentially bind to different receptors. Type I IFNs interact with IFN-&#x003b1;/&#x003b2; receptors (IFNAR), whereas type III IFNs interact with IFN-&#x003bb; receptors (IFNLR). Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway is then activated, resulting in transcription of numerous IFN-stimulated genes (ISGs) [<xref rid="B147-viruses-12-00376" ref-type="bibr">147</xref>,<xref rid="B148-viruses-12-00376" ref-type="bibr">148</xref>]. Though IFN-&#x003bb;s share many characteristics such as expression patterns, signaling pathways, etc. with type I IFNs, they are the first IFNs produced at the infected epithelial sites to block virus spread [<xref rid="B149-viruses-12-00376" ref-type="bibr">149</xref>]. Furthermore, IFN-&#x003bb;s served an important role in programming DCs to direct effective T cell immunity against IAV infection [<xref rid="B150-viruses-12-00376" ref-type="bibr">150</xref>].</p><p>ISGs encode various antiviral proteins functioning in different ways to defend IAV infection. For instance, MxA GTPase from the Mx family could retain viral genome from entry to the cytoplasm via blocking the function of IAV NP. In addition, in vitro research found that avian IAVs were more sensitive to MxA than human IAVs [<xref rid="B151-viruses-12-00376" ref-type="bibr">151</xref>,<xref rid="B152-viruses-12-00376" ref-type="bibr">152</xref>]. Cholesterol 25-hydroxylase (CH25H) were identified to block IAV entry via altering the cellular membrane properties to interfere with viral fusion, and amplified the activation of immune cells [<xref rid="B153-viruses-12-00376" ref-type="bibr">153</xref>]. Guanylate-binding protein 3 (GBP3) of IFN-inducible GTPases inhibited IAV replication via binding to the viral polymerase complex [<xref rid="B154-viruses-12-00376" ref-type="bibr">154</xref>]. Members of the tripartite motif-containing (TRIM) family are also involved in cellular anti-IAV processes. For instance, TRIM14 could interact with IAV NP for ubiquitination and proteasomal degradation, thus restricting IAV replication in a type I IFN and NF-&#x003ba;B independent manner [<xref rid="B155-viruses-12-00376" ref-type="bibr">155</xref>]. TRIM22 degraded IAV NP via polyubiquitination, thus resulting in inhibition of IAV infection [<xref rid="B156-viruses-12-00376" ref-type="bibr">156</xref>]. TRIM 25 regulated the re-localization of RIG-I and was responsible for RIG-I ubiquitination as well as RIG-I-mediated IFN production [<xref rid="B157-viruses-12-00376" ref-type="bibr">157</xref>]. TRIM32 recognized IAV PB1 protein and reduced its polymerase activity [<xref rid="B158-viruses-12-00376" ref-type="bibr">158</xref>]. TRIM41 targeted NP for ubiquitination and degradation in vitro [<xref rid="B159-viruses-12-00376" ref-type="bibr">159</xref>]. For further reading on other ISGs, several reviews regarding IFN responses during IAV infection are recommended here [<xref rid="B160-viruses-12-00376" ref-type="bibr">160</xref>,<xref rid="B161-viruses-12-00376" ref-type="bibr">161</xref>]. A general description of activation of innate immunity and IFN signaling pathway after IAV infection is illustrated in <xref ref-type="fig" rid="viruses-12-00376-f001">Figure 1</xref>.</p><p>In order to counter IFN-stimulated antiviral proteins, IAV viral proteins apply multiple strategies. For instance, HA protein was shown to trigger ubiquitination of IFNAR to attenuate the type I IFN signaling pathway [<xref rid="B162-viruses-12-00376" ref-type="bibr">162</xref>]. The follow-up work showed that poly (ADP-ribose) polymerase 1 (PARP1) functions as an interacting partner of HA protein to mediate the HA-induced IFNAR degradation [<xref rid="B163-viruses-12-00376" ref-type="bibr">163</xref>]. NS1 is the most important IFNs antagonist protein via mechanisms including inhibition of the TRIM25-mediated RIG-I ubiquitination, suppression of protein kinase R (PKR), phosphorylation of I&#x003ba;B kinases (IKK) &#x003b1; and &#x003b2; in the NF-&#x003ba;B pathway, interruption of the phosphorylation of STAT1, STAT2, and STAT3 [<xref rid="B39-viruses-12-00376" ref-type="bibr">39</xref>,<xref rid="B115-viruses-12-00376" ref-type="bibr">115</xref>], and degradation of OTUB1 [<xref rid="B138-viruses-12-00376" ref-type="bibr">138</xref>]. Phosphorylation of NS1 is crucial for its function of antagonizing IFN-&#x003b2; expression, since dephosphorylation at position 73 and 83 of the protein induced a high level of IFN-&#x003b2; [<xref rid="B91-viruses-12-00376" ref-type="bibr">91</xref>]. Non-structural protein PB1-F2, identified from a+1 open reading frame (ORF) of PB1 gene segment [<xref rid="B164-viruses-12-00376" ref-type="bibr">164</xref>], is multifunctional in deregulation of type I interferon [<xref rid="B165-viruses-12-00376" ref-type="bibr">165</xref>,<xref rid="B166-viruses-12-00376" ref-type="bibr">166</xref>]. It counteracted RLR-mediated activation of IFN pathway not only by targeting mitochondrial MAVS [<xref rid="B115-viruses-12-00376" ref-type="bibr">115</xref>,<xref rid="B165-viruses-12-00376" ref-type="bibr">165</xref>,<xref rid="B167-viruses-12-00376" ref-type="bibr">167</xref>], but also by binding to the DEAD-box helicase DDX3 to induce proteasome-dependent degradation [<xref rid="B166-viruses-12-00376" ref-type="bibr">166</xref>]. Furthermore, PB1-F2 interacted with mitochondrial Tu translation elongation factor (TUFM) to mediate formation of autophagosome, thus inducing complete mitophagy, which is critical for MAVS degradation [<xref rid="B167-viruses-12-00376" ref-type="bibr">167</xref>]. Novel PA-X protein could also modulate innate immune responses. A review regarding the function of NS1 and PA-X proteins in antagonizing host innate immunity is recommended here [<xref rid="B114-viruses-12-00376" ref-type="bibr">114</xref>].</p></sec><sec id="sec3dot4-viruses-12-00376"><title>3.4. Autophagy</title><p>Though autophagy is essential for cellular metabolism and homeostasis, it also plays important roles in innate immune responses against pathogen infection. For cellular homeostasis, the mTOR pathway is one of the most conserved autophagic pathways. The mTOR complex 1 (MTORC1) negatively regulates the ULK1 kinase activity, thus affecting the autophagy induction [<xref rid="B168-viruses-12-00376" ref-type="bibr">168</xref>]. c-Jun N-terminal protein kinase 1 (JNK1) disrupts the Bcl-2/Beclin-1 complex through phosphorylation, thus regulating the autophagy induction [<xref rid="B169-viruses-12-00376" ref-type="bibr">169</xref>,<xref rid="B170-viruses-12-00376" ref-type="bibr">170</xref>]. JNK1 is also reported to upregulate Beclin-1 expression through phosphorylation of transcription factor c-Jun in vitro [<xref rid="B171-viruses-12-00376" ref-type="bibr">171</xref>].</p><p>In contrast to the autophagic pathways for cellular metabolism and homeostasis, less is known about autophagosome formation after IAV infection [<xref rid="B172-viruses-12-00376" ref-type="bibr">172</xref>]. To restrict infection of multiple viruses including IAVs, TRIM23 is essential to mediate autophagy via its RING E3 ligase and ADP-ribosylation factor (ARF) GTPase activity [<xref rid="B173-viruses-12-00376" ref-type="bibr">173</xref>]. Beclin-1 and TUFM-regulated autophagy also inhibited IAV replication [<xref rid="B112-viruses-12-00376" ref-type="bibr">112</xref>]. In HeLa cells and A549 cells, IAV infection activated JNK1 to induce autophagosome formation and TGF-&#x003b2;-activated kinase 1 might contribute to the process [<xref rid="B174-viruses-12-00376" ref-type="bibr">174</xref>,<xref rid="B175-viruses-12-00376" ref-type="bibr">175</xref>]. Furthermore, autophagy was involved in maintaining memory B cells to counteract IAV infection [<xref rid="B176-viruses-12-00376" ref-type="bibr">176</xref>].</p><p>IAV also utilizes autophagy to complete its life cycle. NS1 protein is proposed to suppress JNK1-mediated autophagy induction [<xref rid="B174-viruses-12-00376" ref-type="bibr">174</xref>]. M2 could also block autophagosome maturation and mediate microtubule-associated protein 1 light chain 3 (LC3)-bound membrane redistribution, thus allowing filamentous budding of IAV [<xref rid="B177-viruses-12-00376" ref-type="bibr">177</xref>,<xref rid="B178-viruses-12-00376" ref-type="bibr">178</xref>,<xref rid="B179-viruses-12-00376" ref-type="bibr">179</xref>]. Circ-GATAD2A (GATA zinc finger domain containing 2A), induced by IAV infection, could inhibit autophagy and promote IAV replication [<xref rid="B180-viruses-12-00376" ref-type="bibr">180</xref>]. For a comprehensive reading on IAV-induced apoptosis, a review is recommended here [<xref rid="B181-viruses-12-00376" ref-type="bibr">181</xref>].</p></sec><sec id="sec3dot5-viruses-12-00376"><title>3.5. Adaptive Immunity against IAV Infection</title><p>Upon detection of IAVs, DCs trigger production of IFNs and cytokines, which in turns assist maturation of the DCs into antigen presenting cells (APCs), and initiate T cell immune responses. Through the activation of Ag-bearing DCs, na&#x000ef;ve CD4<sup>+</sup> T cells differentiate into Th1, Th2, Th7, regulatory T cells (Treg cells), follicular helper T cells, and killer cells. Th1 and follicular helper T cells are the most abundant CD4<sup>+</sup> T helper cells. They can secret antiviral cytokines, regulate CD8<sup>+</sup> T cell differentiation, promote B cell activation, and maintain immunological memory [<xref rid="B182-viruses-12-00376" ref-type="bibr">182</xref>,<xref rid="B183-viruses-12-00376" ref-type="bibr">183</xref>]. Th17 cells induced pulmonary pathogenesis and could decrease mortality of IAV-infected mice [<xref rid="B184-viruses-12-00376" ref-type="bibr">184</xref>,<xref rid="B185-viruses-12-00376" ref-type="bibr">185</xref>]. In addition, &#x003b3;&#x003b4; T cells, expanding in the late stage of IAV infection with a T cell receptor (TCR)-independent manner, could efficient eliminate IAV-infected airway epithelial cells, resulting in lower viral titers [<xref rid="B186-viruses-12-00376" ref-type="bibr">186</xref>]. New surrogate markers CD49d and CD11a were used to explore the kinetics of IAV-specific CD4 T cells responses, revealing endogenous CD4 T cell response to primary IAV infection is predominantly composed of T-bet+ cells [<xref rid="B187-viruses-12-00376" ref-type="bibr">187</xref>].</p><p>CD8<sup>+</sup> T cells are major components for virus clearance in adaptive immunity. After activated by DCs, CD8<sup>+</sup> T cells undergo rapid expansion, differentiation, and migration to the infected sites. In general, to establish effective primary cytotoxic T lymphocyte (CTL) responses, CD4<sup>+</sup> T cells play an essential role, with a mouse model as an exception [<xref rid="B188-viruses-12-00376" ref-type="bibr">188</xref>]. CTLs produce cytotoxic granules containing perforin and granzymes (GrA and GrB) to induce apoptosis and interrupt IAV replication [<xref rid="B189-viruses-12-00376" ref-type="bibr">189</xref>]. In addition, CTLs produce cytokines, such as TNF, FASL, and TRAIL, which recruit death receptors to induce apoptosis [<xref rid="B190-viruses-12-00376" ref-type="bibr">190</xref>]. In addition, IL16 deficiency enhanced the Th1 and CTL responses upon IAV infection [<xref rid="B191-viruses-12-00376" ref-type="bibr">191</xref>]. Furthermore, as CD8<sup>+</sup> cells could last for two years in murine models, IAV-specific memory CTLs reacted specific to epitopes in conserved IAV proteins [<xref rid="B192-viruses-12-00376" ref-type="bibr">192</xref>]. In the nasal epithelia, they could prevent the spread of the virus from the URT to the lung [<xref rid="B193-viruses-12-00376" ref-type="bibr">193</xref>]. To establish memory CD8<sup>+</sup> T cells, autophagy plays an important role [<xref rid="B194-viruses-12-00376" ref-type="bibr">194</xref>], while the function of CD4<sup>+</sup> T cells in memory CTL responses is &#x0201c;context-dependent&#x0201d;. A recent study showed that CD4+ T cells promoted IAV-specific CTL memory at the initial priming stage of viral infection [<xref rid="B195-viruses-12-00376" ref-type="bibr">195</xref>]. Grant and her colleagues summarized and discussed the importance of CD8<sup>+</sup> T cell immunity against IAVs [<xref rid="B192-viruses-12-00376" ref-type="bibr">192</xref>], and this review is recommended for further reading.</p><p>With the help of CD40 ligand (CD40L), CD4<sup>+</sup> cells contribute to B cell activation [<xref rid="B183-viruses-12-00376" ref-type="bibr">183</xref>]. With the help of memory T cells, na&#x000ef;ve B cells could reduce morbidity and promote recovery on heterosubtypic infection [<xref rid="B196-viruses-12-00376" ref-type="bibr">196</xref>]. For different types of antibodies, IgG could inhibit pathogenesis, while IgA functions in blocking IAV transmission [<xref rid="B197-viruses-12-00376" ref-type="bibr">197</xref>]. In addition, IAV-specific antibody-dependent cell-mediated cytotoxicity (CDCC) also plays a role in cross-protection against IAV infection. A general description of adaptive immunity against primary IAV infection is illustrated in <xref ref-type="fig" rid="viruses-12-00376-f002">Figure 2</xref>.</p><p>Antigenic shift and drift, resulting in reassorted and mutated HA and/or NA, are responsible for AIV escaping from host immunity [<xref rid="B50-viruses-12-00376" ref-type="bibr">50</xref>,<xref rid="B51-viruses-12-00376" ref-type="bibr">51</xref>,<xref rid="B52-viruses-12-00376" ref-type="bibr">52</xref>]. Furthermore, additional glycosylation on H5 HA could also induce virus escape from neutralizing antibodies [<xref rid="B198-viruses-12-00376" ref-type="bibr">198</xref>].</p></sec><sec id="sec3dot6-viruses-12-00376"><title>3.6. Apoptosis against IAV Infection</title><p>Apoptosis represents programmed single cell death that occurs in cell physiological remodeling, cell proliferation, or immune response to invading pathogens [<xref rid="B199-viruses-12-00376" ref-type="bibr">199</xref>]. Besides prototypical changes, cells undergoing apoptosis can be detected through DNA and biochemical assays, take the TUNEL and in situ end-labeling (ISEL) techniques for instance. Two primary pathways are involved in activation of apoptosis: the intrinsic or mitochondrial pathway, and the extrinsic or death receptor pathway.</p><sec id="sec3dot6dot1-viruses-12-00376"><title>3.6.1. The Intrinsic and Extrinsic Apoptosis Pathway</title><p>The intrinsic pathway is also known as &#x0201c;the mitochondrial pathway&#x0201d;, which operates in response to various intracellular stress. Several factors such as nitric oxide (NO), cytochrome c, and second mitochondria-derived activator of caspases (SMAC) can activate this pathway, and the key player of this pathway is proteins in the bcl-2 family, which are activated by stress signals and then release apoptotic factors via destabilizing the mitochondrial membrane [<xref rid="B200-viruses-12-00376" ref-type="bibr">200</xref>,<xref rid="B201-viruses-12-00376" ref-type="bibr">201</xref>], resulting in release of mitochondrial cytochrome c. Cytochrome c then binds to apoptosis protease activating factor-1 (APAF-1) and forms a complex with pro-caspase 9 (then cleaved into caspase 9), the function of which is to cleave its effector pro-caspase 3 [<xref rid="B202-viruses-12-00376" ref-type="bibr">202</xref>]. In addition, SMAC, localizing in the cytosol, could initiate activation of caspase 9 via blocking the activity of IAP [<xref rid="B203-viruses-12-00376" ref-type="bibr">203</xref>]. The extrinsic pathway is regulated by extracellular ligands acting on transmembrane &#x0201c;death receptors&#x0201d;: the first apoptosis signal (FAS) receptor-FAS ligand (FASR/FASL) and the TNF-&#x003b1;TNF receptor 1 (TNF&#x003b1;/TNFR1) [<xref rid="B199-viruses-12-00376" ref-type="bibr">199</xref>]. In the FASR/FASL model, FAS ligand binds to its receptor FASR [<xref rid="B204-viruses-12-00376" ref-type="bibr">204</xref>], forming the death-inducing signaling complex (DISC) with pro-caspase 8, resulting in activation of caspase 8 and downstream activation of other caspases (caspase-3, caspase-6, and caspase-7) [<xref rid="B199-viruses-12-00376" ref-type="bibr">199</xref>]. In the TNF&#x003b1;/TNFR1 pathway, TNFR1-associated death domain protein (TRADD) is activated after binding of TNF&#x003b1; to TNFR1, leading to recruitment of FADD and receptor interacting protein (RIP) [<xref rid="B205-viruses-12-00376" ref-type="bibr">205</xref>]. FADD then associates with pro-caspase 8 to form the DISC, resulting in activation of caspase 8 and apoptosis.</p></sec><sec id="sec3dot6dot2-viruses-12-00376"><title>3.6.2. Apoptosis after IAV Infection</title><p>During IAV infection, viruses modulate host apoptotic responses in a time-dependent manner [<xref rid="B206-viruses-12-00376" ref-type="bibr">206</xref>]. For instance, in order to earn enough time for replication and virion formation, IAV inhibited apoptosis via upregulating the anti-apoptotic phophoinositide-3-kinase-protein kinase B (PI3K-AKT) pathway at the beginning of infection. However, in the later phase of infection, the virus suppressed this pathway to upregulate the pro-apoptotic p53 pathway, thus allowing successful release of virions [<xref rid="B207-viruses-12-00376" ref-type="bibr">207</xref>].</p><p>Several viral proteins are involved in regulation of host apoptosis. NP protein induces host apoptosis to favor viral replication through interaction with ring finger 43 (RNF43) [<xref rid="B208-viruses-12-00376" ref-type="bibr">208</xref>], apoptotic inhibitor 5 (API5) [<xref rid="B209-viruses-12-00376" ref-type="bibr">209</xref>], or clusterin [<xref rid="B111-viruses-12-00376" ref-type="bibr">111</xref>]. PB1-F2 also induced apoptosis and promoted viral replication through dysregulating mitochondrial potential [<xref rid="B206-viruses-12-00376" ref-type="bibr">206</xref>]. Furthermore, M1 promoted apoptosis by binding to heat shock protein 70, thus activating caspase and the subsequent apoptosis [<xref rid="B210-viruses-12-00376" ref-type="bibr">210</xref>]. In addition, NS1 expression was reported to induce apoptosis in MDCK and HeLa cells [<xref rid="B211-viruses-12-00376" ref-type="bibr">211</xref>]. However, mutant IAV lacking the NS1 gene could induce apoptosis in cultured cells [<xref rid="B212-viruses-12-00376" ref-type="bibr">212</xref>]. The function of NS1 in inhibiting apoptosis may be explained by its ability to inhibit type I IFN [<xref rid="B213-viruses-12-00376" ref-type="bibr">213</xref>,<xref rid="B214-viruses-12-00376" ref-type="bibr">214</xref>]. These data demonstrate sophisticated mechanisms of IAV in regulating host apoptosis. Furthermore, the role of these viral proteins in apoptosis suggests that these proteins may present suitable targets for anti-IAV therapies. A comprehensive review on influenza A virus-induced apoptosis discussed by Ampomah and Lim is recommended here [<xref rid="B181-viruses-12-00376" ref-type="bibr">181</xref>]. In addition, recent in vitro research found that apoptosis was induced at early IAV infection stage, while later the cell death pathway was shifted to pyroptosis. The switch process was promoted by the type I IFN-mediated JAK-STAT signaling pathway through expression of the Bcl-xL gene [<xref rid="B215-viruses-12-00376" ref-type="bibr">215</xref>].</p></sec></sec></sec><sec id="sec4-viruses-12-00376"><title>4. Perspectives</title><p>During IAV infection, multiple immune systems coordinate together to protect the host. Accordingly, viruses antagonize the immune system through multiple measures to establish a successful infection. Considering the high frequencies in genome mutations and recombination, vaccination is the most effective way to defend against the viruses via inducing cross-protective antibodies and/or enhancing immune responses. Several studies in vaccine development have tried to enhance host immune responses. For instance, vaccine candidate containing HA targeted to chemokine receptor (porcine MIP1&#x003b1;) was shown to enhance T cell responses, resulting in a strong and cross-reactive cellular immunity in vaccinated pigs [<xref rid="B216-viruses-12-00376" ref-type="bibr">216</xref>]. Another example is an attempt to intranasally administer a polyanhydride nano vaccine (IAV-nanovax), which could promote robust lung-resident germinal center (GC) B cells with lung-localized IAV-specific antibody responses as well as lung-resident memory CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses [<xref rid="B217-viruses-12-00376" ref-type="bibr">217</xref>].</p><p>For anti-IAV drugs, currently, NA inhibitors (Relenza<sup>TM</sup> and Tamiflu<sup>TM</sup>) are applied clinically as anti-influenza drugs [<xref rid="B218-viruses-12-00376" ref-type="bibr">218</xref>]. These drugs inhibit the activity of NA by preventing viral budding [<xref rid="B21-viruses-12-00376" ref-type="bibr">21</xref>]. In addition, cap-dependent endonuclease inhibitor (Baloxavir Marboxil) targeting PA is also applied against influenza A and B virus infection [<xref rid="B219-viruses-12-00376" ref-type="bibr">219</xref>]. Our progressing understanding of the IAV life cycle of the virus and IAV&#x02013;host interaction could contribute to anti-influenza drug design.</p><p>Since the recognition of HA protein to SA linked glycoproteins is the first step in IAV infection, effective blocking of the interaction between viral HA and SA receptor serves as a favorable target in drug design [<xref rid="B220-viruses-12-00376" ref-type="bibr">220</xref>,<xref rid="B221-viruses-12-00376" ref-type="bibr">221</xref>]. Favipiravir, a nucleotide analogue that selectively inhibits the RNA-dependent RNA polymerase, is licensed in Japan to be applied against emerging influenza viruses resistant to other antivirals [<xref rid="B222-viruses-12-00376" ref-type="bibr">222</xref>,<xref rid="B223-viruses-12-00376" ref-type="bibr">223</xref>]. Oleanolic acid (OA), a kind of pentacyclic triterpene natural product, and its analogues, as well as its derivatives, were shown to bind to HA, thus blocking the attachment of IAVs to MDCK cells [<xref rid="B224-viruses-12-00376" ref-type="bibr">224</xref>,<xref rid="B225-viruses-12-00376" ref-type="bibr">225</xref>,<xref rid="B226-viruses-12-00376" ref-type="bibr">226</xref>]. PVF-tet is a peptide-based HA inhibitor, which was shown to sequester HA into amphisome (fusion of late endosome with autophagosome) and protected mice from the lethal IAV infection [<xref rid="B227-viruses-12-00376" ref-type="bibr">227</xref>].</p><p>New effective drugs targeting the polymerase would be a promising strategy against IAV infection, since they would directly reduce or eliminate viral replication. Numerous sites, including the cap-binding site [<xref rid="B228-viruses-12-00376" ref-type="bibr">228</xref>], the endonuclease [<xref rid="B229-viruses-12-00376" ref-type="bibr">229</xref>,<xref rid="B230-viruses-12-00376" ref-type="bibr">230</xref>], and PA-PB1 inter-subunit interface [<xref rid="B231-viruses-12-00376" ref-type="bibr">231</xref>] can serve as potential targeting sites for new drug design. Coumarin compounds, including Eleutheroside B<sub>1</sub>, Isofraxidin, Fraxin, Esculetin, Fraxetin, and Scoparone, were investigated for their antiviral and anti-inflammatory activities against influenza virus in vitro [<xref rid="B31-viruses-12-00376" ref-type="bibr">31</xref>].</p><p>Other candidates, such as Naproxen, a non-steroidal anti-inflammatory drug, was shown to target NP protein at residues F209 and Y148, thus antagonizes the CRM1-mediated nuclear export of NP. It is suggested to have a broad-spectrum anti-influenza activity [<xref rid="B232-viruses-12-00376" ref-type="bibr">232</xref>]. Verdinexor (KPT-335), a novel orally bioavailable drug, blocks CRM1-mediated nuclear export of NP and repress NF-&#x003ba;B activation, thus reducing cytokine production and eliminating virus-associated immunopathology [<xref rid="B233-viruses-12-00376" ref-type="bibr">233</xref>]. For further reading on candidate anti-IV therapeutics, a review summarized by Davidson is recommended here [<xref rid="B234-viruses-12-00376" ref-type="bibr">234</xref>].</p><p>With the increasing knowledge obtained through massive investigations on host immunity against IAV infection, promoting host immune responses not limited to antibody enhancement would have good prospects not only for vaccine design, but also for development of novel antiviral agents.</p></sec></body><back><notes><title>Author Contributions</title><p>Manuscript preparation, Y.Z.; Revision, Z.X.; Supervision, Y.C.; Funding Acquisition, Y.Z. All authors read and approved the final version of the manuscript.</p></notes><notes><title>Funding</title><p>This study was supported by the &#x0201c;Zhujiang talent program&#x0201d; overseas youth talent introduction program (post-doctoral program) and Doctoral Initiative Project of Natural Science Foundation of Guangdong Province (18zxxt49).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that they have no financial and personal relationships with other people or organizations that can influence the work. There is no professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the position presented in this review. They do not have any commercial or associative interest that represents conflicts of interest in connection with the work submitted.</p></notes><ref-list><title>References</title><ref id="B1-viruses-12-00376"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikitin</surname><given-names>N.</given-names></name><name><surname>Petrova</surname><given-names>E.D.</given-names></name><name><surname>Trifonova</surname><given-names>E.</given-names></name><name><surname>Karpova</surname><given-names>O.</given-names></name></person-group><article-title>Influenza Virus Aerosols in the Air and Their Infectiousness</article-title><source>Adv. Virol.</source><year>2014</year><volume>2014</volume><fpage>859090</fpage><pub-id pub-id-type="doi">10.1155/2014/859090</pub-id><?supplied-pmid 25197278?><pub-id pub-id-type="pmid">25197278</pub-id></element-citation></ref><ref id="B2-viruses-12-00376"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taubenberger</surname><given-names>J.K.</given-names></name><name><surname>Morens</surname><given-names>D.M.</given-names></name></person-group><article-title>Influenza: The once and future pandemic</article-title><source>Public Health Rep.</source><year>2010</year><volume>125</volume><fpage>16</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1177/00333549101250S305</pub-id><?supplied-pmid 20568566?><pub-id pub-id-type="pmid">20568566</pub-id></element-citation></ref><ref id="B3-viruses-12-00376"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamayoshi</surname><given-names>S.</given-names></name><name><surname>Watanabe</surname><given-names>M.</given-names></name><name><surname>Goto</surname><given-names>H.</given-names></name><name><surname>Kawaoka</surname><given-names>Y.</given-names></name></person-group><article-title>Identification of a Novel Viral Protein Expressed from the PB2 Segment of Influenza A Virus</article-title><source>J. Virol.</source><year>2015</year><volume>90</volume><fpage>444</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1128/JVI.02175-15</pub-id><?supplied-pmid 26491155?><pub-id pub-id-type="pmid">26491155</pub-id></element-citation></ref><ref id="B4-viruses-12-00376"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jagger</surname><given-names>B.W.</given-names></name><name><surname>Wise</surname><given-names>H.M.</given-names></name><name><surname>Kash</surname><given-names>J.C.</given-names></name><name><surname>Walters</surname><given-names>K.-A.</given-names></name><name><surname>Wills</surname><given-names>N.M.</given-names></name><name><surname>Xiao</surname><given-names>Y.-L.</given-names></name><name><surname>Dunfee</surname><given-names>R.L.</given-names></name><name><surname>Schwartzman</surname><given-names>L.M.</given-names></name><name><surname>Ozinsky</surname><given-names>A.</given-names></name><name><surname>Bell</surname><given-names>G.L.</given-names></name><etal/></person-group><article-title>An Overlapping Protein-Coding Region in Influenza A Virus Segment 3 Modulates the Host Response</article-title><source>Science</source><year>2012</year><volume>337</volume><fpage>199</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1126/science.1222213</pub-id><pub-id pub-id-type="pmid">22745253</pub-id></element-citation></ref><ref id="B5-viruses-12-00376"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muramoto</surname><given-names>Y.</given-names></name><name><surname>Noda</surname><given-names>T.</given-names></name><name><surname>Kawakami</surname><given-names>E.</given-names></name><name><surname>Akkina</surname><given-names>R.</given-names></name><name><surname>Kawaoka</surname><given-names>Y.</given-names></name></person-group><article-title>Identification of Novel Influenza A Virus Proteins Translated from PA mRNA</article-title><source>J. Virol.</source><year>2012</year><volume>87</volume><fpage>2455</fpage><lpage>2462</lpage><pub-id pub-id-type="doi">10.1128/JVI.02656-12</pub-id><pub-id pub-id-type="pmid">23236060</pub-id></element-citation></ref><ref id="B6-viruses-12-00376"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wise</surname><given-names>H.M.</given-names></name><name><surname>Hutchinson</surname><given-names>E.C.</given-names></name><name><surname>Jagger</surname><given-names>B.W.</given-names></name><name><surname>Stuart</surname><given-names>A.D.</given-names></name><name><surname>Kang</surname><given-names>Z.H.</given-names></name><name><surname>Robb</surname><given-names>N.</given-names></name><name><surname>Schwartzman</surname><given-names>L.M.</given-names></name><name><surname>Kash</surname><given-names>J.C.</given-names></name><name><surname>Fodor</surname><given-names>E.</given-names></name><name><surname>Firth</surname><given-names>A.E.</given-names></name><etal/></person-group><article-title>Identification of a Novel Splice Variant Form of the Influenza A Virus M2 Ion Channel with an Antigenically Distinct Ectodomain</article-title><source>PLoS Pathog.</source><year>2012</year><volume>8</volume><elocation-id>e1002998</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002998</pub-id><pub-id pub-id-type="pmid">23133386</pub-id></element-citation></ref><ref id="B7-viruses-12-00376"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selman</surname><given-names>M.</given-names></name><name><surname>Dankar</surname><given-names>S.K.</given-names></name><name><surname>Forbes</surname><given-names>N.</given-names></name><name><surname>Jia</surname><given-names>J.-J.</given-names></name><name><surname>Brown</surname><given-names>E.G.</given-names></name></person-group><article-title>Adaptive mutation in influenza A virus non-structural gene is linked to host switching and induces a novel protein by alternative splicing</article-title><source>Emerg. Microbes Infect.</source><year>2012</year><volume>1</volume><fpage>e42</fpage><pub-id pub-id-type="doi">10.1038/emi.2012.38</pub-id><pub-id pub-id-type="pmid">26038410</pub-id></element-citation></ref><ref id="B8-viruses-12-00376"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Rivailler</surname><given-names>P.</given-names></name><name><surname>Conrardy</surname><given-names>C.</given-names></name><name><surname>Castillo</surname><given-names>D.A.A.</given-names></name><name><surname>Chen</surname><given-names>L.-M.</given-names></name><name><surname>Recuenco-Cabrera</surname><given-names>S.</given-names></name><name><surname>Ellison</surname><given-names>J.A.</given-names></name><name><surname>Davis</surname><given-names>C.T.</given-names></name><name><surname>York</surname><given-names>I.</given-names></name><etal/></person-group><article-title>A distinct lineage of influenza A virus from bats</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2012</year><volume>109</volume><fpage>4269</fpage><lpage>4274</lpage><pub-id pub-id-type="doi">10.1073/pnas.1116200109</pub-id><pub-id pub-id-type="pmid">22371588</pub-id></element-citation></ref><ref id="B9-viruses-12-00376"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Shi</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Bourgeois</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Recuenco-Cabrera</surname><given-names>S.</given-names></name><name><surname>G&#x000f3;mez</surname><given-names>J.</given-names></name><etal/></person-group><article-title>New World Bats Harbor Diverse Influenza A Viruses</article-title><source>PLoS Pathog.</source><year>2013</year><volume>9</volume><elocation-id>e1003657</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003657</pub-id><pub-id pub-id-type="pmid">24130481</pub-id></element-citation></ref><ref id="B10-viruses-12-00376"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>S.</given-names></name><name><surname>Gu</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Cui</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>G.F.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name></person-group><article-title>Epidemiology, Evolution, and Pathogenesis of H7N9 Influenza Viruses in Five Epidemic Waves since 2013 in China</article-title><source>Trends Microbiol.</source><year>2017</year><volume>25</volume><fpage>713</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2017.06.008</pub-id><pub-id pub-id-type="pmid">28734617</pub-id></element-citation></ref><ref id="B11-viruses-12-00376"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Impagliazzo</surname><given-names>A.</given-names></name><name><surname>Milder</surname><given-names>F.</given-names></name><name><surname>Kuipers</surname><given-names>H.</given-names></name><name><surname>Wagner</surname><given-names>M.V.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Hoffman</surname><given-names>R.M.B.</given-names></name><name><surname>Van Meersbergen</surname><given-names>R.</given-names></name><name><surname>Huizingh</surname><given-names>J.</given-names></name><name><surname>Wanningen</surname><given-names>P.</given-names></name><name><surname>Verspuij</surname><given-names>J.</given-names></name><etal/></person-group><article-title>A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen</article-title><source>Science</source><year>2015</year><volume>349</volume><fpage>1301</fpage><lpage>1306</lpage><pub-id pub-id-type="doi">10.1126/science.aac7263</pub-id><?supplied-pmid 26303961?><pub-id pub-id-type="pmid">26303961</pub-id></element-citation></ref><ref id="B12-viruses-12-00376"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyoglu-Barnum</surname><given-names>S.</given-names></name><name><surname>Hutchinson</surname><given-names>G.B.</given-names></name><name><surname>Boyington</surname><given-names>J.C.</given-names></name><name><surname>Moin</surname><given-names>S.M.</given-names></name><name><surname>Gillespie</surname><given-names>R.A.</given-names></name><name><surname>Tsybovsky</surname><given-names>Y.</given-names></name><name><surname>Stephens</surname><given-names>T.</given-names></name><name><surname>Vaile</surname><given-names>J.R.</given-names></name><name><surname>Lederhofer</surname><given-names>J.</given-names></name><name><surname>Corbett</surname><given-names>K.S.</given-names></name><etal/></person-group><article-title>Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>791</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-14579-4</pub-id><?supplied-pmid 32034141?><pub-id pub-id-type="pmid">32034141</pub-id></element-citation></ref><ref id="B13-viruses-12-00376"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matrosovich</surname><given-names>M.</given-names></name><name><surname>Tuzikov</surname><given-names>A.</given-names></name><name><surname>Bovin</surname><given-names>N.</given-names></name><name><surname>Gambaryan</surname><given-names>A.</given-names></name><name><surname>Klimov</surname><given-names>A.</given-names></name><name><surname>Castrucci</surname><given-names>M.R.</given-names></name><name><surname>Donatelli</surname><given-names>I.</given-names></name><name><surname>Kawaoka</surname><given-names>Y.</given-names></name></person-group><article-title>Early Alterations of the Receptor-Binding Properties of H1, H2, and H3 Avian Influenza Virus Hemagglutinins after Their Introduction into Mammals</article-title><source>J. Virol.</source><year>2000</year><volume>74</volume><fpage>8502</fpage><lpage>8512</lpage><pub-id pub-id-type="doi">10.1128/JVI.74.18.8502-8512.2000</pub-id><?supplied-pmid 10954551?><pub-id pub-id-type="pmid">10954551</pub-id></element-citation></ref><ref id="B14-viruses-12-00376"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamblin</surname><given-names>S.</given-names></name><name><surname>Skehel</surname><given-names>J.J.</given-names></name></person-group><article-title>Influenza hemagglutinin and neuraminidase membrane glycoproteins</article-title><source>J. Biol. Chem.</source><year>2010</year><volume>285</volume><fpage>28403</fpage><lpage>28409</lpage><pub-id pub-id-type="doi">10.1074/jbc.R110.129809</pub-id><?supplied-pmid 20538598?><pub-id pub-id-type="pmid">20538598</pub-id></element-citation></ref><ref id="B15-viruses-12-00376"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shelton</surname><given-names>H.</given-names></name><name><surname>Ayora-Talavera</surname><given-names>G.</given-names></name><name><surname>Ren</surname><given-names>J.</given-names></name><name><surname>Loureiro</surname><given-names>S.</given-names></name><name><surname>Pickles</surname><given-names>R.J.</given-names></name><name><surname>Barclay</surname><given-names>W.S.</given-names></name><name><surname>Jones</surname><given-names>I.</given-names></name></person-group><article-title>Receptor binding profiles of avian influenza virus hemagglutinin subtypes on human cells as a predictor of pandemic potential</article-title><source>J. Virol.</source><year>2010</year><volume>85</volume><fpage>1875</fpage><lpage>1880</lpage><pub-id pub-id-type="doi">10.1128/JVI.01822-10</pub-id><?supplied-pmid 21106732?><pub-id pub-id-type="pmid">21106732</pub-id></element-citation></ref><ref id="B16-viruses-12-00376"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Graaf</surname><given-names>M.</given-names></name><name><surname>Fouchier</surname><given-names>R.A.</given-names></name></person-group><article-title>Role of receptor binding specificity in influenza A virus transmission and pathogenesis</article-title><source>EMBO J.</source><year>2014</year><volume>33</volume><fpage>823</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1002/embj.201387442</pub-id><pub-id pub-id-type="pmid">24668228</pub-id></element-citation></ref><ref id="B17-viruses-12-00376"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Qi</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>H.</given-names></name><name><surname>Gao</surname><given-names>F.</given-names></name><name><surname>Bi</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Fan</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Structures and Receptor Binding of Hemagglutinins from Human-Infecting H7N9 Influenza Viruses</article-title><source>Science</source><year>2013</year><volume>342</volume><fpage>243</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1126/science.1242917</pub-id><pub-id pub-id-type="pmid">24009358</pub-id></element-citation></ref><ref id="B18-viruses-12-00376"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Peng</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Qi</surname><given-names>J.</given-names></name><name><surname>Song</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Xiao</surname><given-names>H.</given-names></name><name><surname>Fu</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Avian-to-Human Receptor-Binding Adaptation of Avian H7N9 Influenza Virus Hemagglutinin</article-title><source>Cell Rep.</source><year>2019</year><volume>29</volume><fpage>2217</fpage><lpage>2228</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.10.047</pub-id><pub-id pub-id-type="pmid">31747596</pub-id></element-citation></ref><ref id="B19-viruses-12-00376"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>X.-Q.</given-names></name><name><surname>Senaati</surname><given-names>H.P.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Varki</surname><given-names>N.M.</given-names></name><name><surname>Schooley</surname><given-names>R.T.</given-names></name><name><surname>Gagneux</surname><given-names>P.</given-names></name></person-group><article-title>Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase</article-title><source>Virol. J.</source><year>2013</year><volume>10</volume><fpage>321</fpage><pub-id pub-id-type="doi">10.1186/1743-422X-10-321</pub-id><pub-id pub-id-type="pmid">24261589</pub-id></element-citation></ref><ref id="B20-viruses-12-00376"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnard</surname><given-names>K.N.</given-names></name><name><surname>Alford-Lawrence</surname><given-names>B.K.</given-names></name><name><surname>Buchholz</surname><given-names>D.W.</given-names></name><name><surname>Wasik</surname><given-names>B.R.</given-names></name><name><surname>LaClair</surname><given-names>J.R.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Honce</surname><given-names>R.</given-names></name><name><surname>Ruhl</surname><given-names>S.</given-names></name><name><surname>Pajic</surname><given-names>P.</given-names></name><name><surname>Daugherity</surname><given-names>E.K.</given-names></name><etal/></person-group><article-title>Modified sialic acids on mucus and erythrocytes inhibit influenza A HA and NA functions</article-title><source>J. Virol.</source><year>2020</year><pub-id pub-id-type="doi">10.1128/JVI.01567-19</pub-id></element-citation></ref><ref id="B21-viruses-12-00376"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Air</surname><given-names>G.M.</given-names></name></person-group><article-title>Influenza neuraminidase</article-title><source>Influenza Other Respir. Viruses</source><year>2012</year><volume>6</volume><fpage>245</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1111/j.1750-2659.2011.00304.x</pub-id><?supplied-pmid 22085243?><pub-id pub-id-type="pmid">22085243</pub-id></element-citation></ref><ref id="B22-viruses-12-00376"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evseenko</surname><given-names>V.A.</given-names></name><name><surname>Svyatchenko</surname><given-names>S.V.</given-names></name><name><surname>Kolosova</surname><given-names>N.P.</given-names></name><name><surname>Kovrizhkina</surname><given-names>V.L.</given-names></name><name><surname>Marchenko</surname><given-names>V.Y.</given-names></name><name><surname>Durymanov</surname><given-names>A.G.</given-names></name><name><surname>Goncharova</surname><given-names>N.I.</given-names></name><name><surname>Ryzhikov</surname><given-names>A.B.</given-names></name></person-group><article-title>Comparative thermostability analysis of zoonotic and human influenza virus A and B neuraminidase</article-title><source>Arch. Virol.</source><year>2019</year><volume>165</volume><fpage>201</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1007/s00705-019-04465-w</pub-id><?supplied-pmid 31745716?><pub-id pub-id-type="pmid">31745716</pub-id></element-citation></ref><ref id="B23-viruses-12-00376"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichelberger</surname><given-names>M.C.</given-names></name><name><surname>Morens</surname><given-names>D.M.</given-names></name><name><surname>Taubenberger</surname><given-names>J.K.</given-names></name></person-group><article-title>Neuraminidase as an influenza vaccine antigen: A low hanging fruit, ready for picking to improve vaccine effectiveness</article-title><source>Curr. Opin. Immunol.</source><year>2018</year><volume>53</volume><fpage>38</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2018.03.025</pub-id><?supplied-pmid 29674167?><pub-id pub-id-type="pmid">29674167</pub-id></element-citation></ref><ref id="B24-viruses-12-00376"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Turner</surname><given-names>H.L.</given-names></name><name><surname>Lang</surname><given-names>S.</given-names></name><name><surname>McBride</surname><given-names>R.</given-names></name><name><surname>Bangaru</surname><given-names>S.</given-names></name><name><surname>Gilchuk</surname><given-names>I.M.</given-names></name><name><surname>Yu</surname><given-names>W.</given-names></name><name><surname>Paulson</surname><given-names>J.C.</given-names></name><name><surname>Crowe</surname><given-names>J.E.</given-names></name><name><surname>Ward</surname><given-names>A.B.</given-names></name><etal/></person-group><article-title>Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies</article-title><source>Cell Host Microbe</source><year>2019</year><volume>26</volume><fpage>729</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2019.10.002</pub-id><pub-id pub-id-type="pmid">31757767</pub-id></element-citation></ref><ref id="B25-viruses-12-00376"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noda</surname><given-names>T.</given-names></name><name><surname>Kawaoka</surname><given-names>Y.</given-names></name></person-group><article-title>Structure of influenza virus ribonucleoprotein complexes and their packaging into virions</article-title><source>Rev. Med. Virol.</source><year>2010</year><volume>20</volume><fpage>380</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1002/rmv.666</pub-id><pub-id pub-id-type="pmid">20853340</pub-id></element-citation></ref><ref id="B26-viruses-12-00376"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisfeld</surname><given-names>A.J.</given-names></name><name><surname>Neumann</surname><given-names>G.</given-names></name><name><surname>Kawaoka</surname><given-names>Y.</given-names></name></person-group><article-title>At the centre: Influenza A virus ribonucleoproteins</article-title><source>Nat. Rev. Genet.</source><year>2015</year><volume>13</volume><fpage>28</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3367</pub-id></element-citation></ref><ref id="B27-viruses-12-00376"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velthuis</surname><given-names>A.T.</given-names></name><name><surname>Fodor</surname><given-names>E.</given-names></name></person-group><article-title>Influenza virus RNA polymerase: Insights into the mechanisms of viral RNA synthesis</article-title><source>Nat. Rev. Genet.</source><year>2016</year><volume>14</volume><fpage>479</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1038/nrmicro.2016.87</pub-id></element-citation></ref><ref id="B28-viruses-12-00376"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000f6;nig</surname><given-names>R.</given-names></name><name><surname>Stertz</surname><given-names>S.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Inoue</surname><given-names>A.</given-names></name><name><surname>Hoffmann</surname><given-names>H.-H.</given-names></name><name><surname>Bhattacharyya</surname><given-names>S.</given-names></name><name><surname>Alamares</surname><given-names>J.G.</given-names></name><name><surname>Tscherne</surname><given-names>N.M.</given-names></name><name><surname>Ortigoza</surname><given-names>M.</given-names></name><name><surname>Liang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Human host factors required for influenza virus replication</article-title><source>Nature</source><year>2010</year><volume>463</volume><fpage>813</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1038/nature08699</pub-id><pub-id pub-id-type="pmid">20027183</pub-id></element-citation></ref><ref id="B29-viruses-12-00376"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlas</surname><given-names>A.</given-names></name><name><surname>Machuy</surname><given-names>N.</given-names></name><name><surname>Shin</surname><given-names>Y.</given-names></name><name><surname>Pleissner</surname><given-names>K.-P.</given-names></name><name><surname>Artarini</surname><given-names>A.</given-names></name><name><surname>Heuer</surname><given-names>D.</given-names></name><name><surname>Becker</surname><given-names>D.</given-names></name><name><surname>Khalil</surname><given-names>H.</given-names></name><name><surname>Ogilvie</surname><given-names>L.</given-names></name><name><surname>Hess</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication</article-title><source>Nature</source><year>2010</year><volume>463</volume><fpage>818</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1038/nature08760</pub-id><pub-id pub-id-type="pmid">20081832</pub-id></element-citation></ref><ref id="B30-viruses-12-00376"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Gao</surname><given-names>Q.</given-names></name><name><surname>Cheng</surname><given-names>T.</given-names></name><name><surname>Xiao</surname><given-names>R.</given-names></name><name><surname>Ming</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Jin</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Ma</surname><given-names>W.</given-names></name><etal/></person-group><article-title>The Nucleolar Protein LYAR Facilitates Ribonucleoprotein Assembly of Influenza A Virus</article-title><source>J. Virol.</source><year>2018</year><volume>92</volume><pub-id pub-id-type="doi">10.1128/JVI.01042-18</pub-id></element-citation></ref><ref id="B31-viruses-12-00376"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Yan</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Huang</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>X.-H.</given-names></name></person-group><article-title>Inhibition viral RNP and anti-inflammatory activity of coumarins against influenza virus</article-title><source>Biomed. Pharmacother.</source><year>2017</year><volume>87</volume><fpage>583</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2016.12.117</pub-id><?supplied-pmid 28081470?><pub-id pub-id-type="pmid">28081470</pub-id></element-citation></ref><ref id="B32-viruses-12-00376"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamb</surname><given-names>R.A.</given-names></name><name><surname>Lai</surname><given-names>C.J.</given-names></name><name><surname>Choppin</surname><given-names>P.W.</given-names></name></person-group><article-title>Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: Colinear and interrupted mRNAs code for overlapping proteins</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1981</year><volume>78</volume><fpage>4170</fpage><lpage>4174</lpage><pub-id pub-id-type="doi">10.1073/pnas.78.7.4170</pub-id><?supplied-pmid 6945577?><pub-id pub-id-type="pmid">6945577</pub-id></element-citation></ref><ref id="B33-viruses-12-00376"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safo</surname><given-names>M.K.</given-names></name><name><surname>Musayev</surname><given-names>F.N.</given-names></name><name><surname>Mosier</surname><given-names>P.D.</given-names></name><name><surname>Zhou</surname><given-names>Q.</given-names></name><name><surname>Xie</surname><given-names>H.</given-names></name><name><surname>Desai</surname><given-names>U.R.</given-names></name></person-group><article-title>Crystal Structures of Influenza A Virus Matrix Protein M1: Variations on a Theme</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e109510</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0109510</pub-id><?supplied-pmid 25295515?><pub-id pub-id-type="pmid">25295515</pub-id></element-citation></ref><ref id="B34-viruses-12-00376"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>L.H.</given-names></name><name><surname>Lamb</surname><given-names>R.A.</given-names></name></person-group><article-title>The M2 Proton Channels of Influenza A and B Viruses</article-title><source>J. Biol. Chem.</source><year>2006</year><volume>281</volume><fpage>8997</fpage><lpage>9000</lpage><pub-id pub-id-type="doi">10.1074/jbc.R500020200</pub-id><?supplied-pmid 16407184?><pub-id pub-id-type="pmid">16407184</pub-id></element-citation></ref><ref id="B35-viruses-12-00376"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>M.</given-names></name><name><surname>Pekosz</surname><given-names>A.</given-names></name><name><surname>Shuck</surname><given-names>K.</given-names></name><name><surname>Pinto</surname><given-names>L.H.</given-names></name><name><surname>A Lamb</surname><given-names>R.</given-names></name></person-group><article-title>Influenza A Virus M2 Ion Channel Activity Is Essential for Efficient Replication in Tissue Culture</article-title><source>J. Virol.</source><year>2002</year><volume>76</volume><fpage>1391</fpage><lpage>1399</lpage><pub-id pub-id-type="doi">10.1128/JVI.76.3.1391-1399.2002</pub-id><?supplied-pmid 11773413?><pub-id pub-id-type="pmid">11773413</pub-id></element-citation></ref><ref id="B36-viruses-12-00376"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhowmick</surname><given-names>S.</given-names></name><name><surname>Chakravarty</surname><given-names>C.</given-names></name><name><surname>Sellathamby</surname><given-names>S.</given-names></name><name><surname>Lal</surname><given-names>S.K.</given-names></name></person-group><article-title>The influenza A virus matrix protein 2 undergoes retrograde transport from the endoplasmic reticulum into the cytoplasm and bypasses cytoplasmic proteasomal degradation</article-title><source>Arch. Virol.</source><year>2016</year><volume>162</volume><fpage>919</fpage><lpage>929</lpage><pub-id pub-id-type="doi">10.1007/s00705-016-3153-8</pub-id><?supplied-pmid 27942972?><pub-id pub-id-type="pmid">27942972</pub-id></element-citation></ref><ref id="B37-viruses-12-00376"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso-Caplen</surname><given-names>F.V.</given-names></name><name><surname>Krug</surname><given-names>R.M.</given-names></name></person-group><article-title>Regulation of the extent of splicing of influenza virus NS1 mRNA: Role of the rates of splicing and of the nucleocytoplasmic transport of NS1 mRNA</article-title><source>Mol. Cell. Biol.</source><year>1991</year><volume>11</volume><fpage>1092</fpage><lpage>1098</lpage><pub-id pub-id-type="doi">10.1128/MCB.11.2.1092</pub-id><pub-id pub-id-type="pmid">1824958</pub-id></element-citation></ref><ref id="B38-viruses-12-00376"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sk&#x000f3;rko</surname><given-names>R.</given-names></name><name><surname>Summers</surname><given-names>D.F.</given-names></name><name><surname>Galarza</surname><given-names>J.M.</given-names></name></person-group><article-title>Influenza A virus in vitro transcription: Roles of NS1 and NP proteins in regulating RNA synthesis</article-title><source>Virology</source><year>1991</year><volume>180</volume><fpage>668</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1016/0042-6822(91)90080-U</pub-id><pub-id pub-id-type="pmid">1824905</pub-id></element-citation></ref><ref id="B39-viruses-12-00376"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marc</surname><given-names>D.</given-names></name></person-group><article-title>Influenza virus non-structural protein NS1: Interferon antagonism and beyond</article-title><source>J. Gen. Virol.</source><year>2014</year><volume>95</volume><fpage>2594</fpage><lpage>2611</lpage><pub-id pub-id-type="doi">10.1099/vir.0.069542-0</pub-id><pub-id pub-id-type="pmid">25182164</pub-id></element-citation></ref><ref id="B40-viruses-12-00376"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hale</surname><given-names>B.</given-names></name><name><surname>Randall</surname><given-names>R.</given-names></name><name><surname>Ort&#x000ed;n</surname><given-names>J.</given-names></name><name><surname>Jackson</surname><given-names>D.</given-names></name></person-group><article-title>The multifunctional NS1 protein of influenza A viruses</article-title><source>J. Gen. Virol.</source><year>2008</year><volume>89</volume><fpage>2359</fpage><lpage>2376</lpage><pub-id pub-id-type="doi">10.1099/vir.0.2008/004606-0</pub-id><pub-id pub-id-type="pmid">18796704</pub-id></element-citation></ref><ref id="B41-viruses-12-00376"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkins</surname><given-names>C.</given-names></name><name><surname>Gale</surname><given-names>M.</given-names></name></person-group><article-title>Recognition of viruses by cytoplasmic sensors</article-title><source>Curr. Opin. Immunol.</source><year>2010</year><volume>22</volume><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2009.12.003</pub-id><?supplied-pmid 20061127?><pub-id pub-id-type="pmid">20061127</pub-id></element-citation></ref><ref id="B42-viruses-12-00376"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehwinkel</surname><given-names>J.</given-names></name><name><surname>Tan</surname><given-names>C.P.</given-names></name><name><surname>Goubau</surname><given-names>D.</given-names></name><name><surname>Schulz</surname><given-names>O.</given-names></name><name><surname>Pichlmair</surname><given-names>A.</given-names></name><name><surname>Bier</surname><given-names>K.</given-names></name><name><surname>Robb</surname><given-names>N.</given-names></name><name><surname>Vreede</surname><given-names>F.</given-names></name><name><surname>Barclay</surname><given-names>W.S.</given-names></name><name><surname>Fodor</surname><given-names>E.</given-names></name><etal/></person-group><article-title>RIG-I Detects Viral Genomic RNA during Negative-Strand RNA Virus Infection</article-title><source>Cell</source><year>2010</year><volume>140</volume><fpage>397</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.01.020</pub-id><?supplied-pmid 20144762?><pub-id pub-id-type="pmid">20144762</pub-id></element-citation></ref><ref id="B43-viruses-12-00376"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Xie</surname><given-names>Y.</given-names></name><name><surname>Mu&#x000f1;oz-Moreno</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Esparza</surname><given-names>M.</given-names></name><name><surname>Garc&#x000ed;a-Sastre</surname><given-names>A.</given-names></name><name><surname>Fontoura</surname><given-names>B.M.A.</given-names></name><name><surname>Ren</surname><given-names>Y.</given-names></name></person-group><article-title>Structural basis for influenza virus NS1 protein block of mRNA nuclear export</article-title><source>Nat. Microbiol.</source><year>2019</year><volume>4</volume><fpage>1671</fpage><lpage>1679</lpage><pub-id pub-id-type="doi">10.1038/s41564-019-0482-x</pub-id><?supplied-pmid 31263181?><pub-id pub-id-type="pmid">31263181</pub-id></element-citation></ref><ref id="B44-viruses-12-00376"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baranovskaya</surname><given-names>I.</given-names></name><name><surname>Sergeeva</surname><given-names>M.</given-names></name><name><surname>Fadeev</surname><given-names>A.</given-names></name><name><surname>Kadirova</surname><given-names>R.</given-names></name><name><surname>Ivanova</surname><given-names>A.</given-names></name><name><surname>Ramsay</surname><given-names>E.</given-names></name><name><surname>Vasin</surname><given-names>A.</given-names></name></person-group><article-title>Changes in RNA secondary structure affect NS1 protein expression during early stage influenza virus infection</article-title><source>Virol. J.</source><year>2019</year><volume>16</volume><fpage>162</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1186/s12985-019-1271-0</pub-id><?supplied-pmid 31864377?><pub-id pub-id-type="pmid">31864377</pub-id></element-citation></ref><ref id="B45-viruses-12-00376"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>C.W.</given-names></name><name><surname>Jeong</surname><given-names>M.S.</given-names></name><name><surname>Jang</surname><given-names>S.B.</given-names></name></person-group><article-title>Structure and Function of the Influenza A Virus Non-Structural Protein 1</article-title><source>J. Microbiol. Biotechnol.</source><year>2019</year><volume>29</volume><fpage>1184</fpage><lpage>1192</lpage><pub-id pub-id-type="doi">10.4014/jmb.1903.03053</pub-id><?supplied-pmid 31154753?><pub-id pub-id-type="pmid">31154753</pub-id></element-citation></ref><ref id="B46-viruses-12-00376"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Neill</surname><given-names>R.E.</given-names></name><name><surname>Talon</surname><given-names>J.</given-names></name><name><surname>Palese</surname><given-names>P.</given-names></name></person-group><article-title>The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins</article-title><source>EMBO J.</source><year>1998</year><volume>17</volume><fpage>288</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1093/emboj/17.1.288</pub-id><?supplied-pmid 9427762?><pub-id pub-id-type="pmid">9427762</pub-id></element-citation></ref><ref id="B47-viruses-12-00376"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elton</surname><given-names>D.</given-names></name><name><surname>Simpson-Holley</surname><given-names>M.</given-names></name><name><surname>Archer</surname><given-names>K.</given-names></name><name><surname>Medcalf</surname><given-names>L.</given-names></name><name><surname>Hallam</surname><given-names>R.</given-names></name><name><surname>McCauley</surname><given-names>J.</given-names></name><name><surname>Digard</surname><given-names>P.</given-names></name></person-group><article-title>Interaction of the Influenza Virus Nucleoprotein with the Cellular CRM1-Mediated Nuclear Export Pathway</article-title><source>J. Virol.</source><year>2001</year><volume>75</volume><fpage>408</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.1.408-419.2001</pub-id><pub-id pub-id-type="pmid">11119609</pub-id></element-citation></ref><ref id="B48-viruses-12-00376"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Yao</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name></person-group><article-title>A Second CRM1-Dependent Nuclear Export Signal in the Influenza A Virus NS2 Protein Contributes to the Nuclear Export of Viral Ribonucleoproteins</article-title><source>J. Virol.</source><year>2012</year><volume>87</volume><fpage>767</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1128/JVI.06519-11</pub-id><pub-id pub-id-type="pmid">23115280</pub-id></element-citation></ref><ref id="B49-viruses-12-00376"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>A.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Jin</surname><given-names>M.</given-names></name></person-group><article-title>CHD3 facilitates vRNP nuclear export by interacting with NES1 of influenza A virus NS2</article-title><source>Cell. Mol. Life Sci.</source><year>2014</year><volume>72</volume><fpage>971</fpage><lpage>982</lpage><pub-id pub-id-type="doi">10.1007/s00018-014-1726-9</pub-id><pub-id pub-id-type="pmid">25213355</pub-id></element-citation></ref><ref id="B50-viruses-12-00376"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>L.-Y.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name></person-group><article-title>Investigational hemagglutinin-targeted influenza virus inhibitors</article-title><source>Expert Opin. Investig. Drugs</source><year>2016</year><volume>26</volume><fpage>63</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1080/13543784.2017.1269170</pub-id></element-citation></ref><ref id="B51-viruses-12-00376"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bui</surname><given-names>C.</given-names></name><name><surname>Chughtai</surname><given-names>A.A.</given-names></name><name><surname>Adam</surname><given-names>D.C.</given-names></name><name><surname>MacIntyre</surname><given-names>C.R.</given-names></name></person-group><article-title>An overview of the epidemiology and emergence of influenza A infection in humans over time</article-title><source>Arch. Public Health</source><year>2017</year><volume>75</volume><fpage>15</fpage><pub-id pub-id-type="doi">10.1186/s13690-017-0182-z</pub-id><?supplied-pmid 28352464?><pub-id pub-id-type="pmid">28352464</pub-id></element-citation></ref><ref id="B52-viruses-12-00376"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrat</surname><given-names>F.</given-names></name><name><surname>Flahault</surname><given-names>A.</given-names></name></person-group><article-title>Influenza vaccine: The challenge of antigenic drift</article-title><source>Vaccine</source><year>2007</year><volume>25</volume><fpage>6852</fpage><lpage>6862</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2007.07.027</pub-id><?supplied-pmid 17719149?><pub-id pub-id-type="pmid">17719149</pub-id></element-citation></ref><ref id="B53-viruses-12-00376"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Madan</surname><given-names>R.</given-names></name><name><surname>Karp</surname><given-names>C.</given-names></name><name><surname>Braciale</surname><given-names>T.J.</given-names></name></person-group><article-title>Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10</article-title><source>Nat. Med.</source><year>2009</year><volume>15</volume><fpage>277</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1038/nm.1929</pub-id><?supplied-pmid 19234462?><pub-id pub-id-type="pmid">19234462</pub-id></element-citation></ref><ref id="B54-viruses-12-00376"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciminski</surname><given-names>K.</given-names></name><name><surname>Thamamongood</surname><given-names>T.</given-names></name><name><surname>Zimmer</surname><given-names>G.</given-names></name><name><surname>Schwemmle</surname><given-names>M.</given-names></name></person-group><article-title>Novel insights into bat influenza A viruses</article-title><source>J. Gen. Virol.</source><year>2017</year><volume>98</volume><fpage>2393</fpage><lpage>2400</lpage><pub-id pub-id-type="doi">10.1099/jgv.0.000927</pub-id><pub-id pub-id-type="pmid">28906230</pub-id></element-citation></ref><ref id="B55-viruses-12-00376"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butt</surname><given-names>K.M.</given-names></name><name><surname>Smith</surname><given-names>G.J.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>L.J.</given-names></name><name><surname>Leung</surname><given-names>Y.H.C.</given-names></name><name><surname>Xu</surname><given-names>K.M.</given-names></name><name><surname>Lim</surname><given-names>W.</given-names></name><name><surname>Webster</surname><given-names>R.G.</given-names></name><name><surname>Yuen</surname><given-names>K.-Y.</given-names></name><name><surname>Peiris</surname><given-names>J.S.M.</given-names></name><etal/></person-group><article-title>Human Infection with an Avian H9N2 Influenza A Virus in Hong Kong in 2003</article-title><source>J. Clin. Microbiol.</source><year>2005</year><volume>43</volume><fpage>5760</fpage><lpage>5767</lpage><pub-id pub-id-type="doi">10.1128/JCM.43.11.5760-5767.2005</pub-id><pub-id pub-id-type="pmid">16272514</pub-id></element-citation></ref><ref id="B56-viruses-12-00376"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Yuan</surname><given-names>H.</given-names></name><name><surname>Gao</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>D.-Y.</given-names></name><name><surname>Xiong</surname><given-names>Y.</given-names></name><name><surname>Fan</surname><given-names>G.</given-names></name><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: A descriptive study</article-title><source>Lancet</source><year>2014</year><volume>383</volume><fpage>714</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(14)60111-2</pub-id><pub-id pub-id-type="pmid">24507376</pub-id></element-citation></ref><ref id="B57-viruses-12-00376"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z.-F.</given-names></name><name><surname>Mok</surname><given-names>C.K.P.</given-names></name><name><surname>Peiris</surname><given-names>J.S.M.</given-names></name><name><surname>Zhong</surname><given-names>N.</given-names></name></person-group><article-title>Human Infection with a Novel Avian Influenza A (H5N6) Virus</article-title><source>N. Engl. J. Med.</source><year>2015</year><volume>373</volume><fpage>487</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1056/NEJMc1502983</pub-id></element-citation></ref><ref id="B58-viruses-12-00376"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>R.</given-names></name><name><surname>Cao</surname><given-names>B.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Feng</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>D.-Y.</given-names></name><name><surname>Hu</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Jie</surname><given-names>Z.</given-names></name><name><surname>Qiu</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus</article-title><source>N. Engl. J. Med.</source><year>2013</year><volume>368</volume><fpage>1888</fpage><lpage>1897</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1304459</pub-id><pub-id pub-id-type="pmid">23577628</pub-id></element-citation></ref><ref id="B59-viruses-12-00376"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Qi</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>G.F.</given-names></name></person-group><article-title>Enabling the &#x02019;host jump&#x02019;: Structural determinants of receptor-binding specificity in influenza A viruses</article-title><source>Nat. Rev. Genet.</source><year>2014</year><volume>12</volume><fpage>822</fpage><lpage>831</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3362</pub-id></element-citation></ref><ref id="B60-viruses-12-00376"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Vries</surname><given-names>R.P.</given-names></name><name><surname>Peng</surname><given-names>W.</given-names></name><name><surname>Grant</surname><given-names>O.</given-names></name><name><surname>Thompson</surname><given-names>A.J.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Bouwman</surname><given-names>K.M.</given-names></name><name><surname>De La Pena</surname><given-names>A.T.T.</given-names></name><name><surname>Van Breemen</surname><given-names>M.J.</given-names></name><name><surname>Wickramasinghe</surname><given-names>I.N.A.</given-names></name><name><surname>De Haan</surname><given-names>C.A.M.</given-names></name><etal/></person-group><article-title>Three mutations switch H7N9 influenza to human-type receptor specificity</article-title><source>PLoS Pathog.</source><year>2017</year><volume>13</volume><elocation-id>e1006390</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006390</pub-id><pub-id pub-id-type="pmid">28617868</pub-id></element-citation></ref><ref id="B61-viruses-12-00376"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>J.</given-names></name><name><surname>Blixt</surname><given-names>O.</given-names></name><name><surname>Tumpey</surname><given-names>T.M.</given-names></name><name><surname>Taubenberger</surname><given-names>J.K.</given-names></name><name><surname>Paulson</surname><given-names>J.C.</given-names></name><name><surname>Wilson</surname><given-names>I.A.</given-names></name></person-group><article-title>Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus</article-title><source>Science</source><year>2006</year><volume>312</volume><fpage>404</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1126/science.1124513</pub-id><?supplied-pmid 16543414?><pub-id pub-id-type="pmid">16543414</pub-id></element-citation></ref><ref id="B62-viruses-12-00376"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Vries</surname><given-names>E.</given-names></name><name><surname>Du</surname><given-names>W.</given-names></name><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>De Haan</surname><given-names>C.A.</given-names></name></person-group><article-title>Influenza A Virus Hemagglutinin-Neuraminidase-Receptor Balance: Preserving Virus Motility</article-title><source>Trends Microbiol.</source><year>2020</year><volume>28</volume><fpage>57</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2019.08.010</pub-id><?supplied-pmid 31629602?><pub-id pub-id-type="pmid">31629602</pub-id></element-citation></ref><ref id="B63-viruses-12-00376"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>J.S.</given-names></name><name><surname>Mistry</surname><given-names>B.</given-names></name><name><surname>Haslam</surname><given-names>S.</given-names></name><name><surname>Barclay</surname><given-names>W.S.</given-names></name></person-group><article-title>Host and viral determinants of influenza A virus species specificity</article-title><source>Nat. Rev. Genet.</source><year>2019</year><volume>17</volume><fpage>67</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1038/s41579-018-0115-z</pub-id><?supplied-pmid 30487536?><pub-id pub-id-type="pmid">30487536</pub-id></element-citation></ref><ref id="B64-viruses-12-00376"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>I.H.</given-names></name></person-group><article-title>History and Epidemiology of Swine Influenza in Europe</article-title><source>Curr. Top. Microbiol. Immunol.</source><year>2011</year><volume>370</volume><fpage>133</fpage><lpage>146</lpage></element-citation></ref><ref id="B65-viruses-12-00376"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skehel</surname><given-names>J.J.</given-names></name><name><surname>Wiley</surname><given-names>D.C.</given-names></name></person-group><article-title>Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin</article-title><source>Annu. Rev. Biochem.</source><year>2000</year><volume>69</volume><fpage>531</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.69.1.531</pub-id><?supplied-pmid 10966468?><pub-id pub-id-type="pmid">10966468</pub-id></element-citation></ref><ref id="B66-viruses-12-00376"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>G.J.</given-names></name><name><surname>Dhanasekaran</surname><given-names>V.</given-names></name><name><surname>Bahl</surname><given-names>J.</given-names></name><name><surname>Lycett</surname><given-names>S.J.</given-names></name><name><surname>Worobey</surname><given-names>M.</given-names></name><name><surname>Pybus</surname><given-names>O.G.</given-names></name><name><surname>Ma</surname><given-names>S.K.</given-names></name><name><surname>Cheung</surname><given-names>C.L.</given-names></name><name><surname>Raghwani</surname><given-names>J.</given-names></name><name><surname>Bhatt</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic</article-title><source>Nature</source><year>2009</year><volume>459</volume><fpage>1122</fpage><lpage>1125</lpage><pub-id pub-id-type="doi">10.1038/nature08182</pub-id><?supplied-pmid 19516283?><pub-id pub-id-type="pmid">19516283</pub-id></element-citation></ref><ref id="B67-viruses-12-00376"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>J.L.</given-names></name><name><surname>Lee</surname><given-names>B.E.</given-names></name><name><surname>Patel</surname><given-names>J.</given-names></name><name><surname>Bastien</surname><given-names>N.</given-names></name><name><surname>Grimsrud</surname><given-names>K.</given-names></name><name><surname>Seal</surname><given-names>R.F.</given-names></name><name><surname>King</surname><given-names>R.</given-names></name><name><surname>Marshall</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group><article-title>Swine Influenza (H3N2) Infection in a Child and Possible Community Transmission, Canada</article-title><source>Emerg. Infect. Dis.</source><year>2007</year><volume>13</volume><fpage>1865</fpage><lpage>1870</lpage><pub-id pub-id-type="doi">10.3201/eid1312.070615</pub-id><pub-id pub-id-type="pmid">18258037</pub-id></element-citation></ref><ref id="B68-viruses-12-00376"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herfst</surname><given-names>S.</given-names></name><name><surname>Imai</surname><given-names>M.</given-names></name><name><surname>Kawaoka</surname><given-names>Y.</given-names></name><name><surname>Fouchier</surname><given-names>R.</given-names></name></person-group><article-title>Avian Influenza Virus Transmission to Mammals</article-title><source>Curr. Top. Microbiol. Immunol.</source><year>2014</year><volume>385</volume><fpage>137</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">25048542</pub-id></element-citation></ref><ref id="B69-viruses-12-00376"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwasaki</surname><given-names>Y.</given-names></name><name><surname>Abe</surname><given-names>T.</given-names></name><name><surname>Wada</surname><given-names>Y.</given-names></name><name><surname>Wada</surname><given-names>K.</given-names></name><name><surname>Ikemura</surname><given-names>T.</given-names></name></person-group><article-title>Novel bioinformatics strategies for prediction of directional sequence changes in influenza virus genomes and for surveillance of potentially hazardous strains</article-title><source>BMC Infect. Dis.</source><year>2013</year><volume>13</volume><elocation-id>386</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2334-13-386</pub-id><pub-id pub-id-type="pmid">23964903</pub-id></element-citation></ref><ref id="B70-viruses-12-00376"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eng</surname><given-names>C.L.P.</given-names></name><name><surname>Tong</surname><given-names>J.C.</given-names></name><name><surname>Tan</surname><given-names>T.W.</given-names></name></person-group><article-title>Distinct Host Tropism Protein Signatures to Identify Possible Zoonotic Influenza A Viruses</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0150173</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0150173</pub-id><pub-id pub-id-type="pmid">26915079</pub-id></element-citation></ref><ref id="B71-viruses-12-00376"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiang</surname><given-names>X.</given-names></name><name><surname>Kou</surname><given-names>Z.</given-names></name><name><surname>Fang</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>Scoring Amino Acid Mutations to Predict Avian-to-Human Transmission of Avian Influenza Viruses</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>1584</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23071584</pub-id><?supplied-pmid 29966263?><pub-id pub-id-type="pmid">29966263</pub-id></element-citation></ref><ref id="B72-viruses-12-00376"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Giallonardo</surname><given-names>F.</given-names></name><name><surname>Schlub</surname><given-names>T.E.</given-names></name><name><surname>Shi</surname><given-names>M.</given-names></name><name><surname>Holmes</surname><given-names>E.C.</given-names></name></person-group><article-title>Dinucleotide Composition in Animal RNA Viruses Is Shaped More by Virus Family than by Host Species</article-title><source>J. Virol.</source><year>2017</year><volume>91</volume><pub-id pub-id-type="doi">10.1128/JVI.02381-16</pub-id><?supplied-pmid 28148785?><pub-id pub-id-type="pmid">28148785</pub-id></element-citation></ref><ref id="B73-viruses-12-00376"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Kang</surname><given-names>X.-P.</given-names></name><name><surname>Wu</surname><given-names>X.-Y.</given-names></name><name><surname>Huang</surname><given-names>M.-T.</given-names></name><name><surname>Li</surname><given-names>Y.-C.</given-names></name><name><surname>Zhao</surname><given-names>Z.-P.</given-names></name><name><surname>Qin</surname><given-names>C.-F.</given-names></name><etal/></person-group><article-title>Machine Learning Methods for Predicting Human-Adaptive Influenza A Viruses Based on Viral Nucleotide Compositions</article-title><source>Mol. Biol. Evol.</source><year>2019</year><volume>37</volume><fpage>1224</fpage><lpage>1236</lpage><pub-id pub-id-type="doi">10.1093/molbev/msz276</pub-id><?supplied-pmid 31750915?><pub-id pub-id-type="pmid">31750915</pub-id></element-citation></ref><ref id="B74-viruses-12-00376"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babayan</surname><given-names>S.A.</given-names></name><name><surname>Orton</surname><given-names>R.J.</given-names></name><name><surname>Streicker</surname><given-names>D.G.</given-names></name></person-group><article-title>Predicting reservoir hosts and arthropod vectors from evolutionary signatures in RNA virus genomes</article-title><source>Science</source><year>2018</year><volume>362</volume><fpage>577</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1126/science.aap9072</pub-id><?supplied-pmid 30385576?><pub-id pub-id-type="pmid">30385576</pub-id></element-citation></ref><ref id="B75-viruses-12-00376"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinheimer</surname><given-names>V.K.</given-names></name><name><surname>Becher</surname><given-names>A.</given-names></name><name><surname>T&#x000f6;nnies</surname><given-names>M.</given-names></name><name><surname>Holland</surname><given-names>G.</given-names></name><name><surname>Knepper</surname><given-names>J.</given-names></name><name><surname>Bauer</surname><given-names>T.T.</given-names></name><name><surname>Schneider</surname><given-names>P.</given-names></name><name><surname>Neudecker</surname><given-names>J.</given-names></name><name><surname>R&#x000fc;ckert</surname><given-names>J.C.</given-names></name><name><surname>Szymanski</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Influenza A Viruses Target Type II Pneumocytes in the Human Lung</article-title><source>J. Infect. Dis.</source><year>2012</year><volume>206</volume><fpage>1685</fpage><lpage>1694</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis455</pub-id><pub-id pub-id-type="pmid">22829640</pub-id></element-citation></ref><ref id="B76-viruses-12-00376"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>K.H.</given-names></name><name><surname>Kakkola</surname><given-names>L.</given-names></name><name><surname>Nagaraj</surname><given-names>A.S.</given-names></name><name><surname>Cheltsov</surname><given-names>A.V.</given-names></name><name><surname>Anastasina</surname><given-names>M.</given-names></name><name><surname>Kainov</surname><given-names>D.</given-names></name></person-group><article-title>Emerging cellular targets for influenza antiviral agents</article-title><source>Trends Pharmacol. Sci.</source><year>2012</year><volume>33</volume><fpage>89</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2011.10.004</pub-id><pub-id pub-id-type="pmid">22196854</pub-id></element-citation></ref><ref id="B77-viruses-12-00376"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Riel</surname><given-names>D.</given-names></name><name><surname>Bakker</surname><given-names>M.A.D.</given-names></name><name><surname>Leijten</surname><given-names>L.M.</given-names></name><name><surname>Chutinimitkul</surname><given-names>S.</given-names></name><name><surname>Munster</surname><given-names>V.</given-names></name><name><surname>De Wit</surname><given-names>E.</given-names></name><name><surname>Rimmelzwaan</surname><given-names>G.F.</given-names></name><name><surname>Fouchier</surname><given-names>R.A.</given-names></name><name><surname>Osterhaus</surname><given-names>A.D.</given-names></name><name><surname>Kuiken</surname><given-names>T.</given-names></name></person-group><article-title>Seasonal and Pandemic Human Influenza Viruses Attach Better to Human Upper Respiratory Tract Epithelium than Avian Influenza Viruses</article-title><source>Am. J. Pathol.</source><year>2010</year><volume>176</volume><fpage>1614</fpage><lpage>1618</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2010.090949</pub-id><pub-id pub-id-type="pmid">20167867</pub-id></element-citation></ref><ref id="B78-viruses-12-00376"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Riel</surname><given-names>D.</given-names></name><name><surname>Munster</surname><given-names>V.</given-names></name><name><surname>De Wit</surname><given-names>E.</given-names></name><name><surname>Rimmelzwaan</surname><given-names>G.F.</given-names></name><name><surname>Fouchier</surname><given-names>R.A.</given-names></name><name><surname>Osterhaus</surname><given-names>A.D.</given-names></name><name><surname>Kuiken</surname><given-names>T.</given-names></name></person-group><article-title>Human and Avian Influenza Viruses Target Different Cells in the Lower Respiratory Tract of Humans and Other Mammals</article-title><source>Am. J. Pathol.</source><year>2007</year><volume>171</volume><fpage>1215</fpage><lpage>1223</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2007.070248</pub-id><pub-id pub-id-type="pmid">17717141</pub-id></element-citation></ref><ref id="B79-viruses-12-00376"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olofsson</surname><given-names>S.</given-names></name><name><surname>Kumlin</surname><given-names>U.</given-names></name><name><surname>Dimock</surname><given-names>K.</given-names></name><name><surname>Arnberg</surname><given-names>N.</given-names></name></person-group><article-title>Avian influenza and sialic acid receptors: More than meets the eye?</article-title><source>Lancet Infect. Dis.</source><year>2005</year><volume>5</volume><fpage>184</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(05)70026-8</pub-id><pub-id pub-id-type="pmid">15766653</pub-id></element-citation></ref><ref id="B80-viruses-12-00376"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Vries</surname><given-names>E.</given-names></name><name><surname>De Vries</surname><given-names>R.P.</given-names></name><name><surname>Wienholts</surname><given-names>M.J.</given-names></name><name><surname>Floris</surname><given-names>C.E.</given-names></name><name><surname>Jacobs</surname><given-names>M.-S.</given-names></name><name><surname>Heuvel</surname><given-names>A.V.D.</given-names></name><name><surname>Rottier</surname><given-names>P.J.M.</given-names></name><name><surname>De Haan</surname><given-names>C.A.M.</given-names></name></person-group><article-title>Influenza A virus entry into cells lacking sialylated N-glycans</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2012</year><volume>109</volume><fpage>7457</fpage><lpage>7462</lpage><pub-id pub-id-type="doi">10.1073/pnas.1200987109</pub-id><pub-id pub-id-type="pmid">22529385</pub-id></element-citation></ref><ref id="B81-viruses-12-00376"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>J.S.</given-names></name><name><surname>Webby</surname><given-names>R.</given-names></name><name><surname>Gilchrist</surname><given-names>M.J.</given-names></name><name><surname>Gray</surname><given-names>G.C.</given-names></name></person-group><article-title>Avian influenza among waterfowl hunters and wildlife professionals</article-title><source>Emerg. Infect. Dis.</source><year>2006</year><volume>12</volume><fpage>1284</fpage><lpage>1286</lpage><pub-id pub-id-type="doi">10.3201/eid1708.060492</pub-id><?supplied-pmid 16965717?><pub-id pub-id-type="pmid">16965717</pub-id></element-citation></ref><ref id="B82-viruses-12-00376"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>L.W.</given-names></name><name><surname>Mao</surname><given-names>H.J.</given-names></name><name><surname>Wu</surname><given-names>Y.-L.</given-names></name><name><surname>Tanaka</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name></person-group><article-title>TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections</article-title><source>Biochimie</source><year>2017</year><volume>142</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2017.07.016</pub-id><?supplied-pmid 28778717?><pub-id pub-id-type="pmid">28778717</pub-id></element-citation></ref><ref id="B83-viruses-12-00376"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>B.S.</given-names></name><name><surname>Gludish</surname><given-names>D.W.J.</given-names></name><name><surname>Whittaker</surname><given-names>G.R.</given-names></name></person-group><article-title>Cleavage Activation of the Human-Adapted Influenza Virus Subtypes by Matriptase Reveals both Subtype and Strain Specificities</article-title><source>J. Virol.</source><year>2012</year><volume>86</volume><fpage>10579</fpage><lpage>10586</lpage><pub-id pub-id-type="doi">10.1128/JVI.00306-12</pub-id><?supplied-pmid 22811538?><pub-id pub-id-type="pmid">22811538</pub-id></element-citation></ref><ref id="B84-viruses-12-00376"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>H.-I.</given-names></name><name><surname>Kim</surname><given-names>Y.-I.</given-names></name><name><surname>Park</surname><given-names>S.-J.</given-names></name><name><surname>Kim</surname><given-names>E.-H.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Si</surname><given-names>Y.-J.</given-names></name><name><surname>Song</surname><given-names>M.-S.</given-names></name><name><surname>Pascua</surname><given-names>P.N.Q.</given-names></name><name><surname>Govorkova</surname><given-names>E.A.</given-names></name><name><surname>Webster</surname><given-names>R.G.</given-names></name><etal/></person-group><article-title>A Novel Neuraminidase-Dependent Hemagglutinin Cleavage Mechanism Enables the Systemic Spread of an H7N6 Avian Influenza Virus</article-title><source>mBio</source><year>2019</year><volume>10</volume><fpage>10</fpage><pub-id pub-id-type="doi">10.1128/mBio.02369-19</pub-id></element-citation></ref><ref id="B85-viruses-12-00376"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaipan</surname><given-names>C.</given-names></name><name><surname>Kobasa</surname><given-names>D.</given-names></name><name><surname>Bertram</surname><given-names>S.</given-names></name><name><surname>Glowacka</surname><given-names>I.</given-names></name><name><surname>Steffen</surname><given-names>I.</given-names></name><name><surname>Tsegaye</surname><given-names>T.S.</given-names></name><name><surname>Takeda</surname><given-names>M.</given-names></name><name><surname>Bugge</surname><given-names>T.H.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Park</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Proteolytic Activation of the 1918 Influenza Virus Hemagglutinin</article-title><source>J. Virol.</source><year>2009</year><volume>83</volume><fpage>3200</fpage><lpage>3211</lpage><pub-id pub-id-type="doi">10.1128/JVI.02205-08</pub-id><pub-id pub-id-type="pmid">19158246</pub-id></element-citation></ref><ref id="B86-viruses-12-00376"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietze</surname><given-names>K.</given-names></name><name><surname>Graaf</surname><given-names>A.</given-names></name><name><surname>Homeier-Bachmann</surname><given-names>T.</given-names></name><name><surname>Grund</surname><given-names>C.</given-names></name><name><surname>Forth</surname><given-names>L.</given-names></name><name><surname>Pohlmann</surname><given-names>A.</given-names></name><name><surname>Jeske</surname><given-names>C.</given-names></name><name><surname>Wintermann</surname><given-names>M.</given-names></name><name><surname>Beer</surname><given-names>M.</given-names></name><name><surname>Conraths</surname><given-names>F.J.</given-names></name><etal/></person-group><article-title>From low to high pathogenicity-Characterization of H7N7 avian influenza viruses in two epidemiologically linked outbreaks</article-title><source>Transbound. Emerg. Dis.</source><year>2018</year><volume>65</volume><fpage>1576</fpage><lpage>1587</lpage><pub-id pub-id-type="doi">10.1111/tbed.12906</pub-id><pub-id pub-id-type="pmid">29790657</pub-id></element-citation></ref><ref id="B87-viruses-12-00376"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gultyaev</surname><given-names>A.P.</given-names></name><name><surname>Spronken</surname><given-names>M.I.</given-names></name><name><surname>Richard</surname><given-names>M.</given-names></name><name><surname>Schrauwen</surname><given-names>E.J.A.</given-names></name><name><surname>Olsthoorn</surname><given-names>R.</given-names></name><name><surname>Fouchier</surname><given-names>R.</given-names></name></person-group><article-title>Subtype-specific structural constraints in the evolution of influenza A virus hemagglutinin genes</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>38892</fpage><pub-id pub-id-type="doi">10.1038/srep38892</pub-id><pub-id pub-id-type="pmid">27966593</pub-id></element-citation></ref><ref id="B88-viruses-12-00376"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulo</surname><given-names>S.</given-names></name><name><surname>Akarsu</surname><given-names>H.</given-names></name><name><surname>Ruigrok</surname><given-names>R.W.</given-names></name><name><surname>Baudin</surname><given-names>F.</given-names></name></person-group><article-title>Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes</article-title><source>Virus Res.</source><year>2007</year><volume>124</volume><fpage>12</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2006.09.013</pub-id><pub-id pub-id-type="pmid">17081640</pub-id></element-citation></ref><ref id="B89-viruses-12-00376"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>A.</given-names></name><name><surname>Bouvier</surname><given-names>D.</given-names></name><name><surname>Crepin</surname><given-names>T.</given-names></name><name><surname>McCarthy</surname><given-names>A.A.</given-names></name><name><surname>Hart</surname><given-names>D.J.</given-names></name><name><surname>Baudin</surname><given-names>F.</given-names></name><name><surname>Cusack</surname><given-names>S.</given-names></name><name><surname>Ruigrok</surname><given-names>R.W.H.</given-names></name></person-group><article-title>The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit</article-title><source>Nature</source><year>2009</year><volume>458</volume><fpage>914</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.1038/nature07745</pub-id><pub-id pub-id-type="pmid">19194459</pub-id></element-citation></ref><ref id="B90-viruses-12-00376"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>P.</given-names></name><name><surname>Marcos-Villar</surname><given-names>L.</given-names></name><name><surname>Zamarre&#x000f1;o</surname><given-names>N.</given-names></name><name><surname>Y&#x000e1;ng&#x000fc;ez</surname><given-names>E.</given-names></name><name><surname>Nieto</surname><given-names>A.</given-names></name></person-group><article-title>Mutations of the segment-specific nucleotides at the 3&#x02032; end of influenza virus NS segment control viral replication</article-title><source>Virology</source><year>2020</year><volume>539</volume><fpage>104</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2019.10.015</pub-id><pub-id pub-id-type="pmid">31706162</pub-id></element-citation></ref><ref id="B91-viruses-12-00376"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>J.</given-names></name><name><surname>Tao</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name></person-group><article-title>The tyrosine 73 and serine 83 dephosphorylation of H1N1 swine influenza virus NS1 protein attenuates virus replication and induces high levels of beta interferon</article-title><source>Virol. J.</source><year>2019</year><volume>16</volume><fpage>152</fpage><pub-id pub-id-type="doi">10.1186/s12985-019-1255-0</pub-id><?supplied-pmid 31805964?><pub-id pub-id-type="pmid">31805964</pub-id></element-citation></ref><ref id="B92-viruses-12-00376"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akarsu</surname><given-names>H.</given-names></name><name><surname>Burmeister</surname><given-names>W.</given-names></name><name><surname>Petosa</surname><given-names>C.</given-names></name><name><surname>Petit</surname><given-names>I.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>C.W.</given-names></name><name><surname>Ruigrok</surname><given-names>R.W.</given-names></name><name><surname>Baudin</surname><given-names>F.</given-names></name></person-group><article-title>Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2)</article-title><source>EMBO J.</source><year>2003</year><volume>22</volume><fpage>4646</fpage><lpage>4655</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdg449</pub-id><?supplied-pmid 12970177?><pub-id pub-id-type="pmid">12970177</pub-id></element-citation></ref><ref id="B93-viruses-12-00376"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Jayaraman</surname><given-names>A.</given-names></name><name><surname>Maniprasad</surname><given-names>P.</given-names></name><name><surname>Raman</surname><given-names>R.</given-names></name><name><surname>Houser</surname><given-names>K.V.</given-names></name><name><surname>Pappas</surname><given-names>C.</given-names></name><name><surname>Zeng</surname><given-names>H.</given-names></name><name><surname>Sasisekharan</surname><given-names>R.</given-names></name><name><surname>Katz</surname><given-names>J.M.</given-names></name><name><surname>Tumpey</surname><given-names>T.M.</given-names></name></person-group><article-title>N-Linked Glycosylation of the Hemagglutinin Protein Influences Virulence and Antigenicity of the 1918 Pandemic and Seasonal H1N1 Influenza A Viruses</article-title><source>J. Virol.</source><year>2013</year><volume>87</volume><fpage>8756</fpage><lpage>8766</lpage><pub-id pub-id-type="doi">10.1128/JVI.00593-13</pub-id><?supplied-pmid 23740978?><pub-id pub-id-type="pmid">23740978</pub-id></element-citation></ref><ref id="B94-viruses-12-00376"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brett</surname><given-names>K.</given-names></name><name><surname>Kordyukova</surname><given-names>L.V.</given-names></name><name><surname>Serebryakova</surname><given-names>M.V.</given-names></name><name><surname>Mintaev</surname><given-names>R.R.</given-names></name><name><surname>Alexeevski</surname><given-names>A.V.</given-names></name><name><surname>Veit</surname><given-names>M.</given-names></name></person-group><article-title>Site-specific S-acylation of influenza virus hemagglutinin: the location of the acylation site relative to the membrane border is the decisive factor for attachment of stearate</article-title><source>J. Biol. Chem.</source><year>2014</year><volume>289</volume><fpage>34978</fpage><lpage>34989</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.586180</pub-id><?supplied-pmid 25349209?><pub-id pub-id-type="pmid">25349209</pub-id></element-citation></ref><ref id="B95-viruses-12-00376"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohkura</surname><given-names>T.</given-names></name><name><surname>Momose</surname><given-names>F.</given-names></name><name><surname>Ichikawa</surname><given-names>R.</given-names></name><name><surname>Takeuchi</surname><given-names>K.</given-names></name><name><surname>Morikawa</surname><given-names>Y.</given-names></name></person-group><article-title>Influenza A Virus Hemagglutinin and Neuraminidase Mutually Accelerate Their Apical Targeting through Clustering of Lipid Rafts</article-title><source>J. Virol.</source><year>2014</year><volume>88</volume><fpage>10039</fpage><lpage>10055</lpage><pub-id pub-id-type="doi">10.1128/JVI.00586-14</pub-id><?supplied-pmid 24965459?><pub-id pub-id-type="pmid">24965459</pub-id></element-citation></ref><ref id="B96-viruses-12-00376"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>R.</given-names></name><name><surname>Okura</surname><given-names>T.</given-names></name><name><surname>Kawahara</surname><given-names>M.</given-names></name><name><surname>Takizawa</surname><given-names>N.</given-names></name><name><surname>Momose</surname><given-names>F.</given-names></name><name><surname>Morikawa</surname><given-names>Y.</given-names></name></person-group><article-title>Apical Trafficking Pathways of Influenza A Virus HA and NA via Rab17- and Rab23-Positive Compartments</article-title><source>Front. Microbiol.</source><year>2019</year><volume>10</volume><fpage>1857</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.01857</pub-id><?supplied-pmid 31456775?><pub-id pub-id-type="pmid">31456775</pub-id></element-citation></ref><ref id="B97-viruses-12-00376"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amorim</surname><given-names>M.J.</given-names></name><name><surname>A Bruce</surname><given-names>E.</given-names></name><name><surname>Read</surname><given-names>E.K.C.</given-names></name><name><surname>Foeglein</surname><given-names>&#x000c1;.</given-names></name><name><surname>Mahen</surname><given-names>R.</given-names></name><name><surname>Stuart</surname><given-names>A.D.</given-names></name><name><surname>Digard</surname><given-names>P.</given-names></name></person-group><article-title>A Rab11- and Microtubule-Dependent Mechanism for Cytoplasmic Transport of Influenza A Virus Viral RNA</article-title><source>J. Virol.</source><year>2011</year><volume>85</volume><fpage>4143</fpage><lpage>4156</lpage><pub-id pub-id-type="doi">10.1128/JVI.02606-10</pub-id><pub-id pub-id-type="pmid">21307188</pub-id></element-citation></ref><ref id="B98-viruses-12-00376"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossman</surname><given-names>J.</given-names></name><name><surname>Lamb</surname><given-names>R.A.</given-names></name></person-group><article-title>Influenza virus assembly and budding</article-title><source>Virology</source><year>2011</year><volume>411</volume><fpage>229</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2010.12.003</pub-id><pub-id pub-id-type="pmid">21237476</pub-id></element-citation></ref><ref id="B99-viruses-12-00376"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palese</surname><given-names>P.</given-names></name><name><surname>Tobita</surname><given-names>K.</given-names></name><name><surname>Ueda</surname><given-names>M.</given-names></name><name><surname>Compans</surname><given-names>R.</given-names></name></person-group><article-title>Characterization of temperature sensitive influenza virus mutants defective in neuraminidase</article-title><source>Virology</source><year>1974</year><volume>61</volume><fpage>397</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/0042-6822(74)90276-1</pub-id><pub-id pub-id-type="pmid">4472498</pub-id></element-citation></ref><ref id="B100-viruses-12-00376"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stertz</surname><given-names>S.</given-names></name><name><surname>Shaw</surname><given-names>M.</given-names></name></person-group><article-title>Uncovering the global host cell requirements for influenza virus replication via RNAi screening</article-title><source>Microbes Infect.</source><year>2011</year><volume>13</volume><fpage>516</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2011.01.012</pub-id><pub-id pub-id-type="pmid">21276872</pub-id></element-citation></ref><ref id="B101-viruses-12-00376"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>A.T.</given-names></name><name><surname>Rahim</surname><given-names>M.N.</given-names></name><name><surname>Ranadheera</surname><given-names>C.</given-names></name><name><surname>Kroeker</surname><given-names>A.</given-names></name><name><surname>Cortens</surname><given-names>J.P.</given-names></name><name><surname>Opanubi</surname><given-names>K.J.</given-names></name><name><surname>A Wilkins</surname><given-names>J.</given-names></name><name><surname>Coombs</surname><given-names>K.M.</given-names></name></person-group><article-title>Knockdown of specific host factors protects against influenza virus-induced cell death</article-title><source>Cell Death Dis.</source><year>2013</year><volume>4</volume><fpage>e769</fpage><pub-id pub-id-type="doi">10.1038/cddis.2013.296</pub-id><?supplied-pmid 23949218?><pub-id pub-id-type="pmid">23949218</pub-id></element-citation></ref><ref id="B102-viruses-12-00376"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>J.</given-names></name><name><surname>Perez</surname><given-names>J.T.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Benitez</surname><given-names>A.</given-names></name><name><surname>Kandasamy</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Andrade</surname><given-names>J.</given-names></name><name><surname>Tenoever</surname><given-names>B.</given-names></name><name><surname>Manicassamy</surname><given-names>B.</given-names></name></person-group><article-title>Genome-wide CRISPR/Cas9 Screen Identifies Host Factors Essential for Influenza Virus Replication</article-title><source>Cell Rep.</source><year>2018</year><volume>23</volume><fpage>596</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.03.045</pub-id><?supplied-pmid 29642015?><pub-id pub-id-type="pmid">29642015</pub-id></element-citation></ref><ref id="B103-viruses-12-00376"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Clohisey</surname><given-names>S.M.</given-names></name><name><surname>Chia</surname><given-names>B.S.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Cui</surname><given-names>A.</given-names></name><name><surname>Eisenhaure</surname><given-names>T.</given-names></name><name><surname>Schweitzer</surname><given-names>L.D.</given-names></name><name><surname>Hoover</surname><given-names>P.</given-names></name><name><surname>Parkinson</surname><given-names>N.J.</given-names></name><name><surname>Nachshon</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>164</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-13965-x</pub-id><?supplied-pmid 31919360?><pub-id pub-id-type="pmid">31919360</pub-id></element-citation></ref><ref id="B104-viruses-12-00376"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Forst</surname><given-names>C.V.</given-names></name><name><surname>Chou</surname><given-names>T.-W.</given-names></name><name><surname>Geber</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Hamou</surname><given-names>W.</given-names></name><name><surname>Smith</surname><given-names>M.</given-names></name><name><surname>Sebra</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Zhou</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Cell-to-Cell Variation in Defective Virus Expression and Effects on Host Responses during Influenza Virus Infection</article-title><source>mBio</source><year>2020</year><volume>11</volume><pub-id pub-id-type="doi">10.1128/mBio.02880-19</pub-id></element-citation></ref><ref id="B105-viruses-12-00376"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwasaki</surname><given-names>A.</given-names></name><name><surname>Pillai</surname><given-names>P.S.</given-names></name></person-group><article-title>Innate immunity to influenza virus infection</article-title><source>Nat. Rev. Immunol.</source><year>2014</year><volume>14</volume><fpage>315</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1038/nri3665</pub-id><pub-id pub-id-type="pmid">24762827</pub-id></element-citation></ref><ref id="B106-viruses-12-00376"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hale</surname><given-names>B.</given-names></name><name><surname>Albrecht</surname><given-names>R.A.</given-names></name><name><surname>Garc&#x000ed;a-Sastre</surname><given-names>A.</given-names></name></person-group><article-title>Innate immune evasion strategies of influenza viruses</article-title><source>Future Microbiol.</source><year>2010</year><volume>5</volume><fpage>23</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.2217/fmb.09.108</pub-id><pub-id pub-id-type="pmid">20020828</pub-id></element-citation></ref><ref id="B107-viruses-12-00376"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>E.B.</given-names></name><name><surname>Brooks</surname><given-names>D.G.</given-names></name></person-group><article-title>The Role of IL-10 in Regulating Immunity to Persistent Viral Infections</article-title><source>Curr. Top. Microbiol. Immunol.</source><year>2011</year><volume>350</volume><fpage>39</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">20703965</pub-id></element-citation></ref><ref id="B108-viruses-12-00376"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ampomah</surname><given-names>P.B.</given-names></name><name><surname>Moraes</surname><given-names>L.A.</given-names></name><name><surname>Lukman</surname><given-names>H.M.</given-names></name><name><surname>Lim</surname><given-names>L.H.K.</given-names></name></person-group><article-title>Formyl peptide receptor 2 is regulated by RNA mimics and viruses through an IFN-&#x003b2;-STAT3-dependent pathway</article-title><source>FASEB J.</source><year>2018</year><volume>32</volume><fpage>1468</fpage><lpage>1478</lpage><pub-id pub-id-type="doi">10.1096/fj.201700584RR</pub-id><pub-id pub-id-type="pmid">29127186</pub-id></element-citation></ref><ref id="B109-viruses-12-00376"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arora</surname><given-names>S.</given-names></name><name><surname>Lim</surname><given-names>W.</given-names></name><name><surname>Bist</surname><given-names>P.</given-names></name><name><surname>Perumalsamy</surname><given-names>R.</given-names></name><name><surname>Lukman</surname><given-names>H.M.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Welker</surname><given-names>L.B.</given-names></name><name><surname>Yan</surname><given-names>B.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>A Tambyah</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Influenza A virus enhances its propagation through the modulation of Annexin-A1 dependent endosomal trafficking and apoptosis</article-title><source>Cell Death Differ.</source><year>2016</year><volume>23</volume><fpage>1243</fpage><lpage>1256</lpage><pub-id pub-id-type="doi">10.1038/cdd.2016.19</pub-id><pub-id pub-id-type="pmid">26943321</pub-id></element-citation></ref><ref id="B110-viruses-12-00376"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>A.T.</given-names></name><name><surname>Cortens</surname><given-names>J.P.</given-names></name><name><surname>Du</surname><given-names>Q.</given-names></name><name><surname>Wilkins</surname><given-names>J.A.</given-names></name><name><surname>Coombs</surname><given-names>K.M.</given-names></name></person-group><article-title>Influenza Virus Induces Apoptosis via BAD-Mediated Mitochondrial Dysregulation</article-title><source>J. Virol.</source><year>2013</year><volume>87</volume><fpage>1049</fpage><lpage>1060</lpage><pub-id pub-id-type="doi">10.1128/JVI.02017-12</pub-id><pub-id pub-id-type="pmid">23135712</pub-id></element-citation></ref><ref id="B111-viruses-12-00376"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>S.</given-names></name><name><surname>Batra</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>W.</given-names></name><name><surname>Sharma</surname><given-names>K.</given-names></name><name><surname>Patel</surname><given-names>J.</given-names></name><name><surname>Ranjan</surname><given-names>P.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Katz</surname><given-names>J.M.</given-names></name><name><surname>Cox</surname><given-names>N.J.</given-names></name><name><surname>Lal</surname><given-names>R.B.</given-names></name><etal/></person-group><article-title>Influenza A virus nucleoprotein induces apoptosis in human airway epithelial cells: Implications of a novel interaction between nucleoprotein and host protein Clusterin</article-title><source>Cell Death Dis.</source><year>2013</year><volume>4</volume><fpage>e562</fpage><pub-id pub-id-type="doi">10.1038/cddis.2013.89</pub-id><?supplied-pmid 23538443?><pub-id pub-id-type="pmid">23538443</pub-id></element-citation></ref><ref id="B112-viruses-12-00376"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feizi</surname><given-names>N.</given-names></name><name><surname>Mehrbod</surname><given-names>P.</given-names></name><name><surname>Romani</surname><given-names>B.</given-names></name><name><surname>Soleimanjahi</surname><given-names>H.</given-names></name><name><surname>Bamdad</surname><given-names>T.</given-names></name><name><surname>Feizi</surname><given-names>A.</given-names></name><name><surname>Jazaeri</surname><given-names>E.O.</given-names></name><name><surname>Targhi</surname><given-names>H.S.</given-names></name><name><surname>Saleh</surname><given-names>M.</given-names></name><name><surname>Jamali</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Autophagy induction regulates influenza virus replication in a time-dependent manner</article-title><source>J. Med. Microbiol.</source><year>2017</year><volume>66</volume><fpage>536</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.000455</pub-id><?supplied-pmid 28463668?><pub-id pub-id-type="pmid">28463668</pub-id></element-citation></ref><ref id="B113-viruses-12-00376"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dougan</surname><given-names>S.K.</given-names></name><name><surname>Ashour</surname><given-names>J.</given-names></name><name><surname>Karssemeijer</surname><given-names>R.A.</given-names></name><name><surname>Popp</surname><given-names>M.W.</given-names></name><name><surname>Avalos</surname><given-names>A.M.</given-names></name><name><surname>Barisa</surname><given-names>M.</given-names></name><name><surname>Altenburg</surname><given-names>A.</given-names></name><name><surname>Ingram</surname><given-names>J.R.</given-names></name><name><surname>Cragnolini</surname><given-names>J.J.</given-names></name><name><surname>Guo</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virus</article-title><source>Nature</source><year>2013</year><volume>503</volume><fpage>406</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1038/nature12637</pub-id><?supplied-pmid 24141948?><pub-id pub-id-type="pmid">24141948</pub-id></element-citation></ref><ref id="B114-viruses-12-00376"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogales</surname><given-names>A.</given-names></name><name><surname>Mart&#x000ed;nez-Sobrido</surname><given-names>L.</given-names></name><name><surname>Topham</surname><given-names>D.J.</given-names></name><name><surname>DeDiego</surname><given-names>M.L.</given-names></name></person-group><article-title>Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins</article-title><source>Viruses</source><year>2018</year><volume>10</volume><elocation-id>708</elocation-id><pub-id pub-id-type="doi">10.3390/v10120708</pub-id><?supplied-pmid 30545063?><pub-id pub-id-type="pmid">30545063</pub-id></element-citation></ref><ref id="B115-viruses-12-00376"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Goraya</surname><given-names>M.U.</given-names></name><name><surname>Maarouf</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>J.-L.</given-names></name></person-group><article-title>Host Immune Response to Influenza A Virus Infection</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><fpage>320</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.00320</pub-id><pub-id pub-id-type="pmid">29556226</pub-id></element-citation></ref><ref id="B116-viruses-12-00376"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendelson</surname><given-names>M.</given-names></name><name><surname>Tekoah</surname><given-names>Y.</given-names></name><name><surname>Zilka</surname><given-names>A.</given-names></name><name><surname>Gershoni-Yahalom</surname><given-names>O.</given-names></name><name><surname>Gazit</surname><given-names>R.</given-names></name><name><surname>Achdout</surname><given-names>H.</given-names></name><name><surname>Bovin</surname><given-names>N.V.</given-names></name><name><surname>Meningher</surname><given-names>T.</given-names></name><name><surname>Mandelboim</surname><given-names>M.</given-names></name><name><surname>Mandelboim</surname><given-names>O.</given-names></name><etal/></person-group><article-title>NKp46 O-Glycan Sequences That Are Involved in the Interaction with Hemagglutinin Type 1 of Influenza Virus</article-title><source>J. Virol.</source><year>2010</year><volume>84</volume><fpage>3789</fpage><lpage>3797</lpage><pub-id pub-id-type="doi">10.1128/JVI.01815-09</pub-id><pub-id pub-id-type="pmid">20147410</pub-id></element-citation></ref><ref id="B117-viruses-12-00376"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Malarkannan</surname><given-names>S.</given-names></name></person-group><article-title>Evasion of natural killer cells by influenza virus</article-title><source>J. Leukoc. Biol.</source><year>2010</year><volume>89</volume><fpage>189</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1189/jlb.0610319</pub-id><pub-id pub-id-type="pmid">20682623</pub-id></element-citation></ref><ref id="B118-viruses-12-00376"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Wei</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>R.</given-names></name><name><surname>Tian</surname><given-names>Z.</given-names></name></person-group><article-title>Respiratory Influenza Virus Infection Induces Memory-like Liver NK Cells in Mice</article-title><source>J. Immunol.</source><year>2016</year><volume>198</volume><fpage>1242</fpage><lpage>1252</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1502186</pub-id><pub-id pub-id-type="pmid">28031334</pub-id></element-citation></ref><ref id="B119-viruses-12-00376"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdul-Careem</surname><given-names>M.F.</given-names></name><name><surname>Mian</surname><given-names>M.F.</given-names></name><name><surname>Yue</surname><given-names>G.</given-names></name><name><surname>Gillgrass</surname><given-names>A.</given-names></name><name><surname>Chenoweth</surname><given-names>M.</given-names></name><name><surname>Barra</surname><given-names>N.G.</given-names></name><name><surname>Chew</surname><given-names>M.V.</given-names></name><name><surname>Chan</surname><given-names>T.</given-names></name><name><surname>Al-Garawi</surname><given-names>A.A.</given-names></name><name><surname>Jordana</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Critical Role of Natural Killer Cells in Lung Immunopathology During Influenza Infection in Mice</article-title><source>J. Infect. Dis.</source><year>2012</year><volume>206</volume><fpage>167</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis340</pub-id><pub-id pub-id-type="pmid">22561366</pub-id></element-citation></ref><ref id="B120-viruses-12-00376"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>G.</given-names></name><name><surname>Juang</surname><given-names>S.W.W.</given-names></name><name><surname>Kane</surname><given-names>K.P.</given-names></name></person-group><article-title>NK cells exacerbate the pathology of influenza virus infection in mice</article-title><source>Eur. J. Immunol.</source><year>2013</year><volume>43</volume><fpage>929</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1002/eji.201242620</pub-id><pub-id pub-id-type="pmid">23436540</pub-id></element-citation></ref><ref id="B121-viruses-12-00376"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>A.</given-names></name><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Yan</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>G.F.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Fang</surname><given-names>M.</given-names></name></person-group><article-title>Swift and Strong NK Cell Responses Protect 129 Mice against High-Dose Influenza Virus Infection</article-title><source>J. Immunol.</source><year>2016</year><volume>196</volume><fpage>1842</fpage><lpage>1854</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1501486</pub-id><?supplied-pmid 26773146?><pub-id pub-id-type="pmid">26773146</pub-id></element-citation></ref><ref id="B122-viruses-12-00376"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camp</surname><given-names>J.</given-names></name><name><surname>Jonsson</surname><given-names>C.B.</given-names></name></person-group><article-title>A Role for Neutrophils in Viral Respiratory Disease</article-title><source>Front. Immunol.</source><year>2017</year><volume>8</volume><fpage>550</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2017.00550</pub-id><?supplied-pmid 28553293?><pub-id pub-id-type="pmid">28553293</pub-id></element-citation></ref><ref id="B123-viruses-12-00376"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>K.</given-names></name><name><surname>Hyun</surname><given-names>Y.-M.</given-names></name><name><surname>Lambert-Emo</surname><given-names>K.</given-names></name><name><surname>Capece</surname><given-names>T.</given-names></name><name><surname>Bae</surname><given-names>S.</given-names></name><name><surname>Miller</surname><given-names>R.</given-names></name><name><surname>Topham</surname><given-names>D.J.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name></person-group><article-title>Neutrophil trails guide influenza-specific CD8+ T cells in the airways</article-title><source>Science</source><year>2015</year><volume>349</volume><fpage>4352</fpage><pub-id pub-id-type="doi">10.1126/science.aaa4352</pub-id><?supplied-pmid 26339033?><pub-id pub-id-type="pmid">26339033</pub-id></element-citation></ref><ref id="B124-viruses-12-00376"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>GeurtsvanKessel</surname><given-names>C.H.</given-names></name><name><surname>Willart</surname><given-names>M.A.</given-names></name><name><surname>Van Rijt</surname><given-names>L.S.</given-names></name><name><surname>Muskens</surname><given-names>F.</given-names></name><name><surname>Kool</surname><given-names>M.</given-names></name><name><surname>Baas</surname><given-names>C.</given-names></name><name><surname>Thielemans</surname><given-names>K.</given-names></name><name><surname>Bennett</surname><given-names>C.L.</given-names></name><name><surname>Clausen</surname><given-names>B.E.</given-names></name><name><surname>Hoogsteden</surname><given-names>H.C.</given-names></name><etal/></person-group><article-title>Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells</article-title><source>J. Exp. Med.</source><year>2008</year><volume>205</volume><fpage>1621</fpage><lpage>1634</lpage><pub-id pub-id-type="doi">10.1084/jem.20071365</pub-id><?supplied-pmid 18591406?><pub-id pub-id-type="pmid">18591406</pub-id></element-citation></ref><ref id="B125-viruses-12-00376"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hintzen</surname><given-names>G.</given-names></name><name><surname>Ohl</surname><given-names>L.</given-names></name><name><surname>Del Rio</surname><given-names>M.-L.</given-names></name><name><surname>Rodriguez-Barbosa</surname><given-names>J.-I.</given-names></name><name><surname>Pabst</surname><given-names>O.</given-names></name><name><surname>Kocks</surname><given-names>J.R.</given-names></name><name><surname>Krege</surname><given-names>J.</given-names></name><name><surname>Hardtke</surname><given-names>S.</given-names></name><name><surname>F&#x000f6;rster</surname><given-names>R.</given-names></name></person-group><article-title>Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node</article-title><source>J. Immunol.</source><year>2006</year><volume>177</volume><fpage>7346</fpage><lpage>7354</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.177.10.7346</pub-id><?supplied-pmid 17082654?><pub-id pub-id-type="pmid">17082654</pub-id></element-citation></ref><ref id="B126-viruses-12-00376"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>K.-J.</given-names></name><name><surname>Ishido</surname><given-names>S.</given-names></name><name><surname>Eisenlohr</surname><given-names>L.C.</given-names></name><name><surname>Roche</surname><given-names>P.A.</given-names></name></person-group><article-title>Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells</article-title><source>J. Immunol.</source><year>2020</year><volume>204</volume><fpage>1621</fpage><lpage>1629</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1901234</pub-id><?supplied-pmid 31996461?><pub-id pub-id-type="pmid">31996461</pub-id></element-citation></ref><ref id="B127-viruses-12-00376"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waithman</surname><given-names>J.</given-names></name><name><surname>Mintern</surname><given-names>J.D.</given-names></name></person-group><article-title>Dendritic cells and influenza A virus infection</article-title><source>Virulence</source><year>2012</year><volume>3</volume><fpage>603</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.4161/viru.21864</pub-id><pub-id pub-id-type="pmid">23076333</pub-id></element-citation></ref><ref id="B128-viruses-12-00376"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeshita</surname><given-names>F.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>Matsuda</surname><given-names>T.</given-names></name><name><surname>Tozuka</surname><given-names>M.</given-names></name><name><surname>Kobiyama</surname><given-names>K.</given-names></name><name><surname>Saha</surname><given-names>S.</given-names></name><name><surname>Matsui</surname><given-names>K.</given-names></name><name><surname>Ishii</surname><given-names>K.J.</given-names></name><name><surname>Coban</surname><given-names>C.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Toll-Like Receptor Adaptor Molecules Enhance DNA-Raised Adaptive Immune Responses against Influenza and Tumors through Activation of Innate Immunity</article-title><source>J. Virol.</source><year>2006</year><volume>80</volume><fpage>6218</fpage><lpage>6224</lpage><pub-id pub-id-type="doi">10.1128/JVI.00121-06</pub-id><pub-id pub-id-type="pmid">16775309</pub-id></element-citation></ref><ref id="B129-viruses-12-00376"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>O.</given-names></name><name><surname>Diebold</surname><given-names>S.S.</given-names></name><name><surname>Chen</surname><given-names>M.S.</given-names></name><name><surname>N&#x000e4;slund</surname><given-names>T.I.</given-names></name><name><surname>Nolte</surname><given-names>M.</given-names></name><name><surname>Alexopoulou</surname><given-names>L.</given-names></name><name><surname>Azuma</surname><given-names>Y.-T.</given-names></name><name><surname>Flavell</surname><given-names>R.A.</given-names></name><name><surname>Liljestrom</surname><given-names>P.</given-names></name><name><surname>E Sousa</surname><given-names>C.R.</given-names></name></person-group><article-title>Toll-like receptor 3 promotes cross-priming to virus-infected cells</article-title><source>Nature</source><year>2005</year><volume>433</volume><fpage>887</fpage><lpage>892</lpage><pub-id pub-id-type="doi">10.1038/nature03326</pub-id><pub-id pub-id-type="pmid">15711573</pub-id></element-citation></ref><ref id="B130-viruses-12-00376"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Goffic</surname><given-names>R.</given-names></name><name><surname>Pothlichet</surname><given-names>J.</given-names></name><name><surname>Vitour</surname><given-names>D.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Meurs</surname><given-names>E.</given-names></name><name><surname>Chignard</surname><given-names>M.</given-names></name><name><surname>Si-Tahar</surname><given-names>M.</given-names></name></person-group><article-title>Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells</article-title><source>J. Immunol.</source><year>2007</year><volume>178</volume><fpage>3368</fpage><lpage>3372</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.6.3368</pub-id><pub-id pub-id-type="pmid">17339430</pub-id></element-citation></ref><ref id="B131-viruses-12-00376"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poux</surname><given-names>C.</given-names></name><name><surname>Dondalska</surname><given-names>A.</given-names></name><name><surname>Bergenstr&#x000e5;hle</surname><given-names>J.</given-names></name><name><surname>P&#x000e5;lsson</surname><given-names>S.</given-names></name><name><surname>Contreras</surname><given-names>V.</given-names></name><name><surname>Arasa</surname><given-names>C.</given-names></name><name><surname>J&#x000e4;rver</surname><given-names>P.</given-names></name><name><surname>Albert</surname><given-names>J.</given-names></name><name><surname>Busse</surname><given-names>D.</given-names></name><name><surname>Legrand</surname><given-names>R.</given-names></name><etal/></person-group><article-title>A Single-Stranded Oligonucleotide Inhibits Toll-Like Receptor 3 Activation and Reduces Influenza A (H1N1) Infection</article-title><source>Front. Immunol.</source><year>2019</year><volume>10</volume><fpage>2161</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2019.02161</pub-id><?supplied-pmid 31572376?><pub-id pub-id-type="pmid">31572376</pub-id></element-citation></ref><ref id="B132-viruses-12-00376"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lund</surname><given-names>J.M.</given-names></name><name><surname>Alexopoulou</surname><given-names>L.</given-names></name><name><surname>Sato</surname><given-names>A.</given-names></name><name><surname>Karow</surname><given-names>M.</given-names></name><name><surname>Adams</surname><given-names>N.C.</given-names></name><name><surname>Gale</surname><given-names>N.W.</given-names></name><name><surname>Iwasaki</surname><given-names>A.</given-names></name><name><surname>Flavell</surname><given-names>R.A.</given-names></name></person-group><article-title>Recognition of single-stranded RNA viruses by Toll-like receptor 7</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>5598</fpage><lpage>5603</lpage><pub-id pub-id-type="doi">10.1073/pnas.0400937101</pub-id><?supplied-pmid 15034168?><pub-id pub-id-type="pmid">15034168</pub-id></element-citation></ref><ref id="B133-viruses-12-00376"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdul-Cader</surname><given-names>M.S.</given-names></name><name><surname>Senapathi</surname><given-names>U.D.S.</given-names></name><name><surname>Nagy</surname><given-names>E.</given-names></name><name><surname>Sharif</surname><given-names>S.</given-names></name><name><surname>Abdul-Careem</surname><given-names>M.F.</given-names></name></person-group><article-title>Antiviral response elicited against avian influenza virus infection following activation of toll-like receptor (TLR)7 signaling pathway is attributable to interleukin (IL)-1&#x003b2; production</article-title><source>BMC Res. Notes</source><year>2018</year><volume>11</volume><elocation-id>859</elocation-id><pub-id pub-id-type="doi">10.1186/s13104-018-3975-4</pub-id><?supplied-pmid 30514372?><pub-id pub-id-type="pmid">30514372</pub-id></element-citation></ref><ref id="B134-viruses-12-00376"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stegemann-Koniszewski</surname><given-names>S.</given-names></name><name><surname>Behrens</surname><given-names>S.</given-names></name><name><surname>Boehme</surname><given-names>J.D.</given-names></name><name><surname>Hochnadel</surname><given-names>I.</given-names></name><name><surname>Riese</surname><given-names>P.</given-names></name><name><surname>Guzm&#x000e1;n</surname><given-names>C.A.</given-names></name><name><surname>Kr&#x000f6;ger</surname><given-names>A.</given-names></name><name><surname>Schreiber</surname><given-names>J.</given-names></name><name><surname>Gunzer</surname><given-names>M.</given-names></name><name><surname>Bruder</surname><given-names>D.</given-names></name></person-group><article-title>Respiratory Influenza A Virus Infection Triggers Local and Systemic Natural Killer Cell Activation via Toll-Like Receptor 7</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><fpage>245</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.00245</pub-id><pub-id pub-id-type="pmid">29497422</pub-id></element-citation></ref><ref id="B135-viruses-12-00376"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeisy-Scott</surname><given-names>V.</given-names></name><name><surname>Kim</surname><given-names>J.H.</given-names></name><name><surname>Davis</surname><given-names>W.G.</given-names></name><name><surname>Cao</surname><given-names>W.</given-names></name><name><surname>Katz</surname><given-names>J.M.</given-names></name><name><surname>Sambhara</surname><given-names>S.</given-names></name></person-group><article-title>TLR7 Recognition Is Dispensable for Influenza Virus A Infection but Important for the Induction of Hemagglutinin-Specific Antibodies in Response to the 2009 Pandemic Split Vaccine in Mice</article-title><source>J. Virol.</source><year>2012</year><volume>86</volume><fpage>10988</fpage><lpage>10998</lpage><pub-id pub-id-type="doi">10.1128/JVI.01064-12</pub-id><pub-id pub-id-type="pmid">22837197</pub-id></element-citation></ref><ref id="B136-viruses-12-00376"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>K.B.</given-names></name><name><surname>Teijaro</surname><given-names>J.R.</given-names></name><name><surname>Zuniga</surname><given-names>E.I.</given-names></name><name><surname>Welch</surname><given-names>M.J.</given-names></name><name><surname>Fremgen</surname><given-names>D.M.</given-names></name><name><surname>Blackburn</surname><given-names>S.D.</given-names></name><name><surname>Von Tiehl</surname><given-names>K.F.</given-names></name><name><surname>Wherry</surname><given-names>E.J.</given-names></name><name><surname>Flavell</surname><given-names>R.A.</given-names></name><name><surname>Oldstone</surname><given-names>M.B.A.</given-names></name></person-group><article-title>Toll-like Receptor 7 Is Required for Effective Adaptive Immune Responses that Prevent Persistent Virus Infection</article-title><source>Cell Host Microbe</source><year>2012</year><volume>11</volume><fpage>643</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2012.04.016</pub-id><pub-id pub-id-type="pmid">22704624</pub-id></element-citation></ref><ref id="B137-viruses-12-00376"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoneyama</surname><given-names>M.</given-names></name><name><surname>Onomoto</surname><given-names>K.</given-names></name><name><surname>Jogi</surname><given-names>M.</given-names></name><name><surname>Akaboshi</surname><given-names>T.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name></person-group><article-title>Viral RNA detection by RIG-I-like receptors</article-title><source>Curr. Opin. Immunol.</source><year>2015</year><volume>32</volume><fpage>48</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2014.12.012</pub-id><pub-id pub-id-type="pmid">25594890</pub-id></element-citation></ref><ref id="B138-viruses-12-00376"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahan</surname><given-names>A.S.</given-names></name><name><surname>Biquand</surname><given-names>E.</given-names></name><name><surname>Mu&#x000f1;oz-Moreno</surname><given-names>R.</given-names></name><name><surname>Le Quang</surname><given-names>A.</given-names></name><name><surname>Mok</surname><given-names>C.K.-P.</given-names></name><name><surname>Wong</surname><given-names>H.H.</given-names></name><name><surname>Teo</surname><given-names>Q.W.</given-names></name><name><surname>Valkenburg</surname><given-names>S.A.</given-names></name><name><surname>Chin</surname><given-names>A.W.</given-names></name><name><surname>Poon</surname><given-names>L.L.M.</given-names></name><etal/></person-group><article-title>OTUB1 Is a Key Regulator of RIG-I-Dependent Immune Signaling and Is Targeted for Proteasomal Degradation by Influenza A NS1</article-title><source>Cell Rep.</source><year>2020</year><volume>30</volume><fpage>1570</fpage><lpage>1584</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.01.015</pub-id><pub-id pub-id-type="pmid">32023470</pub-id></element-citation></ref><ref id="B139-viruses-12-00376"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pichlmair</surname><given-names>A.</given-names></name><name><surname>Schulz</surname><given-names>O.</given-names></name><name><surname>Tan</surname><given-names>C.P.</given-names></name><name><surname>N&#x000e4;slund</surname><given-names>T.I.</given-names></name><name><surname>Liljestr&#x000f6;m</surname><given-names>P.</given-names></name><name><surname>Weber</surname><given-names>F.</given-names></name><name><surname>Sousa</surname><given-names>C.</given-names></name></person-group><article-title>RIG-I-mediated antiviral responses to single-stranded RNA bearing 5&#x02032;-phosphates</article-title><source>Science</source><year>2006</year><volume>314</volume><fpage>997</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1126/science.1132998</pub-id><pub-id pub-id-type="pmid">17038589</pub-id></element-citation></ref><ref id="B140-viruses-12-00376"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philpott</surname><given-names>D.J.</given-names></name><name><surname>Sorbara</surname><given-names>M.T.</given-names></name><name><surname>Robertson</surname><given-names>S.J.</given-names></name><name><surname>Croitoru</surname><given-names>K.</given-names></name><name><surname>Girardin</surname><given-names>S.E.</given-names></name></person-group><article-title>NOD proteins: Regulators of inflammation in health and disease</article-title><source>Nat. Rev. Immunol.</source><year>2014</year><volume>14</volume><fpage>9</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1038/nri3565</pub-id><pub-id pub-id-type="pmid">24336102</pub-id></element-citation></ref><ref id="B141-viruses-12-00376"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichinohe</surname><given-names>T.</given-names></name><name><surname>Pang</surname><given-names>I.K.-S.</given-names></name><name><surname>Iwasaki</surname><given-names>A.</given-names></name></person-group><article-title>Influenza virus activates inflammasomes via its intracellular M2 ion channel</article-title><source>Nat. Immunol.</source><year>2010</year><volume>11</volume><fpage>404</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1038/ni.1861</pub-id><?supplied-pmid 20383149?><pub-id pub-id-type="pmid">20383149</pub-id></element-citation></ref><ref id="B142-viruses-12-00376"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAuley</surname><given-names>J.</given-names></name><name><surname>Tate</surname><given-names>M.</given-names></name><name><surname>MacKenzie-Kludas</surname><given-names>C.J.</given-names></name><name><surname>Pinar</surname><given-names>A.</given-names></name><name><surname>Zeng</surname><given-names>W.</given-names></name><name><surname>Stutz</surname><given-names>A.</given-names></name><name><surname>Latz</surname><given-names>E.</given-names></name><name><surname>Brown</surname><given-names>L.</given-names></name><name><surname>Mansell</surname><given-names>A.</given-names></name></person-group><article-title>Activation of the NLRP3 Inflammasome by IAV Virulence Protein PB1-F2 Contributes to Severe Pathophysiology and Disease</article-title><source>PLoS Pathog.</source><year>2013</year><volume>9</volume><elocation-id>e1003392</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003392</pub-id><?supplied-pmid 23737748?><pub-id pub-id-type="pmid">23737748</pub-id></element-citation></ref><ref id="B143-viruses-12-00376"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarvestani</surname><given-names>S.T.</given-names></name><name><surname>McAuley</surname><given-names>J.L.</given-names></name></person-group><article-title>The role of the NLRP3 inflammasome in regulation of antiviral responses to influenza A virus infection</article-title><source>Antivir. Res.</source><year>2017</year><volume>148</volume><fpage>32</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2017.10.020</pub-id><?supplied-pmid 29097227?><pub-id pub-id-type="pmid">29097227</pub-id></element-citation></ref><ref id="B144-viruses-12-00376"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Bao</surname><given-names>L.</given-names></name><name><surname>Lv</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>An</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Cao</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name></person-group><article-title>Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration</article-title><source>PLoS Pathog.</source><year>2018</year><volume>14</volume><elocation-id>e1007428</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007428</pub-id><pub-id pub-id-type="pmid">30422993</pub-id></element-citation></ref><ref id="B145-viruses-12-00376"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randall</surname><given-names>R.</given-names></name><name><surname>Goodbourn</surname><given-names>S.</given-names></name></person-group><article-title>Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures</article-title><source>J. Gen. Virol.</source><year>2008</year><volume>89</volume><fpage>1</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1099/vir.0.83391-0</pub-id><pub-id pub-id-type="pmid">18089727</pub-id></element-citation></ref><ref id="B146-viruses-12-00376"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mordstein</surname><given-names>M.</given-names></name><name><surname>Kochs</surname><given-names>G.</given-names></name><name><surname>Dumoutier</surname><given-names>L.</given-names></name><name><surname>Renauld</surname><given-names>J.C.</given-names></name><name><surname>Paludan</surname><given-names>S.R.</given-names></name><name><surname>Klucher</surname><given-names>K.</given-names></name><name><surname>Staeheil</surname><given-names>P.</given-names></name></person-group><article-title>Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses</article-title><source>PLoS Pathog</source><year>2008</year><volume>4</volume><elocation-id>e1000151</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000151</pub-id><pub-id pub-id-type="pmid">18787692</pub-id></element-citation></ref><ref id="B147-viruses-12-00376"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>W.M.</given-names></name><name><surname>Chevillotte</surname><given-names>M.D.</given-names></name><name><surname>Rice</surname><given-names>C.M.</given-names></name></person-group><article-title>Interferon-stimulated genes: A complex web of host defenses</article-title><source>Annu. Rev. Immunol.</source><year>2014</year><volume>32</volume><fpage>513</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120231</pub-id><pub-id pub-id-type="pmid">24555472</pub-id></element-citation></ref><ref id="B148-viruses-12-00376"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crotta</surname><given-names>S.</given-names></name><name><surname>Davidson</surname><given-names>S.</given-names></name><name><surname>Mahlak&#x000f5;iv</surname><given-names>T.</given-names></name><name><surname>Desmet</surname><given-names>C.J.</given-names></name><name><surname>Buckwalter</surname><given-names>M.R.</given-names></name><name><surname>Albert</surname><given-names>M.L.</given-names></name><name><surname>Staeheli</surname><given-names>P.</given-names></name><name><surname>Wack</surname><given-names>A.</given-names></name></person-group><article-title>Type I and Type III Interferons Drive Redundant Amplification Loops to Induce a Transcriptional Signature in Influenza-Infected Airway Epithelia</article-title><source>PLoS Pathog.</source><year>2013</year><volume>9</volume><elocation-id>e1003773</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003773</pub-id><pub-id pub-id-type="pmid">24278020</pub-id></element-citation></ref><ref id="B149-viruses-12-00376"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galani</surname><given-names>I.E.</given-names></name><name><surname>Triantafyllia</surname><given-names>V.</given-names></name><name><surname>Eleminiadou</surname><given-names>E.-E.</given-names></name><name><surname>Koltsida</surname><given-names>O.</given-names></name><name><surname>Stavropoulos</surname><given-names>A.</given-names></name><name><surname>Manioudaki</surname><given-names>M.</given-names></name><name><surname>Thanos</surname><given-names>D.</given-names></name><name><surname>Doyle</surname><given-names>S.E.</given-names></name><name><surname>Kotenko</surname><given-names>S.V.</given-names></name><name><surname>Thanopoulou</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Interferon-&#x003bb; Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness</article-title><source>Immunity</source><year>2017</year><volume>46</volume><fpage>875</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2017.04.025</pub-id><pub-id pub-id-type="pmid">28514692</pub-id></element-citation></ref><ref id="B150-viruses-12-00376"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemann</surname><given-names>E.A.</given-names></name><name><surname>Green</surname><given-names>R.</given-names></name><name><surname>Turnbull</surname><given-names>J.B.</given-names></name><name><surname>Langlois</surname><given-names>R.A.</given-names></name><name><surname>Savan</surname><given-names>R.</given-names></name><name><surname>Gale</surname><given-names>M.</given-names></name></person-group><article-title>Interferon-&#x003bb; modulates dendritic cells to facilitate T cell immunity during infection with influenza A virus</article-title><source>Nat. Immunol.</source><year>2019</year><volume>20</volume><fpage>1035</fpage><lpage>1045</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0408-z</pub-id><pub-id pub-id-type="pmid">31235953</pub-id></element-citation></ref><ref id="B151-viruses-12-00376"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>H.</given-names></name><name><surname>Killip</surname><given-names>M.J.</given-names></name><name><surname>Staeheli</surname><given-names>P.</given-names></name><name><surname>Randall</surname><given-names>R.</given-names></name><name><surname>Jackson</surname><given-names>D.</given-names></name></person-group><article-title>The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm</article-title><source>J. Virol.</source><year>2013</year><volume>87</volume><fpage>13053</fpage><lpage>13058</lpage><pub-id pub-id-type="doi">10.1128/JVI.02220-13</pub-id><?supplied-pmid 24049170?><pub-id pub-id-type="pmid">24049170</pub-id></element-citation></ref><ref id="B152-viruses-12-00376"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000e4;nz</surname><given-names>B.</given-names></name><name><surname>Dornfeld</surname><given-names>D.</given-names></name><name><surname>G&#x000f6;tz</surname><given-names>V.</given-names></name><name><surname>Zell</surname><given-names>R.</given-names></name><name><surname>Zimmermann</surname><given-names>P.</given-names></name><name><surname>Haller</surname><given-names>O.</given-names></name><name><surname>Kochs</surname><given-names>G.</given-names></name><name><surname>Schwemmle</surname><given-names>M.</given-names></name></person-group><article-title>Pandemic Influenza A Viruses Escape from Restriction by Human MxA through Adaptive Mutations in the Nucleoprotein</article-title><source>PLoS Pathog.</source><year>2013</year><volume>9</volume><elocation-id>e1003279</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003279</pub-id><?supplied-pmid 23555271?><pub-id pub-id-type="pmid">23555271</pub-id></element-citation></ref><ref id="B153-viruses-12-00376"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>E.S.</given-names></name><name><surname>Diercks</surname><given-names>A.H.</given-names></name><name><surname>Podolsky</surname><given-names>I.</given-names></name><name><surname>Podyminogin</surname><given-names>R.L.</given-names></name><name><surname>Askovich</surname><given-names>P.S.</given-names></name><name><surname>Treuting</surname><given-names>P.M.</given-names></name><name><surname>Aderem</surname><given-names>A.</given-names></name></person-group><article-title>25-Hydroxycholesterol acts as an amplifier of inflammatory signaling</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2014</year><volume>111</volume><fpage>10666</fpage><lpage>10671</lpage><pub-id pub-id-type="doi">10.1073/pnas.1404271111</pub-id><pub-id pub-id-type="pmid">24994901</pub-id></element-citation></ref><ref id="B154-viruses-12-00376"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordmann</surname><given-names>A.</given-names></name><name><surname>Wixler</surname><given-names>L.</given-names></name><name><surname>Boergeling</surname><given-names>Y.</given-names></name><name><surname>Wixler</surname><given-names>V.</given-names></name><name><surname>Ludwig</surname><given-names>S.</given-names></name></person-group><article-title>A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replication</article-title><source>FASEB J.</source><year>2012</year><volume>26</volume><fpage>1290</fpage><lpage>1300</lpage><pub-id pub-id-type="doi">10.1096/fj.11-189886</pub-id><?supplied-pmid 22106366?><pub-id pub-id-type="pmid">22106366</pub-id></element-citation></ref><ref id="B155-viruses-12-00376"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>F.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Cheng</surname><given-names>G.</given-names></name><name><surname>Qin</surname><given-names>F.X.-F.</given-names></name></person-group><article-title>Inhibition of Influenza A Virus Replication by TRIM14 via Its Multifaceted Protein-Protein Interaction with NP</article-title><source>Front. Microbiol.</source><year>2019</year><volume>10</volume><fpage>344</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.00344</pub-id><?supplied-pmid 30873142?><pub-id pub-id-type="pmid">30873142</pub-id></element-citation></ref><ref id="B156-viruses-12-00376"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Pietro</surname><given-names>A.</given-names></name><name><surname>Kajaste-Rudnitski</surname><given-names>A.</given-names></name><name><surname>Oteiza</surname><given-names>A.</given-names></name><name><surname>Nicora</surname><given-names>L.</given-names></name><name><surname>Towers</surname><given-names>G.J.</given-names></name><name><surname>Mechti</surname><given-names>N.</given-names></name><name><surname>Vicenzi</surname><given-names>E.</given-names></name></person-group><article-title>TRIM22 Inhibits Influenza A Virus Infection by Targeting the Viral Nucleoprotein for Degradation</article-title><source>J. Virol.</source><year>2013</year><volume>87</volume><fpage>4523</fpage><lpage>4533</lpage><pub-id pub-id-type="doi">10.1128/JVI.02548-12</pub-id><?supplied-pmid 23408607?><pub-id pub-id-type="pmid">23408607</pub-id></element-citation></ref><ref id="B157-viruses-12-00376"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gack</surname><given-names>M.U.</given-names></name><name><surname>Shin</surname><given-names>Y.C.</given-names></name><name><surname>Joo</surname><given-names>C.-H.</given-names></name><name><surname>Urano</surname><given-names>T.</given-names></name><name><surname>Liang</surname><given-names>C.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Takeuchi</surname><given-names>O.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Inoue</surname><given-names>S.</given-names></name><etal/></person-group><article-title>TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity</article-title><source>Nature</source><year>2007</year><volume>446</volume><fpage>916</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.1038/nature05732</pub-id><pub-id pub-id-type="pmid">17392790</pub-id></element-citation></ref><ref id="B158-viruses-12-00376"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Ding</surname><given-names>H.</given-names></name><name><surname>Schwamborn</surname><given-names>J.C.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Dorf</surname><given-names>M.E.</given-names></name></person-group><article-title>TRIM32 Senses and Restricts Influenza A Virus by Ubiquitination of PB1 Polymerase</article-title><source>PLoS Pathog.</source><year>2015</year><volume>11</volume><elocation-id>e1004960</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004960</pub-id><pub-id pub-id-type="pmid">26057645</pub-id></element-citation></ref><ref id="B159-viruses-12-00376"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname><given-names>G.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Song</surname><given-names>K.</given-names></name><name><surname>Hao</surname><given-names>W.</given-names></name><name><surname>Bouchereau</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name></person-group><article-title>TRIM41-Mediated Ubiquitination of Nucleoprotein Limits Influenza A Virus Infection</article-title><source>J. Virol.</source><year>2018</year><volume>92</volume><pub-id pub-id-type="doi">10.1128/JVI.00905-18</pub-id></element-citation></ref><ref id="B160-viruses-12-00376"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shim</surname><given-names>J.M.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Tenson</surname><given-names>T.</given-names></name><name><surname>Min</surname><given-names>J.-Y.</given-names></name><name><surname>Kainov</surname><given-names>D.</given-names></name></person-group><article-title>Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis</article-title><source>Viruses</source><year>2017</year><volume>9</volume><elocation-id>223</elocation-id><pub-id pub-id-type="doi">10.3390/v9080223</pub-id></element-citation></ref><ref id="B161-viruses-12-00376"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Killip</surname><given-names>M.J.</given-names></name><name><surname>Fodor</surname><given-names>E.</given-names></name><name><surname>Randall</surname><given-names>R.</given-names></name></person-group><article-title>Influenza virus activation of the interferon system</article-title><source>Virus Res.</source><year>2015</year><volume>209</volume><fpage>11</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2015.02.003</pub-id><?supplied-pmid 25678267?><pub-id pub-id-type="pmid">25678267</pub-id></element-citation></ref><ref id="B162-viruses-12-00376"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>C.</given-names></name><name><surname>Vijayan</surname><given-names>M.</given-names></name><name><surname>Pritzl</surname><given-names>C.J.</given-names></name><name><surname>Fuchs</surname><given-names>S.Y.</given-names></name><name><surname>McDermott</surname><given-names>A.B.</given-names></name><name><surname>Hahm</surname><given-names>B.</given-names></name></person-group><article-title>Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1</article-title><source>J. Virol.</source><year>2015</year><volume>90</volume><fpage>2403</fpage><lpage>2417</lpage><pub-id pub-id-type="doi">10.1128/JVI.02749-15</pub-id><?supplied-pmid 26676772?><pub-id pub-id-type="pmid">26676772</pub-id></element-citation></ref><ref id="B163-viruses-12-00376"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>C.</given-names></name><name><surname>Wolf</surname><given-names>J.J.</given-names></name><name><surname>Sun</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Studstill</surname><given-names>C.J.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Ngo</surname><given-names>H.</given-names></name><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Hahm</surname><given-names>B.</given-names></name></person-group><article-title>PARP1 Enhances Influenza A Virus Propagation by Facilitating Degradation of Host Type I Interferon Receptor</article-title><source>J. Virol.</source><year>2020</year><volume>94</volume><pub-id pub-id-type="doi">10.1128/JVI.01572-19</pub-id><?supplied-pmid 31915279?><pub-id pub-id-type="pmid">31915279</pub-id></element-citation></ref><ref id="B164-viruses-12-00376"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Calvo</surname><given-names>P.A.</given-names></name><name><surname>Malide</surname><given-names>D.</given-names></name><name><surname>Gibbs</surname><given-names>J.</given-names></name><name><surname>Schubert</surname><given-names>U.</given-names></name><name><surname>Bacik</surname><given-names>I.</given-names></name><name><surname>Basta</surname><given-names>S.</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>R.</given-names></name><name><surname>Schickli</surname><given-names>J.</given-names></name><name><surname>Palese</surname><given-names>P.</given-names></name><etal/></person-group><article-title>A novel influenza A virus mitochondrial protein that induces cell death</article-title><source>Nat. Med.</source><year>2001</year><volume>7</volume><fpage>1306</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1038/nm1201-1306</pub-id><pub-id pub-id-type="pmid">11726970</pub-id></element-citation></ref><ref id="B165-viruses-12-00376"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varga</surname><given-names>Z.T.</given-names></name><name><surname>Grant</surname><given-names>A.</given-names></name><name><surname>Manicassamy</surname><given-names>B.</given-names></name><name><surname>Palese</surname><given-names>P.</given-names></name></person-group><article-title>Influenza Virus Protein PB1-F2 Inhibits the Induction of Type I Interferon by Binding to MAVS and Decreasing Mitochondrial Membrane Potential</article-title><source>J. Virol.</source><year>2012</year><volume>86</volume><fpage>8359</fpage><lpage>8366</lpage><pub-id pub-id-type="doi">10.1128/JVI.01122-12</pub-id><pub-id pub-id-type="pmid">22674996</pub-id></element-citation></ref><ref id="B166-viruses-12-00376"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>E.</given-names></name><name><surname>Byun</surname><given-names>Y.H.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Jang</surname><given-names>Y.H.</given-names></name><name><surname>Han</surname><given-names>W.</given-names></name><name><surname>Won</surname><given-names>J.</given-names></name><name><surname>Cho</surname><given-names>K.C.</given-names></name><name><surname>Kim</surname><given-names>D.H.</given-names></name><name><surname>Lee</surname><given-names>A.R.</given-names></name><name><surname>Shin</surname><given-names>G.-C.</given-names></name><etal/></person-group><article-title>Co-degradation of interferon signaling factor DDX3 by PB1-F2 as a basis for high virulence of 1918 pandemic influenza</article-title><source>EMBO J.</source><year>2019</year><volume>38</volume><fpage>e99475</fpage><pub-id pub-id-type="doi">10.15252/embj.201899475</pub-id><pub-id pub-id-type="pmid">30979777</pub-id></element-citation></ref><ref id="B167-viruses-12-00376"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Ren</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Tian</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Jin</surname><given-names>M.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name></person-group><article-title>Influenza A virus protein PB1-F2 impairs innate immunity by inducing mitophagy</article-title><source>Autophagy</source><year>2020</year><volume>11</volume><pub-id pub-id-type="doi">10.1080/15548627.2020.1725375</pub-id></element-citation></ref><ref id="B168-viruses-12-00376"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosokawa</surname><given-names>N.</given-names></name><name><surname>Hara</surname><given-names>T.</given-names></name><name><surname>Kaizuka</surname><given-names>T.</given-names></name><name><surname>Kishi</surname><given-names>C.</given-names></name><name><surname>Takamura</surname><given-names>A.</given-names></name><name><surname>Miura</surname><given-names>Y.</given-names></name><name><surname>Iemura</surname><given-names>S.-I.</given-names></name><name><surname>Natsume</surname><given-names>T.</given-names></name><name><surname>Takehana</surname><given-names>K.</given-names></name><name><surname>Yamada</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Nutrient-dependent mTORC1 Association with the ULK1&#x02013;Atg13&#x02013;FIP200 Complex Required for Autophagy</article-title><source>Mol. Biol. Cell</source><year>2009</year><volume>20</volume><fpage>1981</fpage><lpage>1991</lpage><pub-id pub-id-type="doi">10.1091/mbc.e08-12-1248</pub-id><pub-id pub-id-type="pmid">19211835</pub-id></element-citation></ref><ref id="B169-viruses-12-00376"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Jiang</surname><given-names>C.C.</given-names></name><name><surname>Fang</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>X.D.</given-names></name><name><surname>Jiang</surname><given-names>Z.W.</given-names></name></person-group><article-title>Connecting endoplasmic reticulum stress to autophagy through IRE1/JNK/beclin-1 in breast cancer cells</article-title><source>Int. J. Mol. Med.</source><year>2014</year><volume>34</volume><fpage>772</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.3892/ijmm.2014.1822</pub-id><pub-id pub-id-type="pmid">24970676</pub-id></element-citation></ref><ref id="B170-viruses-12-00376"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>L.</given-names></name><name><surname>Shu</surname><given-names>W.</given-names></name><name><surname>Dai</surname><given-names>W.</given-names></name><name><surname>Gao</surname><given-names>B.</given-names></name><name><surname>Xiong</surname><given-names>S.</given-names></name></person-group><article-title>Reactive Oxygen Species-Mediated c-Jun NH2-Terminal Kinase Activation Contributes to Hepatitis B Virus X Protein-Induced Autophagy via Regulation of the Beclin-1/Bcl-2 Interaction</article-title><source>J. Virol.</source><year>2017</year><volume>91</volume><pub-id pub-id-type="doi">10.1128/JVI.00001-17</pub-id></element-citation></ref><ref id="B171-viruses-12-00376"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>D.-D.</given-names></name><name><surname>Wang</surname><given-names>L.-L.</given-names></name><name><surname>Deng</surname><given-names>R.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>J.-F.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Xia</surname><given-names>L.-P.</given-names></name><name><surname>Feng</surname><given-names>G.-K.</given-names></name><name><surname>Liu</surname><given-names>Q.Q.</given-names></name><etal/></person-group><article-title>The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells</article-title><source>Oncogene</source><year>2009</year><volume>28</volume><fpage>886</fpage><lpage>898</lpage><pub-id pub-id-type="doi">10.1038/onc.2008.441</pub-id><?supplied-pmid 19060920?><pub-id pub-id-type="pmid">19060920</pub-id></element-citation></ref><ref id="B172-viruses-12-00376"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Chi</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Qi</surname><given-names>B.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>J.-L.</given-names></name></person-group><article-title>The Regulation of Autophagy by Influenza A Virus</article-title><source>BioMed Res. Int.</source><year>2014</year><volume>2014</volume><fpage>498083</fpage><pub-id pub-id-type="doi">10.1155/2014/498083</pub-id><?supplied-pmid 24779013?><pub-id pub-id-type="pmid">24779013</pub-id></element-citation></ref><ref id="B173-viruses-12-00376"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sparrer</surname><given-names>K.M.J.</given-names></name><name><surname>Gableske</surname><given-names>S.</given-names></name><name><surname>Zurenski</surname><given-names>M.A.</given-names></name><name><surname>Parker</surname><given-names>Z.M.</given-names></name><name><surname>Full</surname><given-names>F.</given-names></name><name><surname>Baumgart</surname><given-names>G.J.</given-names></name><name><surname>Kato</surname><given-names>J.</given-names></name><name><surname>Pacheco-Rodriguez</surname><given-names>G.</given-names></name><name><surname>Liang</surname><given-names>C.</given-names></name><name><surname>Pornillos</surname><given-names>O.</given-names></name><etal/></person-group><article-title>TRIM23 mediates virus-induced autophagy via activation of TBK1</article-title><source>Nat. Microbiol.</source><year>2017</year><volume>2</volume><fpage>1543</fpage><lpage>1557</lpage><pub-id pub-id-type="doi">10.1038/s41564-017-0017-2</pub-id><?supplied-pmid 28871090?><pub-id pub-id-type="pmid">28871090</pub-id></element-citation></ref><ref id="B174-viruses-12-00376"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroki</surname><given-names>T.</given-names></name><name><surname>Osari</surname><given-names>S.</given-names></name><name><surname>Nagata</surname><given-names>K.</given-names></name><name><surname>Kawaguchi</surname><given-names>A.</given-names></name></person-group><article-title>Influenza A Virus NS1 Protein Suppresses JNK1-Dependent Autophagosome Formation Mediated by Rab11a Recycling Endosomes</article-title><source>Front. Microbiol.</source><year>2018</year><volume>9</volume><fpage>3120</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.03120</pub-id><?supplied-pmid 30619194?><pub-id pub-id-type="pmid">30619194</pub-id></element-citation></ref><ref id="B175-viruses-12-00376"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>T.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Prinz</surname><given-names>R.A.</given-names></name><name><surname>Peng</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name></person-group><article-title>Role of TGF-&#x003b2;-activated kinase 1 (TAK1) activation in H5N1 influenza A virus-induced c-Jun terminal kinase activation and virus replication</article-title><source>Virology</source><year>2019</year><volume>537</volume><fpage>263</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2019.09.004</pub-id><?supplied-pmid 31539775?><pub-id pub-id-type="pmid">31539775</pub-id></element-citation></ref><ref id="B176-viruses-12-00376"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Hong</surname><given-names>M.J.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Shi</surname><given-names>X.</given-names></name><name><surname>Gilbert</surname><given-names>B.E.</given-names></name><name><surname>Corry</surname><given-names>D.B.</given-names></name><name><surname>Kheradmand</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name></person-group><article-title>Essential role for autophagy in the maintenance of immunological memory against influenza infection</article-title><source>Nat. Med.</source><year>2014</year><volume>20</volume><fpage>503</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1038/nm.3521</pub-id><?supplied-pmid 24747745?><pub-id pub-id-type="pmid">24747745</pub-id></element-citation></ref><ref id="B177-viruses-12-00376"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gannag&#x000e9;</surname><given-names>M.</given-names></name><name><surname>Dormann</surname><given-names>R.</given-names></name><name><surname>Albrecht</surname><given-names>R.A.</given-names></name><name><surname>Dengjel</surname><given-names>J.</given-names></name><name><surname>Torossi</surname><given-names>T.</given-names></name><name><surname>R&#x000e4;mer</surname><given-names>P.C.</given-names></name><name><surname>Lee</surname><given-names>M.</given-names></name><name><surname>Strowig</surname><given-names>T.</given-names></name><name><surname>Arrey</surname><given-names>F.</given-names></name><name><surname>Conenello</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Matrix Protein 2 of Influenza A Virus Blocks Autophagosome Fusion with Lysosomes</article-title><source>Cell Host Microbe</source><year>2009</year><volume>6</volume><fpage>367</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2009.09.005</pub-id><pub-id pub-id-type="pmid">19837376</pub-id></element-citation></ref><ref id="B178-viruses-12-00376"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beale</surname><given-names>R.</given-names></name><name><surname>Wise</surname><given-names>H.</given-names></name><name><surname>Stuart</surname><given-names>A.</given-names></name><name><surname>Ravenhill</surname><given-names>B.J.</given-names></name><name><surname>Digard</surname><given-names>P.</given-names></name><name><surname>Randow</surname><given-names>F.</given-names></name></person-group><article-title>A LIR motif in influenza A virus M2 is required for virion stability</article-title><source>Cell Host Microbe</source><year>2014</year><volume>15</volume><fpage>239</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2014.01.006</pub-id><pub-id pub-id-type="pmid">24528869</pub-id></element-citation></ref><ref id="B179-viruses-12-00376"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Feng</surname><given-names>L.</given-names></name><name><surname>Pan</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Han</surname><given-names>L.</given-names></name><name><surname>Zheng</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Proton Channel Activity of Influenza A Virus Matrix Protein 2 Contributes to Autophagy Arrest</article-title><source>J. Virol.</source><year>2015</year><volume>90</volume><fpage>591</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1128/JVI.00576-15</pub-id><pub-id pub-id-type="pmid">26468520</pub-id></element-citation></ref><ref id="B180-viruses-12-00376"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>T.</given-names></name><name><surname>Ding</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Lei</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Song</surname><given-names>S.</given-names></name><name><surname>Hu</surname><given-names>B.</given-names></name></person-group><article-title>Circular RNA GATAD2A promotes H1N1 replication through inhibiting autophagy</article-title><source>Vet. Microbiol.</source><year>2019</year><volume>231</volume><fpage>238</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2019.03.012</pub-id><pub-id pub-id-type="pmid">30955816</pub-id></element-citation></ref><ref id="B181-viruses-12-00376"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ampomah</surname><given-names>P.B.</given-names></name><name><surname>Lim</surname><given-names>L.H.K.</given-names></name></person-group><article-title>Influenza A virus-induced apoptosis and virus propagation</article-title><source>Apoptosis</source><year>2020</year><volume>25</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1007/s10495-019-01575-3</pub-id><?supplied-pmid 31667646?><pub-id pub-id-type="pmid">31667646</pub-id></element-citation></ref><ref id="B182-viruses-12-00376"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>T.</given-names></name><name><surname>Castrucci</surname><given-names>M.R.</given-names></name><name><surname>Padrick</surname><given-names>R.C.</given-names></name><name><surname>Bradley</surname><given-names>L.M.</given-names></name><name><surname>Topham</surname><given-names>D.J.</given-names></name></person-group><article-title>Antigen-specific and non-specific CD4+ T cell recruitment and proliferation during influenza infection</article-title><source>Virology</source><year>2005</year><volume>340</volume><fpage>296</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2005.06.023</pub-id><?supplied-pmid 16054188?><pub-id pub-id-type="pmid">16054188</pub-id></element-citation></ref><ref id="B183-viruses-12-00376"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swain</surname><given-names>S.L.</given-names></name><name><surname>McKinstry</surname><given-names>K.</given-names></name><name><surname>Strutt</surname><given-names>T.M.</given-names></name></person-group><article-title>Expanding roles for CD4+ T cells in immunity to viruses</article-title><source>Nat. Rev. Immunol.</source><year>2012</year><volume>12</volume><fpage>136</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1038/nri3152</pub-id><?supplied-pmid 22266691?><pub-id pub-id-type="pmid">22266691</pub-id></element-citation></ref><ref id="B184-viruses-12-00376"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>S.</given-names></name><name><surname>Lindell</surname><given-names>D.M.</given-names></name><name><surname>Berlin</surname><given-names>A.A.</given-names></name><name><surname>Morris</surname><given-names>S.B.</given-names></name><name><surname>Shanley</surname><given-names>T.</given-names></name><name><surname>Hershenson</surname><given-names>M.B.</given-names></name><name><surname>Lukacs</surname><given-names>N.W.</given-names></name></person-group><article-title>IL-17&#x02013;Induced Pulmonary Pathogenesis during Respiratory Viral Infection and Exacerbation of Allergic Disease</article-title><source>Am. J. Pathol.</source><year>2011</year><volume>179</volume><fpage>248</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2011.03.003</pub-id><?supplied-pmid 21703407?><pub-id pub-id-type="pmid">21703407</pub-id></element-citation></ref><ref id="B185-viruses-12-00376"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almansa</surname><given-names>R.</given-names></name><name><surname>Socias</surname><given-names>L.</given-names></name><name><surname>Ramirez</surname><given-names>P.</given-names></name><name><surname>Martin-Loeches</surname><given-names>I.</given-names></name><name><surname>Vall&#x000e9;s</surname><given-names>J.</given-names></name><name><surname>Loza</surname><given-names>A.</given-names></name><name><surname>Jordi</surname><given-names>R.</given-names></name><name><surname>David</surname><given-names>J.K.</given-names></name><name><surname>Cristobal</surname><given-names>L.</given-names></name><name><surname>Jes&#x000fa;s</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Imbalanced pro- and anti-Th17 responses (IL-17/granulocyte colony-stimulating factor) predict fatal outcome in 2009 pandemic influenza</article-title><source>Crit. Care</source><year>2011</year><volume>15</volume><fpage>448</fpage><pub-id pub-id-type="doi">10.1186/cc10426</pub-id><pub-id pub-id-type="pmid">22040730</pub-id></element-citation></ref><ref id="B186-viruses-12-00376"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>E.L.</given-names></name><name><surname>Molony</surname><given-names>R.D.</given-names></name><name><surname>Kudo</surname><given-names>E.</given-names></name><name><surname>Sidorov</surname><given-names>S.</given-names></name><name><surname>Kong</surname><given-names>Y.</given-names></name><name><surname>Dixit</surname><given-names>V.D.</given-names></name><name><surname>Iwasaki</surname><given-names>A.</given-names></name></person-group><article-title>Ketogenic diet activates protective &#x003b3;&#x003b4; T cell responses against influenza virus infection</article-title><source>Sci. Immunol.</source><year>2019</year><volume>4</volume><fpage>2026</fpage><pub-id pub-id-type="doi">10.1126/sciimmunol.aav2026</pub-id></element-citation></ref><ref id="B187-viruses-12-00376"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hornick</surname><given-names>E.E.</given-names></name><name><surname>Zacharias</surname><given-names>Z.R.</given-names></name><name><surname>Legge</surname><given-names>K.L.</given-names></name></person-group><article-title>Kinetics and Phenotype of the CD4 T Cell Response to Influenza Virus Infections</article-title><source>Front. Immunol.</source><year>2019</year><volume>10</volume><fpage>2351</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2019.02351</pub-id><pub-id pub-id-type="pmid">31632414</pub-id></element-citation></ref><ref id="B188-viruses-12-00376"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Gruta</surname><given-names>N.L.</given-names></name><name><surname>Turner</surname><given-names>S.J.</given-names></name></person-group><article-title>T cell mediated immunity to influenza: Mechanisms of viral control</article-title><source>Trends Immunol.</source><year>2014</year><volume>35</volume><fpage>396</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/j.it.2014.06.004</pub-id><pub-id pub-id-type="pmid">25043801</pub-id></element-citation></ref><ref id="B189-viruses-12-00376"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>F.</given-names></name></person-group><article-title>Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state</article-title><source>Immunol. Rev.</source><year>2010</year><volume>235</volume><fpage>128</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1111/j.0105-2896.2010.00909.x</pub-id><pub-id pub-id-type="pmid">20536560</pub-id></element-citation></ref><ref id="B190-viruses-12-00376"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allie</surname><given-names>S.R.</given-names></name><name><surname>Randall</surname><given-names>T.D.</given-names></name></person-group><article-title>Pulmonary immunity to viruses</article-title><source>Clin. Sci.</source><year>2017</year><volume>131</volume><fpage>1737</fpage><lpage>1762</lpage><pub-id pub-id-type="doi">10.1042/CS20160259</pub-id><pub-id pub-id-type="pmid">28667071</pub-id></element-citation></ref><ref id="B191-viruses-12-00376"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Liang</surname><given-names>X.</given-names></name></person-group><article-title>IL16 deficiency enhances Th1 and cytotoxic T lymphocyte response against influenza A virus infection</article-title><source>Biosci. Trends</source><year>2020</year><volume>13</volume><fpage>516</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.5582/bst.2019.01286</pub-id><?supplied-pmid 31852865?><pub-id pub-id-type="pmid">31852865</pub-id></element-citation></ref><ref id="B192-viruses-12-00376"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>E.J.</given-names></name><name><surname>Qui&#x000f1;ones-Parra</surname><given-names>S.M.</given-names></name><name><surname>Clemens</surname><given-names>E.B.</given-names></name><name><surname>Kedzierska</surname><given-names>K.</given-names></name></person-group><article-title>Human influenza viruses and CD8 + T cell responses</article-title><source>Curr. Opin. Virol.</source><year>2016</year><volume>16</volume><fpage>132</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1016/j.coviro.2016.01.016</pub-id><?supplied-pmid 26974887?><pub-id pub-id-type="pmid">26974887</pub-id></element-citation></ref><ref id="B193-viruses-12-00376"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizzolla</surname><given-names>A.</given-names></name><name><surname>Nguyen</surname><given-names>T.H.O.</given-names></name><name><surname>Smith</surname><given-names>J.M.</given-names></name><name><surname>Brooks</surname><given-names>A.G.</given-names></name><name><surname>Kedzierska</surname><given-names>K.</given-names></name><name><surname>Heath</surname><given-names>W.R.</given-names></name><name><surname>Reading</surname><given-names>P.</given-names></name><name><surname>Wakim</surname><given-names>L.M.</given-names></name></person-group><article-title>Resident memory CD8+T cells in the upper respiratory tract prevent pulmonary influenza virus infection</article-title><source>Sci. Immunol.</source><year>2017</year><volume>2</volume><fpage>6970</fpage><pub-id pub-id-type="doi">10.1126/sciimmunol.aam6970</pub-id><?supplied-pmid 28783656?><pub-id pub-id-type="pmid">28783656</pub-id></element-citation></ref><ref id="B194-viruses-12-00376"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puleston</surname><given-names>D.J.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Powell</surname><given-names>T.J.</given-names></name><name><surname>Lipina</surname><given-names>E.</given-names></name><name><surname>Sims</surname><given-names>S.</given-names></name><name><surname>Panse</surname><given-names>I.</given-names></name><name><surname>Watson</surname><given-names>A.S.</given-names></name><name><surname>Cerundolo</surname><given-names>V.</given-names></name><name><surname>Townsend</surname><given-names>A.R.M.</given-names></name><name><surname>Klenerman</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Autophagy is a critical regulator of memory CD8+ T cell formation</article-title><source>ELife</source><year>2014</year><volume>3</volume><fpage>e03706</fpage><pub-id pub-id-type="doi">10.7554/eLife.03706</pub-id></element-citation></ref><ref id="B195-viruses-12-00376"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cullen</surname><given-names>J.G.</given-names></name><name><surname>McQuilten</surname><given-names>H.A.</given-names></name><name><surname>Quinn</surname><given-names>K.M.</given-names></name><name><surname>Olshansky</surname><given-names>M.</given-names></name><name><surname>Russ</surname><given-names>B.E.</given-names></name><name><surname>Morey</surname><given-names>A.</given-names></name><name><surname>Wei</surname><given-names>S.</given-names></name><name><surname>Prier</surname><given-names>J.E.</given-names></name><name><surname>La Gruta</surname><given-names>N.L.</given-names></name><name><surname>Doherty</surname><given-names>P.C.</given-names></name><etal/></person-group><article-title>CD4+T help promotes influenza virus-specific CD8+T cell memory by limiting metabolic dysfunction</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2019</year><volume>116</volume><fpage>4481</fpage><lpage>4488</lpage><pub-id pub-id-type="doi">10.1073/pnas.1808849116</pub-id><pub-id pub-id-type="pmid">30787194</pub-id></element-citation></ref><ref id="B196-viruses-12-00376"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangel-Moreno</surname><given-names>J.</given-names></name><name><surname>Carragher</surname><given-names>D.</given-names></name><name><surname>Misra</surname><given-names>R.S.</given-names></name><name><surname>Kusser</surname><given-names>K.</given-names></name><name><surname>Hartson</surname><given-names>L.</given-names></name><name><surname>Moquin</surname><given-names>A.</given-names></name><name><surname>Lund</surname><given-names>F.E.</given-names></name><name><surname>Randall</surname><given-names>T.D.</given-names></name></person-group><article-title>B cells promote resistance to heterosubtypic strains of influenza via multiple mechanisms1</article-title><source>J. Immunol.</source><year>2008</year><volume>180</volume><fpage>454</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.1.454</pub-id><pub-id pub-id-type="pmid">18097047</pub-id></element-citation></ref><ref id="B197-viruses-12-00376"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seibert</surname><given-names>C.W.</given-names></name><name><surname>Rahmat</surname><given-names>S.</given-names></name><name><surname>Krause</surname><given-names>J.C.</given-names></name><name><surname>Eggink</surname><given-names>D.</given-names></name><name><surname>Albrecht</surname><given-names>R.A.</given-names></name><name><surname>Goff</surname><given-names>P.H.</given-names></name><name><surname>Krammer</surname><given-names>F.</given-names></name><name><surname>Duty</surname><given-names>J.A.</given-names></name><name><surname>Bouvier</surname><given-names>N.</given-names></name><name><surname>Garc&#x000ed;a-Sastre</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Recombinant IgA Is Sufficient To Prevent Influenza Virus Transmission in Guinea Pigs</article-title><source>J. Virol.</source><year>2013</year><volume>87</volume><fpage>7793</fpage><lpage>7804</lpage><pub-id pub-id-type="doi">10.1128/JVI.00979-13</pub-id><pub-id pub-id-type="pmid">23698296</pub-id></element-citation></ref><ref id="B198-viruses-12-00376"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herv&#x000e9;</surname><given-names>P.-L.</given-names></name><name><surname>Lorin</surname><given-names>V.</given-names></name><name><surname>Jouvion</surname><given-names>G.</given-names></name><name><surname>Da Costa</surname><given-names>B.</given-names></name><name><surname>Escriou</surname><given-names>N.</given-names></name></person-group><article-title>Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity</article-title><source>Virology</source><year>2015</year><volume>486</volume><fpage>134</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2015.08.033</pub-id><pub-id pub-id-type="pmid">26433051</pub-id></element-citation></ref><ref id="B199-viruses-12-00376"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>A Elmore</surname><given-names>S.</given-names></name></person-group><article-title>Apoptosis: A Review of Programmed Cell Death</article-title><source>Toxicol. Pathol.</source><year>2007</year><volume>35</volume><fpage>495</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1080/01926230701320337</pub-id><pub-id pub-id-type="pmid">17562483</pub-id></element-citation></ref><ref id="B200-viruses-12-00376"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapranos</surname><given-names>N.</given-names></name><name><surname>Kontogeorgos</surname><given-names>G.</given-names></name></person-group><article-title>Bcl-2 Gene Family in Endocrine Pathology: A Review</article-title><source>Endocr. Pathol.</source><year>2000</year><volume>11</volume><fpage>205</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">12114693</pub-id></element-citation></ref><ref id="B201-viruses-12-00376"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Br&#x000fc;ne</surname><given-names>B.</given-names></name></person-group><article-title>Nitric oxide: NO apoptosis or turning it ON?</article-title><source>Cell Death Differ.</source><year>2003</year><volume>10</volume><fpage>864</fpage><lpage>869</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4401261</pub-id><?supplied-pmid 12867993?><pub-id pub-id-type="pmid">12867993</pub-id></element-citation></ref><ref id="B202-viruses-12-00376"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerrero</surname><given-names>A.D.</given-names></name><name><surname>Schmitz</surname><given-names>I.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name></person-group><article-title>Promotion of Caspase Activation by Caspase-9-mediated Feedback Amplification of Mitochondrial Damage</article-title><source>J. Clin. Cell. Immunol.</source><year>2012</year><volume>3</volume><pub-id pub-id-type="doi">10.4172/2155-9899.1000126</pub-id><?supplied-pmid 23539542?><pub-id pub-id-type="pmid">23539542</pub-id></element-citation></ref><ref id="B203-viruses-12-00376"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>C.</given-names></name><name><surname>Fang</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Smac, a Mitochondrial Protein that Promotes Cytochrome c&#x02013;Dependent Caspase Activation by Eliminating IAP Inhibition</article-title><source>Cell</source><year>2000</year><volume>102</volume><fpage>33</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)00008-8</pub-id><pub-id pub-id-type="pmid">10929711</pub-id></element-citation></ref><ref id="B204-viruses-12-00376"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strasser</surname><given-names>A.</given-names></name><name><surname>Jost</surname><given-names>P.J.</given-names></name><name><surname>Nagata</surname><given-names>S.</given-names></name></person-group><article-title>The Many Roles of FAS Receptor Signaling in the Immune System</article-title><source>Immunity</source><year>2009</year><volume>30</volume><fpage>180</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.01.001</pub-id><pub-id pub-id-type="pmid">19239902</pub-id></element-citation></ref><ref id="B205-viruses-12-00376"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wajant</surname><given-names>H.</given-names></name></person-group><article-title>The Fas Signaling Pathway: More Than a Paradigm</article-title><source>Science</source><year>2002</year><volume>296</volume><fpage>1635</fpage><lpage>1636</lpage><pub-id pub-id-type="doi">10.1126/science.1071553</pub-id><pub-id pub-id-type="pmid">12040174</pub-id></element-citation></ref><ref id="B206-viruses-12-00376"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galluzzi</surname><given-names>L.</given-names></name><name><surname>Brenner</surname><given-names>C.</given-names></name><name><surname>Morselli</surname><given-names>E.</given-names></name><name><surname>Touat</surname><given-names>Z.</given-names></name><name><surname>Kroemer</surname><given-names>G.</given-names></name></person-group><article-title>Viral Control of Mitochondrial Apoptosis</article-title><source>PLoS Pathog.</source><year>2008</year><volume>4</volume><elocation-id>e1000018</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000018</pub-id><pub-id pub-id-type="pmid">18516228</pub-id></element-citation></ref><ref id="B207-viruses-12-00376"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhirnov</surname><given-names>O.P.</given-names></name><name><surname>Klenk</surname><given-names>H.-D.</given-names></name></person-group><article-title>Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling</article-title><source>Apoptosis</source><year>2007</year><volume>12</volume><fpage>1419</fpage><lpage>1432</lpage><pub-id pub-id-type="doi">10.1007/s10495-007-0071-y</pub-id><pub-id pub-id-type="pmid">17468837</pub-id></element-citation></ref><ref id="B208-viruses-12-00376"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nailwal</surname><given-names>H.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Mayank</surname><given-names>A.K.</given-names></name><name><surname>Lal</surname><given-names>S.K.</given-names></name></person-group><article-title>The nucleoprotein of influenza A virus induces p53 signaling and apoptosis via attenuation of host ubiquitin ligase RNF43</article-title><source>Cell Death Dis.</source><year>2015</year><volume>6</volume><fpage>e1768</fpage><pub-id pub-id-type="doi">10.1038/cddis.2015.131</pub-id><pub-id pub-id-type="pmid">25996295</pub-id></element-citation></ref><ref id="B209-viruses-12-00376"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayank</surname><given-names>A.K.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Nailwal</surname><given-names>H.</given-names></name><name><surname>Lal</surname><given-names>S.K.</given-names></name></person-group><article-title>Nucleoprotein of influenza A virus negatively impacts antiapoptotic protein API5 to enhance E2F1-dependent apoptosis and virus replication</article-title><source>Cell Death Dis.</source><year>2015</year><volume>6</volume><fpage>e2018</fpage><pub-id pub-id-type="doi">10.1038/cddis.2015.360</pub-id></element-citation></ref><ref id="B210-viruses-12-00376"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halder</surname><given-names>U.C.</given-names></name><name><surname>Bagchi</surname><given-names>P.</given-names></name><name><surname>Chattopadhyay</surname><given-names>S.</given-names></name><name><surname>Dutta</surname><given-names>D.</given-names></name><name><surname>Chawla-Sarkar</surname><given-names>M.</given-names></name></person-group><article-title>Cell death regulation during influenza A virus infection by matrix (M1) protein: A model of viral control over the cellular survival pathway</article-title><source>Cell Death Dis.</source><year>2011</year><volume>2</volume><fpage>e197</fpage><pub-id pub-id-type="doi">10.1038/cddis.2011.75</pub-id><pub-id pub-id-type="pmid">21881599</pub-id></element-citation></ref><ref id="B211-viruses-12-00376"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schultz-Cherry</surname><given-names>S.</given-names></name><name><surname>Dybdahl-Sissoko</surname><given-names>N.</given-names></name><name><surname>Neumann</surname><given-names>G.</given-names></name><name><surname>Kawaoka</surname><given-names>Y.</given-names></name><name><surname>Hinshaw</surname><given-names>V.S.</given-names></name></person-group><article-title>Influenza Virus NS1 Protein Induces Apoptosis in Cultured Cells</article-title><source>J. Virol.</source><year>2001</year><volume>75</volume><fpage>7875</fpage><lpage>7881</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.17.7875-7881.2001</pub-id><?supplied-pmid 11483732?><pub-id pub-id-type="pmid">11483732</pub-id></element-citation></ref><ref id="B212-viruses-12-00376"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>D.</given-names></name><name><surname>Killip</surname><given-names>M.J.</given-names></name><name><surname>Galloway</surname><given-names>C.S.</given-names></name><name><surname>Russell</surname><given-names>R.J.</given-names></name><name><surname>Randall</surname><given-names>R.E.</given-names></name></person-group><article-title>Loss of function of the influenza A virus NS1 protein promotes apoptosis but this is not due to a failure to activate phosphatidylinositol 3-kinase (PI3K)</article-title><source>Virology</source><year>2010</year><volume>396</volume><fpage>94</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2009.10.004</pub-id><?supplied-pmid 19880155?><pub-id pub-id-type="pmid">19880155</pub-id></element-citation></ref><ref id="B213-viruses-12-00376"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>S.</given-names></name><name><surname>Crotta</surname><given-names>S.</given-names></name><name><surname>McCabe</surname><given-names>T.M.</given-names></name><name><surname>Wack</surname><given-names>A.</given-names></name></person-group><article-title>Pathogenic potential of interferon &#x003b1;&#x003b2; in acute influenza infection</article-title><source>Nat. Commun.</source><year>2014</year><volume>5</volume><fpage>3864</fpage><pub-id pub-id-type="doi">10.1038/ncomms4864</pub-id><?supplied-pmid 24844667?><pub-id pub-id-type="pmid">24844667</pub-id></element-citation></ref><ref id="B214-viruses-12-00376"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>S.</given-names></name><name><surname>McCabe</surname><given-names>T.M.</given-names></name><name><surname>Crotta</surname><given-names>S.</given-names></name><name><surname>Gad</surname><given-names>H.H.</given-names></name><name><surname>Hessel</surname><given-names>E.M.</given-names></name><name><surname>Beinke</surname><given-names>S.</given-names></name><name><surname>Rune</surname><given-names>H.</given-names></name><name><surname>Andreas</surname><given-names>W.</given-names></name></person-group><article-title>IFN&#x003bb; is a potent anti-influenza therapeutic without the inflammatory side effects of IFN&#x003b1; treatment</article-title><source>EMBO Mol. Med.</source><year>2016</year><volume>8</volume><fpage>1099</fpage><lpage>1112</lpage><pub-id pub-id-type="doi">10.15252/emmm.201606413</pub-id><?supplied-pmid 27520969?><pub-id pub-id-type="pmid">27520969</pub-id></element-citation></ref><ref id="B215-viruses-12-00376"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Hirohama</surname><given-names>M.</given-names></name><name><surname>Noguchi</surname><given-names>M.</given-names></name><name><surname>Nagata</surname><given-names>K.</given-names></name><name><surname>Kawaguchi</surname><given-names>A.</given-names></name></person-group><article-title>Influenza A Virus Infection Triggers Pyroptosis and Apoptosis of Respiratory Epithelial Cells through the Type I Interferon Signaling Pathway in a Mutually Exclusive Manner</article-title><source>J. Virol.</source><year>2018</year><volume>92</volume><pub-id pub-id-type="doi">10.1128/JVI.00396-18</pub-id><?supplied-pmid 29743359?><pub-id pub-id-type="pmid">29743359</pub-id></element-citation></ref><ref id="B216-viruses-12-00376"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grodeland</surname><given-names>G.</given-names></name><name><surname>Fossum</surname><given-names>E.</given-names></name><name><surname>Bogen</surname><given-names>B.</given-names></name></person-group><article-title>Targeting of HA to chemokine receptors induces strong and cross-reactive T cell responses after DNA vaccination in pigs</article-title><source>Vaccine</source><year>2020</year><volume>38</volume><fpage>1280</fpage><lpage>1285</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2019.11.084</pub-id><pub-id pub-id-type="pmid">31836256</pub-id></element-citation></ref><ref id="B217-viruses-12-00376"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zacharias</surname><given-names>Z.R.</given-names></name><name><surname>Ross</surname><given-names>K.A.</given-names></name><name><surname>Hornick</surname><given-names>E.E.</given-names></name><name><surname>Goodman</surname><given-names>J.T.</given-names></name><name><surname>Narasimhan</surname><given-names>B.</given-names></name><name><surname>Waldschmidt</surname><given-names>T.</given-names></name><name><surname>Legge</surname><given-names>K.L.</given-names></name></person-group><article-title>Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><fpage>1953</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.01953</pub-id><pub-id pub-id-type="pmid">30233573</pub-id></element-citation></ref><ref id="B218-viruses-12-00376"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKimm-Breschkin</surname><given-names>J.</given-names></name></person-group><article-title>Influenza neuraminidase inhibitors: Antiviral action and mechanisms of resistance</article-title><source>Influenza Other Respir. Viruses</source><year>2013</year><volume>7</volume><fpage>25</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1111/irv.12047</pub-id><pub-id pub-id-type="pmid">23279894</pub-id></element-citation></ref><ref id="B219-viruses-12-00376"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Hanlon</surname><given-names>R.</given-names></name><name><surname>Shaw</surname><given-names>M.</given-names></name></person-group><article-title>Baloxavir marboxil: The new influenza drug on the market</article-title><source>Curr. Opin. Virol.</source><year>2019</year><volume>35</volume><fpage>14</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.coviro.2019.01.006</pub-id><pub-id pub-id-type="pmid">30852344</pub-id></element-citation></ref><ref id="B220-viruses-12-00376"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanderlinden</surname><given-names>E.</given-names></name><name><surname>Naesens</surname><given-names>L.</given-names></name></person-group><article-title>Emerging Antiviral Strategies to Interfere with Influenza Virus Entry</article-title><source>Med. Res. Rev.</source><year>2014</year><volume>34</volume><fpage>301</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1002/med.21289</pub-id><pub-id pub-id-type="pmid">23801557</pub-id></element-citation></ref><ref id="B221-viruses-12-00376"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>G.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Ding</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group><article-title>Discovery of the First Series of Small Molecule H5N1 Entry Inhibitors</article-title><source>J. Med. Chem.</source><year>2009</year><volume>52</volume><fpage>7368</fpage><lpage>7371</lpage><pub-id pub-id-type="doi">10.1021/jm900275m</pub-id><?supplied-pmid 19537689?><pub-id pub-id-type="pmid">19537689</pub-id></element-citation></ref><ref id="B222-viruses-12-00376"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furuta</surname><given-names>Y.</given-names></name><name><surname>Gowen</surname><given-names>B.B.</given-names></name><name><surname>Takahashi</surname><given-names>K.</given-names></name><name><surname>Shiraki</surname><given-names>K.</given-names></name><name><surname>Smee</surname><given-names>N.F.</given-names></name><name><surname>Barnard</surname><given-names>D.L.</given-names></name></person-group><article-title>Favipiravir (T-705), a novel viral RNA polymerase inhibitor</article-title><source>Antivir. Res.</source><year>2013</year><volume>100</volume><fpage>446</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2013.09.015</pub-id><?supplied-pmid 24084488?><pub-id pub-id-type="pmid">24084488</pub-id></element-citation></ref><ref id="B223-viruses-12-00376"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furuta</surname><given-names>Y.</given-names></name><name><surname>Komeno</surname><given-names>T.</given-names></name><name><surname>Nakamura</surname><given-names>T.</given-names></name></person-group><article-title>Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase</article-title><source>Proc. Jpn. Acad. Ser. B</source><year>2017</year><volume>93</volume><fpage>449</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.2183/pjab.93.027</pub-id><?supplied-pmid 28769016?><pub-id pub-id-type="pmid">28769016</pub-id></element-citation></ref><ref id="B224-viruses-12-00376"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Meng</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Su</surname><given-names>Y.</given-names></name><name><surname>Shao</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>D.</given-names></name><name><surname>Yu</surname><given-names>F.</given-names></name></person-group><article-title>Synthesis, Structure Activity Relationship and Anti-influenza A Virus Evaluation of Oleanolic Acid-Linear Amino Derivatives</article-title><source>Chem. Pharm. Bull.</source><year>2019</year><volume>67</volume><fpage>1201</fpage><lpage>1207</lpage><pub-id pub-id-type="doi">10.1248/cpb.c19-00485</pub-id><?supplied-pmid 31434835?><pub-id pub-id-type="pmid">31434835</pub-id></element-citation></ref><ref id="B225-viruses-12-00376"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Y.</given-names></name><name><surname>Meng</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Shao</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Zhou</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Yu</surname><given-names>F.</given-names></name></person-group><article-title>Design, synthesis of oleanolic acid-saccharide conjugates using click chemistry methodology and study of their anti-influenza activity</article-title><source>Eur. J. Med. Chem.</source><year>2019</year><volume>182</volume><fpage>111622</fpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2019.111622</pub-id><pub-id pub-id-type="pmid">31425909</pub-id></element-citation></ref><ref id="B226-viruses-12-00376"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>L.</given-names></name><name><surname>Su</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Xiao</surname><given-names>S.</given-names></name><name><surname>Yin</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Zhong</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>D.</given-names></name><name><surname>Yu</surname><given-names>F.</given-names></name></person-group><article-title>Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors</article-title><source>Bioorg. Med. Chem.</source><year>2019</year><volume>27</volume><fpage>115147</fpage><pub-id pub-id-type="doi">10.1016/j.bmc.2019.115147</pub-id><pub-id pub-id-type="pmid">31635892</pub-id></element-citation></ref><ref id="B227-viruses-12-00376"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omi</surname><given-names>J.</given-names></name><name><surname>Watanabe-Takahashi</surname><given-names>M.</given-names></name><name><surname>Igai</surname><given-names>K.</given-names></name><name><surname>Shimizu</surname><given-names>E.</given-names></name><name><surname>Tseng</surname><given-names>C.-Y.</given-names></name><name><surname>Miyasaka</surname><given-names>T.</given-names></name><name><surname>Waku</surname><given-names>T.</given-names></name><name><surname>Hama</surname><given-names>S.</given-names></name><name><surname>Nakanishi</surname><given-names>R.</given-names></name><name><surname>Goto</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>The inducible amphisome isolates viral hemagglutinin and defends against influenza A virus infection</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>162</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-13974-w</pub-id><pub-id pub-id-type="pmid">31919357</pub-id></element-citation></ref><ref id="B228-viruses-12-00376"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>M.P.</given-names></name><name><surname>Ledeboer</surname><given-names>M.W.</given-names></name><name><surname>Davies</surname><given-names>I.</given-names></name><name><surname>Byrn</surname><given-names>R.A.</given-names></name><name><surname>Jones</surname><given-names>S.M.</given-names></name><name><surname>Perola</surname><given-names>E.</given-names></name><name><surname>Tsai</surname><given-names>A.</given-names></name><name><surname>Jacobs</surname><given-names>M.</given-names></name><name><surname>Nti-Addae</surname><given-names>K.</given-names></name><name><surname>Bandarage</surname><given-names>U.K.</given-names></name><etal/></person-group><article-title>Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2</article-title><source>J. Med. Chem.</source><year>2014</year><volume>57</volume><fpage>6668</fpage><lpage>6678</lpage><pub-id pub-id-type="doi">10.1021/jm5007275</pub-id><pub-id pub-id-type="pmid">25019388</pub-id></element-citation></ref><ref id="B229-viruses-12-00376"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>J.C.</given-names></name><name><surname>Marathe</surname><given-names>B.M.</given-names></name><name><surname>Lerner</surname><given-names>C.</given-names></name><name><surname>Kreis</surname><given-names>L.</given-names></name><name><surname>Gasser</surname><given-names>R.</given-names></name><name><surname>Pascua</surname><given-names>P.N.Q.</given-names></name><name><surname>Najera</surname><given-names>I.</given-names></name><name><surname>Govorkova</surname><given-names>E.A.</given-names></name></person-group><article-title>A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus ActivityIn Vitro</article-title><source>Antimicrob. Agents Chemother.</source><year>2016</year><volume>60</volume><fpage>5504</fpage><lpage>5514</lpage><pub-id pub-id-type="doi">10.1128/AAC.00888-16</pub-id><pub-id pub-id-type="pmid">27381402</pub-id></element-citation></ref><ref id="B230-viruses-12-00376"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>M.-S.</given-names></name><name><surname>Kumar</surname><given-names>G.</given-names></name><name><surname>Shadrick</surname><given-names>W.R.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Jeevan</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Slavish</surname><given-names>P.J.</given-names></name><name><surname>Fabrizio</surname><given-names>T.</given-names></name><name><surname>Yoon</surname><given-names>S.-W.</given-names></name><name><surname>Webb</surname><given-names>T.R.</given-names></name><etal/></person-group><article-title>Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2016</year><volume>113</volume><fpage>3669</fpage><lpage>3674</lpage><pub-id pub-id-type="doi">10.1073/pnas.1519772113</pub-id><pub-id pub-id-type="pmid">26976575</pub-id></element-citation></ref><ref id="B231-viruses-12-00376"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massari</surname><given-names>S.</given-names></name><name><surname>Goracci</surname><given-names>L.</given-names></name><name><surname>DeSantis</surname><given-names>J.</given-names></name><name><surname>Tabarrini</surname><given-names>O.</given-names></name></person-group><article-title>Polymerase Acidic Protein&#x02013;Basic Protein 1 (PA&#x02013;PB1) Protein-Protein Interaction as a Target for Next-Generation Anti-influenza Therapeutics</article-title><source>J. Med. Chem.</source><year>2016</year><volume>59</volume><fpage>7699</fpage><lpage>7718</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b01474</pub-id><?supplied-pmid 27046062?><pub-id pub-id-type="pmid">27046062</pub-id></element-citation></ref><ref id="B232-viruses-12-00376"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>W.</given-names></name><name><surname>Fan</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Jiao</surname><given-names>P.</given-names></name><name><surname>Shang</surname><given-names>Y.</given-names></name><name><surname>Cui</surname><given-names>L.</given-names></name><name><surname>Mahesutihan</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Gao</surname><given-names>G.F.</given-names></name><etal/></person-group><article-title>Naproxen Exhibits Broad Anti-influenza Virus Activity in Mice by Impeding Viral Nucleoprotein Nuclear Export</article-title><source>Cell Rep.</source><year>2019</year><volume>27</volume><fpage>1875</fpage><lpage>1885</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.04.053</pub-id><?supplied-pmid 31067470?><pub-id pub-id-type="pmid">31067470</pub-id></element-citation></ref><ref id="B233-viruses-12-00376"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickens</surname><given-names>J.A.</given-names></name><name><surname>Tripp</surname><given-names>R.A.</given-names></name></person-group><article-title>Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses</article-title><source>Viruses</source><year>2018</year><volume>10</volume><elocation-id>48</elocation-id><pub-id pub-id-type="doi">10.3390/v10010048</pub-id><?supplied-pmid 29361733?><pub-id pub-id-type="pmid">29361733</pub-id></element-citation></ref><ref id="B234-viruses-12-00376"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>S.</given-names></name></person-group><article-title>Treating Influenza Infection, From Now and Into the Future</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><fpage>1946</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.01946</pub-id><?supplied-pmid 30250466?><pub-id pub-id-type="pmid">30250466</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="viruses-12-00376-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Schematic diagram for activation of innate immune responses and interferon (IFN) signaling pathway after influenza A virus (IAV) infection. Intracellular detection conducted by pathogen recognition receptors (PRRs), including retinoic acid-inducible gene-I proteins (RIG-I), melanoma differentiation-associated gene 5 (MDA5), and toll-like receptors (TLRs), activate transcription factors such as IRFs and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-&#x003ba;B), resulting in expression of IFNs and interferon-stimulated genes (ISGs).</p></caption><graphic xlink:href="viruses-12-00376-g001"/></fig><fig id="viruses-12-00376-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Schematic diagram for adaptive immune responses against primary IAV infection.</p></caption><graphic xlink:href="viruses-12-00376-g002"/></fig></floats-group></article>